BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12(3): 354-362 [PMID: 16489633 DOI: 10.3748/wjg.v12.i3.354] [Cited by in CrossRef: 1071] [Cited by in F6Publishing: 975] [Article Influence: 66.9] [Reference Citation Analysis]
Number Citing Articles
1 Leung WK, Wu M, Kakugawa Y, Kim JJ, Yeoh K, Goh KL, Wu K, Wu D, Sollano J, Kachintorn U, Gotoda T, Lin J, You W, Ng EK, Sung JJ. Screening for gastric cancer in Asia: current evidence and practice. The Lancet Oncology 2008;9:279-87. [DOI: 10.1016/s1470-2045(08)70072-x] [Cited by in Crossref: 533] [Cited by in F6Publishing: 289] [Article Influence: 38.1] [Reference Citation Analysis]
2 Shibasaki S, Suda K, Obama K, Yoshida M, Uyama I. Should robotic gastrectomy become a standard surgical treatment option for gastric cancer? Surg Today. 2019;. [PMID: 31512060 DOI: 10.1007/s00595-019-01875-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
3 Zhou K, Wen F, Zhang P, Zhou J, Chen H, Zheng H, Yang Y, Li Q. Efficacy and cost-effectiveness of second-line chemotherapy in elderly patients with advanced gastric cancer. Clin Transl Oncol 2017;19:1117-24. [DOI: 10.1007/s12094-017-1647-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhao M, Wang Q, Ouyang Z, Han B, Wang W, Wei Y, Wu Y, Yang B. Selective fraction of Atractylodes lancea (Thunb.) DC. and its growth inhibitory effect on human gastric cancer cells. Cytotechnology 2014;66:201-8. [PMID: 23564282 DOI: 10.1007/s10616-013-9559-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
5 Dammann K, Khare V, Gasche C. Tracing PAKs from GI inflammation to cancer. Gut 2014;63:1173-84. [PMID: 24811999 DOI: 10.1136/gutjnl-2014-306768] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
6 Longo F, Jorge M, Yaya R, Montes AF, Lago NM, Brozos E, Aparicio J, Quintero G, Ceballos E, Buxó E, Lopez AM, Pellón ML, Molina R, Diaz-Paniagua L, Cerdà P, Leiva PL, Carnicero AM, Cousillas A, Paris L, García-Paredes B, Romero C, Ortega M, Molero A, la Torre S, Jen MH, Díaz-Cerezo S. Real-life use of ramucirumab in gastric cancer in Spain: the RAMIS study. Future Oncol 2021;17:1777-91. [PMID: 33590772 DOI: 10.2217/fon-2020-1216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhou L, Wu Y, Guo Y, Li Y, Li N, Yang Y, Qin X. Calycosin Enhances Some Chemotherapeutic Drugs Inhibition of Akt Signaling Pathway in Gastric Cells. Cancer Invest 2017;35:289-300. [PMID: 28368679 DOI: 10.1080/07357907.2016.1278226] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
8 Shi J, Yao D, Liu W, Wang N, Lv H, He N, Shi B, Hou P, Ji M. Frequent gene amplification predicts poor prognosis in gastric cancer. Int J Mol Sci. 2012;13:4714-4726. [PMID: 22606006 DOI: 10.3390/ijms13044714] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
9 Shao LJ, Liu SH, Liu FK, Zou Y, Hou HJ, Tian M, Xue FS. Comparison of two supplement oxygen methods during gastroscopy with intravenous propofol anesthesia in obese patients: study protocol for a randomized controlled trial. Trials. 2018;19:602. [PMID: 30382904 DOI: 10.1186/s13063-018-2994-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 So J, Rajnakova A, Chan YH, Tay A, Shah N, Salto-Tellez M, Teh M, Uedo N. Endoscopic tri-modal imaging improves detection of gastric intestinal metaplasia among a high-risk patient population in Singapore. Dig Dis Sci. 2013;58:3566-3575. [PMID: 23996468 DOI: 10.1007/s10620-013-2843-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
11 Amal H, Leja M, Broza YY, Tisch U, Funka K, Liepniece-Karele I, Skapars R, Xu ZQ, Liu H, Haick H. Geographical variation in the exhaled volatile organic compounds. J Breath Res. 2013;7:047102. [PMID: 24184568 DOI: 10.1088/1752-7155/7/4/047102] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
12 Luo JM, Cao FL, Meng C, Lin LJ, Ma SQ, Peng SH, Gao HL, Javidiparsijani S, Wang GR, Zhang ML, Xin JG, Wang YC, Zhang SK. Clinicopathological and molecular characteristics of synchronous gastric adenocarcinoma and gastrointestinal stromal tumors. Sci Rep 2017;7:12890. [PMID: 29018259 DOI: 10.1038/s41598-017-12622-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
13 Murugan RS, Mohan KV, Nagini S. Modulatory effects of black tea polyphenols on rat forestomach carcinogenesis. Toxicol Mech Methods 2007;17:467-74. [PMID: 20020873 DOI: 10.1080/15376510701190797] [Reference Citation Analysis]
14 Yang H, Huang S, Wei Y, Cao S, Pi C, Feng T, Liang J, Zhao L, Ren G. Curcumin Enhances the Anticancer Effect Of 5-fluorouracil against Gastric Cancer through Down-Regulation of COX-2 and NF- κB Signaling Pathways. J Cancer 2017;8:3697-706. [PMID: 29151957 DOI: 10.7150/jca.20196] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 6.6] [Reference Citation Analysis]
15 Ballard DH, Wake N, Witowski J, Rybicki FJ, Sheikh A; RSNA Special Interest Group for 3D Printing Abdominal, Hepatobiliary, and Gastrointestinal Conditions Voting Group. Radiological Society of North America (RSNA) 3D Printing Special Interest Group (SIG) clinical situations for which 3D printing is considered an appropriate representation or extension of data contained in a medical imaging examination: abdominal, hepatobiliary, and gastrointestinal conditions. 3D Print Med 2020;6:13. [PMID: 32514795 DOI: 10.1186/s41205-020-00065-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
16 Hu M, Han C, Guo T, Tian H, Zhan W, Yang J, Jing W, Deng Y, Li X, Ma S, Cai H, Ma Y. Application of da Vinci robot with the"3 + 2" mode in radical gastrectomy for gastric cancer. Medicine (Baltimore) 2020;99:e22988. [PMID: 33181662 DOI: 10.1097/MD.0000000000022988] [Reference Citation Analysis]
17 Buzzoni C, Crocetti E, Guzzinati S, Dal Maso L, Francisci S; AIRTUM Working Group. Cancer incidence and mortality trends from 2003 to 2014 in Italy. Tumori 2019;105:121-37. [PMID: 30917768 DOI: 10.1177/0300891619839844] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
18 Hsu WH, Wu TS, Hsieh MS, Kung YM, Wang YK, Wu JY, Yu FJ, Kuo CH, Su YC, Wang JY, Wu DC, Hu HM. Comparison of Endoscopic Submucosal Dissection Application on Mucosal Tumor and Subepithelial Tumor in stomach. J Cancer 2021;12:765-70. [PMID: 33403034 DOI: 10.7150/jca.47653] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Spolverato G, Kim Y, Ejaz A, Valero V 3rd, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Acher AW, Votanopoulos K, Schmidt C, Cho CS, Maithel SK, Pawlik TM. A multi-institutional analysis of open versus minimally-invasive surgery for gastric adenocarcinoma: results of the US gastric cancer collaborative. J Gastrointest Surg 2014;18:1563-74. [PMID: 24912915 DOI: 10.1007/s11605-014-2562-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
20 Tak Manesh A, Azizi G, Heydari A, Kiaee F, Shaghaghi M, Hossein-khannazer N, Yazdani R, Abolhassani H, Aghamohammadi A. Epidemiology and pathophysiology of malignancy in common variable immunodeficiency? Allergologia et Immunopathologia 2017;45:602-15. [DOI: 10.1016/j.aller.2017.01.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
21 Martinson HA, Shelby NJ, Alberts SR, Olnes MJ. Gastric cancer in Alaska Native people: A cancer health disparity. World J Gastroenterol 2018; 24(25): 2722-2732 [PMID: 29991877 DOI: 10.3748/wjg.v24.i25.2722] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
22 Li RK, Zhao WY, Fang F, Zhuang C, Zhang XX, Yang XM, Jiang SH, Kong FZ, Tu L, Zhang WM, Yang SL, Cao H, Zhang ZG. Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK/Src pathway. J Cancer Res Clin Oncol 2015;141:269-81. [PMID: 25216702 DOI: 10.1007/s00432-014-1823-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
23 Deng N, Liu JW, Sun LP, Xu Q, Duan ZP, Dong NN, Yuan Y. Expression of XPG protein in the development, progression and prognosis of gastric cancer. PLoS One. 2014;9:e108704. [PMID: 25268735 DOI: 10.1371/journal.pone.0108704] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
24 Lee HS, Park CK, Oh E, Erkin ÖC, Jung HS, Cho MH, Kwon MJ, Chae SW, Kim SH, Wang LH, Park MJ, Lee SY, Yang HB, Jia L, Choi YL, Shin YK. Low SP1 expression differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma. PLoS One 2013;8:e55522. [PMID: 23437057 DOI: 10.1371/journal.pone.0055522] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
25 Wang GS, Wang MW, Wu BY, Yang XY, Wang WH, You WD. LINE-1 family member GCRG123 gene is up-regulated in human gastric signet-ring cell carcinoma. World J Gastroenterol 2008; 14(5): 758-763 [PMID: 18205268 DOI: 10.3748/wjg.14.758] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
26 Resende ALDS, Mattos IE, Koifman S. Dieta e câncer gástrico: aspectos históricos associados ao padrão de consumo alimentar no estado do Pará. Rev Nutr 2006;19:511-9. [DOI: 10.1590/s1415-52732006000400010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Ayala G, Flores-Luna L, Hernández-Amaro D, Mendoza-Hernández G, Chihu-Amparán L, Bernal-Sahagún F, Camorlinga M, Lazcano-Ponce E, Torres J. Association of circulating VacA-neutralizing antibodies with gastric cancer and duodenal ulcer. Cancer Causes Control. 2011;22:1425-1434. [PMID: 21779758 DOI: 10.1007/s10552-011-9817-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
28 Liu CJ, Wang YK, Kuo FC, Hsu WH, Yu FJ, Hsieh S, Tai MH, Wu DC, Kuo CH. Helicobacter pylori Infection-Induced Hepatoma-Derived Growth Factor Regulates the Differentiation of Human Mesenchymal Stem Cells to Myofibroblast-Like Cells. Cancers (Basel) 2018;10:E479. [PMID: 30513684 DOI: 10.3390/cancers10120479] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
29 Curado MP, Silva DRME, Oliveira MM, Soares F, Begnami MD, Coimbra FJF, Assumpção PP, de Sant'Ana RO, Demachki S, Dias-Neto E. Disparities in Epidemiological Profile of Gastric Adenocarcinoma in Selected Cities of Brazil. Asian Pac J Cancer Prev 2019;20:2253-8. [PMID: 31450892 DOI: 10.31557/APJCP.2019.20.8.2253] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Liu TS, Wang Y, Chen SY, Sun YH. An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer. Eur J Surg Oncol. 2008;34:1208-1216. [PMID: 18353606 DOI: 10.1016/j.ejso.2008.02.002] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 3.2] [Reference Citation Analysis]
31 Leal MF, Calcagno DQ, Chung J, de Freitas VM, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith MC. Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients. Clin Exp Med 2015;15:415-20. [PMID: 25034653 DOI: 10.1007/s10238-014-0299-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
32 Jafari N, Zargar SJ, Yassa N, Delnavazi MR. Induction of Apoptosis and Cell Cycle Arrest by Dorema Glabrum Root Extracts in a Gastric Adenocarcinoma (AGS) Cell Line. Asian Pac J Cancer Prev 2016;17:5189-93. [PMID: 28124886 DOI: 10.22034/APJCP.2016.17.12.5189] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
33 Emura F, Mejía J, Donneys A, Ricaurte O, Sabbagh L, Giraldo-Cadavid L, Oda I, Saito Y, Osorio C. Therapeutic outcomes of endoscopic submucosal dissection of differentiated early gastric cancer in a Western endoscopy setting (with video). Gastrointest Endosc 2015;82:804-11. [PMID: 25952087 DOI: 10.1016/j.gie.2015.03.1960] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.9] [Reference Citation Analysis]
34 Guo MM, Hu LH, Wang YQ, Chen P, Huang JG, Lu N, He JH, Liao CG. miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1. Med Oncol. 2013;30:542. [PMID: 23529765 DOI: 10.1007/s12032-013-0542-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 5.2] [Reference Citation Analysis]
35 Liu JL, Liang Y, Wang ZN, Zhou X, Xing LL. Cyclooxygenase-2 polymorphisms and susceptibility to gastric carcinoma: A meta-analysis. World J Gastroenterol 2010; 16(43): 5510-5517 [PMID: 21086572 DOI: 10.3748/wjg.v16.i43.5510] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
36 Abreu MR, Vilar E, Arús ER, Mejia JM, Martínez Y, Yasells AA. Trends in digestive cancer mortality, Cuba 1987–2008. European Journal of Public Health 2013;23:164-70. [DOI: 10.1093/eurpub/ckr210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
37 Chen S, Feng X, Li Y, Yuan X, Zhou Z, Chen Y. Efficacy and safety of XELOX and FOLFOX6 adjuvant chemotherapy following radical total gastrectomy. Oncol Lett 2012;3:781-6. [PMID: 22740993 DOI: 10.3892/ol.2012.577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
38 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)60617-6] [Cited by in Crossref: 635] [Cited by in F6Publishing: 407] [Article Influence: 48.8] [Reference Citation Analysis]
39 Kang SY, Hwang D, Shin S, Park J, Kim M, Rahman MDH, Rahman MA, Ko SG, Kim B. Potential of Bioactive Food Components against Gastric Cancer: Insights into Molecular Mechanism and Therapeutic Targets. Cancers (Basel) 2021;13:4502. [PMID: 34572730 DOI: 10.3390/cancers13184502] [Reference Citation Analysis]
40 Yuan XL, Chen L, Zhang TT, Ma YH, Zhou YL, Zhao Y, Wang WW, Dong P, Yu L, Zhang YY, Shen LS. Gastric cancer cells induce human CD4+Foxp3+ regulatory T cells through the production of TGF-β1. World J Gastroenterol 2011; 17(15): 2019-2027 [PMID: 21528082 DOI: 10.3748/wjg.v17.i15.2019] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
41 Riihimäki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. Metastatic spread in patients with gastric cancer. Oncotarget 2016;7:52307-16. [PMID: 27447571 DOI: 10.18632/oncotarget.10740] [Cited by in Crossref: 106] [Cited by in F6Publishing: 106] [Article Influence: 26.5] [Reference Citation Analysis]
42 Lianos GD, Hasemaki N, Glantzounis GK, Mitsis M, Rausei S. Assessing safety and feasibility of 'pure' laparoscopic total gastrectomy for advanced gastric cancer in the West. Review article. Int J Surg. 2018;53:275-278. [PMID: 29602017 DOI: 10.1016/j.ijsu.2018.03.048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
43 Bacanli M, Başaran N, Başaran AA. Lycopene: Is it Beneficial to Human Health as an Antioxidant? Turk J Pharm Sci 2017;14:311-8. [PMID: 32454630 DOI: 10.4274/tjps.43043] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
44 Halajzadeh J, Dana PM, Asemi Z, Mansournia MA, Yousefi B. An insight into the roles of piRNAs and PIWI proteins in the diagnosis and pathogenesis of oral, esophageal, and gastric cancer. Pathol Res Pract 2020;216:153112. [PMID: 32853949 DOI: 10.1016/j.prp.2020.153112] [Reference Citation Analysis]
45 Lordick F. [Novel pharmaceutical treatment approaches for gastric cancer]. Pathologe 2017;38:87-92. [PMID: 28220199 DOI: 10.1007/s00292-017-0272-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
46 Saniee P, Jalili S, Ghadersoltani P, Daliri L, Siavoshi F. Individual hosts carry H. pylori isolates with different cagA features - motifs and copy number. Infect Genet Evol 2021;93:104961. [PMID: 34119688 DOI: 10.1016/j.meegid.2021.104961] [Reference Citation Analysis]
47 Nakauchi M, Uyama I, Suda K, Mahran M, Nakamura T, Shibasaki S, Kikuchi K, Kadoya S, Inaba K. Robotic surgery for the upper gastrointestinal tract: Current status and future perspectives. Asian J Endosc Surg 2017;10:354-63. [PMID: 29076277 DOI: 10.1111/ases.12437] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
48 Kayamba V, Asombang AW, Mudenda V, Lisulo MM, Sinkala E, Mwanamakondo S, Mweemba I, Kelly P. Gastric adenocarcinoma in Zambia: a case-control study of HIV, lifestyle risk factors, and biomarkers of pathogenesis. S Afr Med J 2013;103:255-9. [PMID: 23547703 DOI: 10.7196/samj.6159] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
49 Ha NH, Park DG, Woo BH, Kim DJ, Choi JI, Park BS, Kim YD, Lee JH, Park HR. Porphyromonas gingivalis increases the invasiveness of oral cancer cells by upregulating IL-8 and MMPs. Cytokine. 2016;86:64-72. [PMID: 27468958 DOI: 10.1016/j.cyto.2016.07.013] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
50 Sexton R, Mahdi Z, Chaudhury R, Beydoun R, Aboukameel A, Khan HY, Baloglu E, Senapedis W, Landesman Y, Tesfaye A, Kim S, Philip PA, Azmi AS. Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer. Int J Mol Sci 2019;20:E4826. [PMID: 31569391 DOI: 10.3390/ijms20194826] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
51 Wu C, Han L, Riaz H, Wang S, Cai K, Yang L. The chemopreventive effect of β-cryptoxanthin from mandarin on human stomach cells (BGC-823). Food Chemistry 2013;136:1122-9. [DOI: 10.1016/j.foodchem.2012.09.073] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
52 Moodi M, Tavakoli T, Tahergorabi Z. Crossroad between Obesity and Gastrointestinal Cancers: A Review of Molecular Mechanisms and Interventions. Int J Prev Med 2021;12:18. [PMID: 34084315 DOI: 10.4103/ijpvm.IJPVM_266_20] [Reference Citation Analysis]
53 Chang KK, Cho SJ, Yoon C, Lee JH, Park DJ, Yoon SS. Increased RhoA Activity Predicts Worse Overall Survival in Patients Undergoing Surgical Resection for Lauren Diffuse-Type Gastric Adenocarcinoma. Ann Surg Oncol 2016;23:4238-46. [PMID: 27364501 DOI: 10.1245/s10434-016-5357-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
54 Dudeja V, Habermann EB, Zhong W, Tuttle TM, Vickers SM, Jensen EH, Al-Refaie WB. Guideline recommended gastric cancer care in the elderly: insights into the applicability of cancer trials to real world. Ann Surg Oncol. 2011;18:26-33. [PMID: 20645007 DOI: 10.1245/s10434-010-1215-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
55 Jiang L, Yang KH, Guan QL, Zhao P, Chen Y, Tian JH. Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis. J Surg Oncol. 2013;107:807-814. [PMID: 23512524 DOI: 10.1002/jso.23325] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
56 Aykan N, Idelevich E. The role of UFT in advanced gastric cancer. Annals of Oncology 2008;19:1045-52. [DOI: 10.1093/annonc/mdn024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
57 Zhou L, Guan P, Sun LP, He QC, Yuan Y, Zhou BS. Health economic assessment for screening of gastric cancer in a high risk population in northeastern china. Chin J Cancer Res 2011;23:21-4. [PMID: 23467677 DOI: 10.1007/s11670-011-0021-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
58 Yamamichi N, Hirano C, Shimamoto T, Minatsuki C, Takahashi Y, Nakayama C, Matsuda R, Fujishiro M, Konno-Shimizu M, Kato J. Associated factors of atrophic gastritis diagnosed by double-contrast upper gastrointestinal barium X-ray radiography: a cross-sectional study analyzing 6,901 healthy subjects in Japan. PLoS One. 2014;9:e111359. [PMID: 25343257 DOI: 10.1371/journal.pone.0111359] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
59 Ohtsu A, Shah MA, Van Cutsem E, Rha SY, Sawaki A, Park SR, Lim HY, Yamada Y, Wu J, Langer B, Starnawski M, Kang Y. Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study. JCO 2011;29:3968-76. [DOI: 10.1200/jco.2011.36.2236] [Cited by in Crossref: 733] [Cited by in F6Publishing: 436] [Article Influence: 66.6] [Reference Citation Analysis]
60 Marrelli D, Polom K, de Manzoni G, Morgagni P, Baiocchi GL, Roviello F. Multimodal treatment of gastric cancer in the west: Where are we going? World J Gastroenterol 2015; 21(26): 7954-7969 [PMID: 26185368 DOI: 10.3748/wjg.v21.i26.7954] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
61 Zilberman Y, Sonkusale SR. Microfluidic optoelectronic sensor for salivary diagnostics of stomach cancer. Biosens Bioelectron 2015;67:465-71. [PMID: 25223554 DOI: 10.1016/j.bios.2014.09.006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
62 Zhao XM, Chen J, Yang L, Luo X, Xu LL, Liu DX, Zhai SL, Li P, Wang XR. Association between IRS-2 G1057D polymorphism and risk of gastric cancer. World J Gastrointest Oncol 2012; 4(1): 9-15 [PMID: 22347534 DOI: 10.4251/wjgo.v4.i1.9] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
63 Han X, Zhang JJ, Han ZQ, Zhang HB, Wang ZA. Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB. Cancer Gene Ther 2018;25:300-8. [PMID: 30237418 DOI: 10.1038/s41417-018-0048-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
64 Choi S, Lee JG, Lee AR, Eun CS, Han DS, Park CH. Helicobacter pylori antibody and pepsinogen testing for predicting gastric microbiome abundance. PLoS One 2019;14:e0225961. [PMID: 31800638 DOI: 10.1371/journal.pone.0225961] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
65 Wang H, Jiang Z, Chen H, Wu X, Xiang J, Peng J. MicroRNA-495 Inhibits Gastric Cancer Cell Migration and Invasion Possibly via Targeting High Mobility Group AT-Hook 2 (HMGA2). Med Sci Monit 2017;23:640-8. [PMID: 28159956 DOI: 10.12659/msm.898740] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
66 Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Waraya M, Kawamata H, Nishimiya H, Nakamura K, Watanabe M. Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer. BMC Cancer. 2011;11:122. [PMID: 21466710 DOI: 10.1186/1471-2407-11-122] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
67 Suleyman H, Cadirci E, Albayrak A, Halici Z, Gundogdu C, Hacimuftuoglu A. Occurrence of anticancer activity of prednisolone via adrenalectomy and inhibition of adrenaline in rats. Int J Cancer 2010;126:1740-8. [PMID: 19711350 DOI: 10.1002/ijc.24869] [Reference Citation Analysis]
68 Kim K, Lee KS, Cho HJ, Kim YH, Yang HK, Kim WH, Kang GH. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers. Human Pathology 2014;45:285-93. [DOI: 10.1016/j.humpath.2013.09.004] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 8.5] [Reference Citation Analysis]
69 Balmagambetova SK, Bekmukhambetov YZ, Tulyaeva AB, Iztleuov YM, Smagulova GA, Koyshybaev AK, Urazayev ON, Djussembekov ST, Begunov VV, Kokhreidze I. Gastric Cancer in Aktobe Region of Western Kazakhstan from 2009 to 2018: Incidence Rates, Trends, and Five-Year Survival. Asian Pac J Cancer Prev 2020;21:1645-52. [PMID: 32592359 DOI: 10.31557/APJCP.2020.21.6.1645] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Morita Y, Ikegami K, Goto-Inoue N, Hayasaka T, Zaima N, Tanaka H, Uehara T, Setoguchi T, Sakaguchi T, Igarashi H. Imaging mass spectrometry of gastric carcinoma in formalin-fixed paraffin-embedded tissue microarray. Cancer Sci. 2010;101:267-273. [PMID: 19961487 DOI: 10.1111/j.1349-7006.2009.01384.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 6.1] [Reference Citation Analysis]
71 Kim KH, Kwon HC, Oh SY, Kim SH, Lee S, Kwon KA, Jang JS, Kim MC, Kim SJ, Kim HJ. Clinicopathologic significance of ERCC1, thymidylate synthase and glutathione S-transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-FU and cisplatin chemotherapy. Biomarkers. 2011;16:74-82. [PMID: 21133646 DOI: 10.3109/1354750X.2010.533284] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
72 Attar M, Mansoori M, Shahbazi M. Interleukin-6 Genetic Variation and Susceptibility to Gastric Cancer in an Iranian Population. Asian Pac J Cancer Prev 2017;18:3025-9. [PMID: 29172275 DOI: 10.22034/APJCP.2017.18.11.3025] [Reference Citation Analysis]
73 Moradzadeh R, Anoushirvani AA. Trend of Gastric Cancer Incidence in an Area Located in the Center of Iran: 2009-2014. J Gastrointest Cancer 2020;51:159-64. [PMID: 30911981 DOI: 10.1007/s12029-019-00227-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
74 Xia LZ, Liu Y, Xu XZ, Jiang PC, Ma G, Bu XF, Zhang YJ, Yu F, Xu KS, Li H. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility. World J Gastroenterol 2014; 20(32): 11429-11438 [PMID: 25170232 DOI: 10.3748/wjg.v20.i32.11429] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
75 Zhang X, Zhang X, Sun B, Lu H, Wang D, Yuan X, Huang Z. Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer. Oncol Lett 2014;8:1745-50. [PMID: 25202403 DOI: 10.3892/ol.2014.2410] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
76 Offermans NS, Vermeulen R, Burdorf A, Goldbohm RA, Keszei AP, Peters S, Kauppinen T, Kromhout H, van den Brandt PA. Occupational asbestos exposure and risk of esophageal, gastric and colorectal cancer in the prospective Netherlands Cohort Study: Occupational Asbestos Exposure and Gastrointestinal Tract Tumors. Int J Cancer 2014;135:1970-7. [DOI: 10.1002/ijc.28817] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
77 Spolverato G, Ejaz A, Kim Y, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Votanopoulos K, Acher AW, Jin LX, Hawkins WG, Schmidt C, Kooby DA, Worhunsky D, Saunders N, Cho CS, Levine EA, Maithel SK, Pawlik TM. Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma. Ann Surg. 2015;262:991-998. [PMID: 25563867 DOI: 10.1097/sla.0000000000001040] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
78 Lin CJ, Liao WC, Lin HJ, Hsu YM, Lin CL, Chen YA, Feng CL, Chen CJ, Kao MC, Lai CH, Kao CH. Statins Attenuate Helicobacter pylori CagA Translocation and Reduce Incidence of Gastric Cancer: In Vitro and Population-Based Case-Control Studies. PLoS One 2016;11:e0146432. [PMID: 26730715 DOI: 10.1371/journal.pone.0146432] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
79 Dai ZJ, Gao J, Ji ZZ, Wang XJ, Ren HT, Liu XX, Wu WY, Kang HF, Guan HT. Matrine induces apoptosis in gastric carcinoma cells via alteration of Fas/FasL and activation of caspase-3. J Ethnopharmacol. 2009;123:91-96. [PMID: 19429345 DOI: 10.1016/j.jep.2009.02.022] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 5.8] [Reference Citation Analysis]
80 Silva-fernandes IJDL, da Silva TA, Agnez-lima LF, Ferreira MVP, Rabenhorst SHB. Helicobacter pylori genotype and polymorphisms in DNA repair enzymes: Where do they correlate in gastric cancer?: H. pylori Genotype and Host Polymorphisms. J Surg Oncol 2012;106:448-55. [DOI: 10.1002/jso.23077] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
81 Wang Q, Wen YG, Li DP, Xia J, Zhou CZ, Yan DW, Tang HM, Peng ZH. Upregulated INHBA expression is associated with poor survival in gastric cancer. Med Oncol. 2012;29:77-83. [PMID: 21132402 DOI: 10.1007/s12032-010-9766-y] [Cited by in Crossref: 123] [Cited by in F6Publishing: 125] [Article Influence: 10.3] [Reference Citation Analysis]
82 Dan L, Jian D, Na L, Xiaozhong W. Crosstalk between EGFR and integrin affects invasion and proliferation of gastric cancer cell line, SGC7901. Onco Targets Ther 2012;5:271-7. [PMID: 23109808 DOI: 10.2147/OTT.S35322] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
83 Harrandah AM, Chukkapalli SS, Bhattacharyya I, Progulske-Fox A, Chan EKL. Fusobacteria modulate oral carcinogenesis and promote cancer progression. J Oral Microbiol 2020;13:1849493. [PMID: 33391626 DOI: 10.1080/20002297.2020.1849493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
84 Suda K, Man-I M, Ishida Y, Kawamura Y, Satoh S, Uyama I. Potential advantages of robotic radical gastrectomy for gastric adenocarcinoma in comparison with conventional laparoscopic approach: a single institutional retrospective comparative cohort study. Surg Endosc. 2015;29:673-685. [PMID: 25030478 DOI: 10.1007/s00464-014-3718-0] [Cited by in Crossref: 97] [Cited by in F6Publishing: 88] [Article Influence: 12.1] [Reference Citation Analysis]
85 Hao Y, Peng X, Zhou XD, Cheng L. [Research progress on the relationship between periodontal disease and common malignancies]. Hua Xi Kou Qiang Yi Xue Za Zhi 2019;37:320-4. [PMID: 31218870 DOI: 10.7518/hxkq.2019.03.018] [Reference Citation Analysis]
86 Wang H, Ding Y, Chen Y, Jiang J, Chen Y, Lu J, Kong M, Mo F, Huang Y, Zhao W, Fang P, Chen X, Teng X, Xu N, Lu Y, Yu X, Li Z, Zhang J, Wang H, Bao X, Zhou D, Chi Y, Zhou T, Zhou Z, Chen S, Teng L. A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics. Gastric Cancer 2021. [PMID: 34095982 DOI: 10.1007/s10120-021-01201-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Yang L, Xu JF, Kang Q, Li AQ, Jin P, Wang X, He YQ, Li N, Cheng T, Sheng JQ. Predictive Value of Stemness Factor Sox2 in Gastric Cancer Is Associated with Tumor Location and Stage. PLoS One 2017;12:e0169124. [PMID: 28046028 DOI: 10.1371/journal.pone.0169124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
88 Naito Y, Uchiyama K, Kinoshita Y, Fukudo S, Joh T, Suzuki H, Takahashi S, Ueno F, Fujiwara Y, Arakawa T, Matsumoto T, Hahm KB, Kachintorn U, Syam AF, Rani AA, Sollano JD, Zhu Q. A questionnaire-based survey on screening for gastric and colorectal cancer by physicians in East Asian countries in 2010. Digestion 2012;86:94-106. [PMID: 22846219 DOI: 10.1159/000339342] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
89 Wang M, Bai J, Tan Y, Wang S, Tian Y, Gong W, Zhou Y, Gao Y, Zhou J, Zhang Z. Genetic variant in PSCA predicts survival of diffuse-type gastric cancer in a Chinese population. Int J Cancer 2011;129:1207-13. [PMID: 21064099 DOI: 10.1002/ijc.25740] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
90 Kemi N, Eskuri M, Herva A, Leppänen J, Huhta H, Helminen O, Saarnio J, Karttunen TJ, Kauppila JH. Tumour-stroma ratio and prognosis in gastric adenocarcinoma. Br J Cancer 2018;119:435-9. [PMID: 30057407 DOI: 10.1038/s41416-018-0202-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
91 Remais JV, Zeng G, Li G, Tian L, Engelgau MM. Convergence of non-communicable and infectious diseases in low- and middle-income countries. Int J Epidemiol 2013;42:221-7. [PMID: 23064501 DOI: 10.1093/ije/dys135] [Cited by in Crossref: 104] [Cited by in F6Publishing: 92] [Article Influence: 10.4] [Reference Citation Analysis]
92 García-Pérez J, López-Cima MF, Pérez-Gómez B, Aragonés N, Pollán M, Vidal E, López-Abente G. Mortality due to tumours of the digestive system in towns lying in the vicinity of metal production and processing installations. Sci Total Environ 2010;408:3102-12. [PMID: 20427078 DOI: 10.1016/j.scitotenv.2010.03.051] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
93 Ehrnström RA, Bjursten LM, Ljungberg O, Veress B, Haglund ME, Lindström CG, Andersson T. Dietary supplementation with carbonate increases expression of ornithine decarboxylase and proliferation in gastric mucosa in a rat model of gastric cancer. Int J Cancer 2008;122:727-33. [PMID: 17960625 DOI: 10.1002/ijc.23151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
94 Kim MJ, Kim H. Anticancer Effect of Lycopene in Gastric Carcinogenesis. J Cancer Prev 2015;20:92-6. [PMID: 26151041 DOI: 10.15430/JCP.2015.20.2.92] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
95 Li Y, Li S, Zhou Y, Meng X, Zhang JJ, Xu DP, Li HB. Melatonin for the prevention and treatment of cancer.Oncotarget. 2017;8:39896-39921. [PMID: 28415828 DOI: 10.18632/oncotarget.16379] [Cited by in Crossref: 137] [Cited by in F6Publishing: 125] [Article Influence: 34.3] [Reference Citation Analysis]
96 Ma J, Shen H, Kapesa L, Zeng S. Lauren classification and individualized chemotherapy in gastric cancer. Oncol Lett. 2016;11:2959-2964. [PMID: 27123046 DOI: 10.3892/ol.2016.4337] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 11.5] [Reference Citation Analysis]
97 Renzulli M, Clemente A, Spinelli D, Ierardi AM, Marasco G, Farina D, Brocchi S, Ravaioli M, Pettinari I, Cescon M, Reginelli A, Cappabianca S, Carrafiello G, Golfieri R. Gastric Cancer Staging: Is It Time for Magnetic Resonance Imaging? Cancers (Basel) 2020;12:E1402. [PMID: 32485933 DOI: 10.3390/cancers12061402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
98 Oh DY, Choi KS, Shin HR, Bang YJ. Public awareness of gastric cancer risk factors and disease screening in a high risk region: a population-based study. Cancer Res Treat 2009;41:59-66. [PMID: 19707502 DOI: 10.4143/crt.2009.41.2.59] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
99 Zhao Z, Li Y, Liu S, Fu W. Serum Helicobacter pylori CagA antibody may not be used as a tumor marker for diagnosing gastric cancer in east Asian countries. Tumour Biol. 2014;35:12217-12224. [PMID: 25168369 DOI: 10.1007/s13277-014-2530-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
100 Zhang JZ, Lu HS, Huang CM, Wu XY, Wang C, Guan GX, Zhen JW, Huang HG, Zhang XF. Outcome of palliative total gastrectomy for stage IV proximal gastric cancer. Am J Surg. 2011;202:91-96. [PMID: 21600557 DOI: 10.1016/j.amjsurg.2010.05.014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
101 Jung JJ, Noh S, Jeung HC, Jung M, Kim TS, Noh SH, Roh JK, Chung HC, Rha SY. Chemokine growth-regulated oncogene 1 as a putative biomarker for gastric cancer progression. Cancer Sci. 2010;101:2200-2206. [PMID: 20731665 DOI: 10.1111/j.1349-7006.2010.01666.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
102 Martínez-López JL, Torres J, Camorlinga-Ponce M, Mantilla A, Leal YA, Fuentes-Pananá EM. Evidence of Epstein-Barr virus association with gastric cancer and non-atrophic gastritis. Viruses 2014;6:301-18. [PMID: 24448220 DOI: 10.3390/v6010301] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
103 Thrumurthy SG, Chaudry MA, Chau I, Allum W. Does surgery have a role in managing incurable gastric cancer? Nat Rev Clin Oncol 2015;12:676-82. [PMID: 26260039 DOI: 10.1038/nrclinonc.2015.132] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 7.4] [Reference Citation Analysis]
104 Park CH, Lee JG, Lee AR, Eun CS, Han DS. Network construction of gastric microbiome and organization of microbial modules associated with gastric carcinogenesis. Sci Rep 2019;9:12444. [PMID: 31455798 DOI: 10.1038/s41598-019-48925-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
105 Sunakawa Y, Cao S, Berger MD, Matsusaka S, Yang D, Zhang W, Ning Y, Parekh A, Stremitzer S, Mendez A, Okazaki S, Wakatsuki T, Azuma M, Shimada K, Watanabe M, Koizumi W, Wu AH, Lenz HJ. Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer. Pharmacogenomics J 2017;17:36-41. [PMID: 26503819 DOI: 10.1038/tpj.2015.77] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
106 Jeong O, Jung MR, Park YK, Ryu SY. Clinicopathological Features and Survival of Patients with Gastric Cancer with a Family History: a Large Analysis of 2,736 Patients with Gastric Cancer. J Gastric Cancer 2017;17:162-72. [PMID: 28680721 DOI: 10.5230/jgc.2017.17.e20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
107 Postlewait LM, Squires MH, Kooby DA, Poultsides GA, Weber SM, Bloomston M, Fields RC, Pawlik TM, Votanopoulos KI, Schmidt CR. Preoperative Helicobacter pylori Infection is Associated with Increased Survival After Resection of Gastric Adenocarcinoma. Ann Surg Oncol. 2016;23:1225-1233. [PMID: 26553442 DOI: 10.1245/s10434-015-4953-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
108 Chen S, Chen YB, Li YF, Feng XY, Zhou ZW, Yuan XH, Qian CN. Normal carcinoembryonic antigen indicates benefit from perioperative chemotherapy to gastric carcinoma patients. World J Gastroenterol 2012; 18(29): 3910-3916 [PMID: 22876045 DOI: 10.3748/wjg.v18.i29.3910] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
109 Choi BJ, Lee S, Lee IJ, Park SW, Lee S. Gastric and rectal cancers in workers exposed to asbestos: a case series. Ann Occup Environ Med 2020;32:e4. [PMID: 32082586 DOI: 10.35371/aoem.2020.32.e4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
110 Oommen AM, Somaiya N, Vijayan J, Kumar S, Venkatachalam S, Joshi L. GlycoGAIT: A web database to browse glycogenes and lectins under gastric inflammatory diseases. J Theor Biol 2016;406:93-8. [PMID: 27436239 DOI: 10.1016/j.jtbi.2016.07.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
111 Shi J, Qu YP, Hou P. Pathogenetic mechanisms in gastric cancer. World J Gastroenterol 2014; 20(38): 13804-13819 [PMID: 25320518 DOI: 10.3748/wjg.v20.i38.13804] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
112 Gurzu S, Jung I, Orlowska J, Sugimura H, Kadar Z, Turdean S, Bara T. Hereditary diffuse gastric cancer--An overview. Pathol Res Pract. 2015;211:629-632. [PMID: 26150395 DOI: 10.1016/j.prp.2015.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
113 Zhang Q, Ni Y, Zhi X, Wang J, Li Z, Tang J, Wang L, Wang W, Xu Z. Involvement of APRIL in Helicobacter pylori-related gastric cancer. J Cancer Res Clin Oncol 2021;147:1685-97. [PMID: 33738544 DOI: 10.1007/s00432-021-03574-x] [Reference Citation Analysis]
114 Kozak J, Forma A, Czeczelewski M, Kozyra P, Sitarz E, Radzikowska-Büchner E, Sitarz M, Baj J. Inhibition or Reversal of the Epithelial-Mesenchymal Transition in Gastric Cancer: Pharmacological Approaches. Int J Mol Sci 2020;22:E277. [PMID: 33383973 DOI: 10.3390/ijms22010277] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
115 Soto-Girón MJ, Ospina OE, Massey SE. Elevated levels of adaption in Helicobacter pylori genomes from Japan; a link to higher incidences of gastric cancer? Evol Med Public Health 2015;2015:88-105. [PMID: 25788149 DOI: 10.1093/emph/eov005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
116 Dai XY, He QS, Jing Z, Yuan JQ. Serum uric acid levels and risk of kidney cancer incidence and mortality: A prospective cohort study. Cancer Med 2020;9:5655-61. [PMID: 32537937 DOI: 10.1002/cam4.3214] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Fukuchi M, Ishiguro T, Ogata K, Suzuki O, Kumagai Y, Ishibashi K, Ishida H, Kuwano H, Mochiki E. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer. Ann Surg Oncol 2015;22:3618-24. [PMID: 25663597 DOI: 10.1245/s10434-015-4422-6] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 8.7] [Reference Citation Analysis]
118 Han KH, Hwang IC, Kim S, Bae JM, Kim YW, Ryu KW, Lee JH, Noh JH, Sohn TS, Shin DW, Yun YH. Factors associated with depression in disease-free stomach cancer survivors. J Pain Symptom Manage 2013;46:511-22. [PMID: 23489829 DOI: 10.1016/j.jpainsymman.2012.10.234] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
119 Chen Z, Hu T, Zhu S, Mukaisho K, El-Rifai W, Peng DF. Glutathione peroxidase 7 suppresses cancer cell growth and is hypermethylated in gastric cancer. Oncotarget 2017;8:54345-56. [PMID: 28903346 DOI: 10.18632/oncotarget.17527] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
120 Pascua I, Fernández-Marcelo T, Sánchez-Pernaute A, de Juan C, Head J, Torres-García AJ, Iniesta P. Prognostic value of telomere function in gastric cancers with and without microsatellite instability. Eur J Gastroenterol Hepatol 2015;27:162-9. [PMID: 25486025 DOI: 10.1097/MEG.0000000000000250] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
121 Saralamma VV, Nagappan A, Hong GE, Lee HJ, Yumnam S, Raha S, Heo JD, Lee SJ, Lee WS, Kim EH. Poncirin Induces Apoptosis in AGS Human Gastric Cancer Cells through Extrinsic Apoptotic Pathway by up-Regulation of Fas Ligand. Int J Mol Sci. 2015;16:22676-22691. [PMID: 26393583 DOI: 10.3390/ijms160922676] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
122 Zhang BY, Yuan J, Cui ZS, Li ZW, Li XH, Lu YY. Evaluation of the prognostic value of the metastatic lymph node ratio for gastric cancer. Am J Surg. 2014;207:555-565. [PMID: 24124661 DOI: 10.1016/j.amjsurg.2013.05.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
123 Marrelli D, Morgagni P, de Manzoni G, Coniglio A, Marchet A, Saragoni L, Tiberio G, Roviello F; Italian Research Group for Gastric Cancer (IRGGC). Prognostic value of the 7th AJCC/UICC TNM classification of noncardia gastric cancer: analysis of a large series from specialized Western centers. Ann Surg. 2012;255:486-491. [PMID: 22167003 DOI: 10.1097/sla.0b013e3182389b1a] [Cited by in Crossref: 92] [Cited by in F6Publishing: 62] [Article Influence: 9.2] [Reference Citation Analysis]
124 Harada K, Lopez A, Shanbhag N, Badgwell B, Baba H, Ajani J. Recent advances in the management of gastric adenocarcinoma patients. F1000Res 2018;7:F1000 Faculty Rev-1365. [PMID: 30228868 DOI: 10.12688/f1000research.15133.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
125 Nuñez F, Bravo S, Cruzat F, Montecino M, De Ferrari GV. Wnt/β-catenin signaling enhances cyclooxygenase-2 (COX2) transcriptional activity in gastric cancer cells. PLoS One 2011;6:e18562. [PMID: 21494638 DOI: 10.1371/journal.pone.0018562] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 6.6] [Reference Citation Analysis]
126 Cattelan L, Ghazawi FM, Le M, Lagacé F, Rahme E, Zubarev A, Sasseville D, Litvinov IV, Waschke KA, Netchiporouk E. Geographic and Socioeconomic Disparity of Gastric Cancer Patients in Canada. Curr Oncol 2021;28:2052-64. [PMID: 34071354 DOI: 10.3390/curroncol28030190] [Reference Citation Analysis]
127 Sampaio AM, Balseiro SC, Silva MR, Alarcão A, d'Aguiar MJ, Ferreira T, Carvalho L. Association Between IL-4 and IL-6 Expression Variants and Gastric Cancer Among Portuguese Population. GE Port J Gastroenterol 2015;22:143-52. [PMID: 28868397 DOI: 10.1016/j.jpge.2015.04.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
128 Junli W, Wenjun H, Jinxin L, Legen N, Yesheng W, Fenglian Y. Association of IL-6 polymorphisms with gastric cancer risk: Evidences from a meta-analysis. Cytokine 2012;59:176-83. [DOI: 10.1016/j.cyto.2012.03.032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
129 Yen C, Chiu H, Wu C, Lu Y, Han Y, Shen Y, Venkatakrishnan K, Wang C. Beneficial efficacy of various propolis extracts and their digestive products by in vitro simulated gastrointestinal digestion. LWT 2017;84:281-9. [DOI: 10.1016/j.lwt.2017.05.074] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
130 Filomena A, Saieva C, Lucchetti V, Santacroce F, Falorni P, Francini V, Carrieri P, Zini E, Ridolfi B, Belli P. Gastric cancer surveillance in a high-risk population in tuscany (Central Italy): preliminary results. Digestion. 2011;84:70-77. [PMID: 21494036 DOI: 10.1159/000322689] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
131 Bashash M, Hislop TG, Shah AM, Le N, Brooks-Wilson A, Bajdik CD. The prognostic effect of ethnicity for gastric and esophageal cancer: the population-based experience in British Columbia, Canada. BMC Cancer 2011;11:164. [PMID: 21554722 DOI: 10.1186/1471-2407-11-164] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
132 Tweed T, van Eijden Y, Tegels J, Brenkman H, Ruurda J, van Hillegersberg R, Sosef M, Stoot J. Safety and efficacy of early oral feeding for enhanced recovery following gastrectomy for gastric cancer: A systematic review. Surg Oncol 2019;28:88-95. [PMID: 30851919 DOI: 10.1016/j.suronc.2018.11.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
133 Tamura T, Wakai K, Lin Y, Tamakoshi A, Utada M, Ozasa K, Sugawara Y, Tsuji I, Ono A, Sawada N, Tsugane S, Ito H, Nagata C, Kitamura T, Naito M, Tanaka K, Shimazu T, Mizoue T, Matsuo K, Inoue M; Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Alcohol intake and stomach cancer risk in Japan: A pooled analysis of six cohort studies. Cancer Sci 2021. [PMID: 34689390 DOI: 10.1111/cas.15172] [Reference Citation Analysis]
134 Serrano CA, González CG, Rollan AR, Duarte I, Torres J, Peña AJ, Harris PR. Lack of Diagnostic Utility of Specific Immunoglobulin M in Helicobacter pylori Infection in Children. Journal of Pediatric Gastroenterology & Nutrition 2008;47:612-7. [DOI: 10.1097/mpg.0b013e3181668648] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
135 Kim JH, Pyun J, Lee KJ, Cho SW, Kwack KB. Study on Association between Single Nucleotide Polymorphisms of MMP7 , MMP8 , MMP9 Genes and Development of Gastric Cancer and Lymph Node Metastasis. Korean J Gastroenterol 2011;58:245. [DOI: 10.4166/kjg.2011.58.5.245] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
136 Aznab M, Ahmadi SM, Khazaei S, Ahmadi SM, Khazaei M, Hamdi H. Relationship between the Expression of the Thymidylate Synthase and the Prognosis of Gastric Cancer Patients Treated with Combinational Chemotherapy Regimen Including Fluorouracil, Docetaxel and Cisplatin. Int J Hematol Oncol Stem Cell Res 2020;14:181-7. [PMID: 33024525 DOI: 10.18502/ijhoscr.v14i3.3727] [Reference Citation Analysis]
137 Bernstein H, Bernstein C, Payne CM, Dvorak K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol 2009; 15(27): 3329-3340 [PMID: 19610133 DOI: 10.3748/wjg.15.3329] [Cited by in CrossRef: 154] [Cited by in F6Publishing: 141] [Article Influence: 11.8] [Reference Citation Analysis]
138 Amorim CA, Moreira JP, Rial L, Carneiro AJ, Fogaça HS, Elia C, Luiz RR, de Souza HSP. Ecological study of gastric cancer in Brazil: Geographic and time trend analysis. World J Gastroenterol 2014; 20(17): 5036-5044 [PMID: 24803816 DOI: 10.3748/wjg.v20.i17.5036] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
139 Zhou Y, Zhang Z, Zhang Z, Wu J, Ren D, Yan X, Wang Q, Wang Y, Wang H, Zhang J, Zhu X, Yang Y, Luo C, Guo X, Tang C, Qiao L. A rising trend of gastric cardia cancer in Gansu Province of China. Cancer Lett. 2008;269:18-25. [PMID: 18501504 DOI: 10.1016/j.canlet.2008.04.013] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
140 Yoon JM, Son KY, Eom CS, Durrance D, Park SM. Pre-existing diabetes mellitus increases the risk of gastric cancer: A meta-analysis. World J Gastroenterol 2013; 19(6): 936-945 [PMID: 23429469 DOI: 10.3748/wjg.v19.i6.936] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
141 Wu SY, Ho MH, Chang HM, Hsu KF, Yu JC, Chan DC. Long-term oncologic result of laparoscopic versus open gastrectomy for gastric cancer: a propensity score matching analysis. World J Surg Oncol 2021;19:101. [PMID: 33827601 DOI: 10.1186/s12957-021-02217-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
142 Rohde C, Yamaguchi R, Mukhina S, Sahin U, Itoh K, Türeci Ö. Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma. Jpn J Clin Oncol 2019;49:870-6. [PMID: 31087075 DOI: 10.1093/jjco/hyz068] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
143 Russo F, Linsalata M, Orlando A. Probiotics against neoplastic transformation of gastric mucosa: Effects on cell proliferation and polyamine metabolism. World J Gastroenterol 2014; 20(37): 13258-13272 [PMID: 25309063 DOI: 10.3748/wjg.v20.i37.13258] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
144 Li HQ, Xue H, Yuan H, Wan GY, Zhang XY. Preferences of first-degree relatives of gastric cancer patients for gastric cancer screening: a discrete choice experiment. BMC Cancer 2021;21:959. [PMID: 34445987 DOI: 10.1186/s12885-021-08677-9] [Reference Citation Analysis]
145 Zhang T, Chen YN, Wang Z, Chen JQ, Huang S. Effect of PSCA gene polymorphisms on gastric cancer risk and survival prediction: A meta-analysis. Exp Ther Med. 2012;4:158-164. [PMID: 23060941 DOI: 10.3892/etm.2012.563] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
146 Kim W, Woo HD, Lee J, Choi IJ, Kim YW, Sung J, Kim J. Dietary folate, one-carbon metabolism-related genes, and gastric cancer risk in Korea. Mol Nutr Food Res. 2016;60:337-345. [PMID: 26833750 DOI: 10.1002/mnfr.201500384] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
147 Oliveros-bastidas A, Calcagno-pissarelli MP, Naya M, Ávila-núñez JL, Alonso-amelot ME. Human gastric cancer, Helicobacter pylori and bracken carcinogens: A connecting hypothesis. Medical Hypotheses 2016;88:91-9. [DOI: 10.1016/j.mehy.2015.11.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
148 Lin JT. Screening of gastric cancer: who, when, and how. Clin Gastroenterol Hepatol. 2014;12:135-138. [PMID: 24107396 DOI: 10.1016/j.cgh.2013.09.064] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
149 Lobo DA, Ginestra P, Ceretti E, Miquel TP, Ciurana J. Cancer Cell Direct Bioprinting: A Focused Review. Micromachines (Basel) 2021;12:764. [PMID: 34203530 DOI: 10.3390/mi12070764] [Reference Citation Analysis]
150 Cross AJ, Freedman ND, Ren J, Ward MH, Hollenbeck AR, Schatzkin A, Sinha R, Abnet CC. Meat consumption and risk of esophageal and gastric cancer in a large prospective study. Am J Gastroenterol. 2011;106:432-442. [PMID: 20978481 DOI: 10.1038/ajg.2010.415] [Cited by in Crossref: 96] [Cited by in F6Publishing: 84] [Article Influence: 8.0] [Reference Citation Analysis]
151 Zhu Z, Li F, Zhuang H. Gastric distension by ingesting food is useful in the evaluation of primary gastric cancer by FDG PET. Clin Nucl Med. 2007;32:106-109. [PMID: 17242562 DOI: 10.1097/01.rlu.0000252181.76139.5e] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
152 Jin H, Wu Z, Tan B, Liu Z, Zhang B. CircITGA7 Suppresses Gastric Cancer Progression Through miR-1471/MTDH Axis. Front Cell Dev Biol 2021;9:688970. [PMID: 34504842 DOI: 10.3389/fcell.2021.688970] [Reference Citation Analysis]
153 Ortiz AP, Soto-Salgado M, Calo WA, Tortolero-Luna G, Pérez CM, Romero CJ, Pérez J, Figueroa-Vallés N, Suárez E. Incidence and mortality rates of selected infection-related cancers in Puerto Rico and in the United States. Infect Agent Cancer 2010;5:10. [PMID: 20470399 DOI: 10.1186/1750-9378-5-10] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
154 Yamakoshi Y, Tanaka H, Sakimura C, Deguchi S, Mori T, Tamura T, Toyokawa T, Muguruma K, Hirakawa K, Ohira M. Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer. Int J Oncol 2020;57:171-82. [PMID: 32319601 DOI: 10.3892/ijo.2020.5042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
155 Park H, Ahn JY, Jung HY, Chun JH, Nam K, Lee JH, Jung KW, Kim DH, Choi KD, Song HJ, Lee GH, Kim JH. Can Endoscopic Bleeding Control Improve the Prognosis of Advanced Gastric Cancer Patients?: A Retrospective Case-Control Study. J Clin Gastroenterol 2017;51:599-606. [PMID: 27775963 DOI: 10.1097/MCG.0000000000000717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
156 Shafaghi A, Mansour- Ghanaei F, Joukar F, Nabavi F, Mansour- Ghanaei A, Esrafilian Soltani A. Stage Association of Preoperative Serum Carcinoembryonic Antigen with Gastric Adenocarcinoma in Iranian Patients. Asian Pac J Cancer Prev. 2017;18:2669-2672. [PMID: 29072067 DOI: 10.22034/apjcp.2017.18.10.2669] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
157 Zhou Y, Du WD, Chen G, Ruan J, Xu S, Zhou FS, Zuo XB, Lv ZJ, Zhang XJ. Association analysis of genetic variants in microRNA networks and gastric cancer risk in a Chinese Han population. J Cancer Res Clin Oncol. 2012;138:939-945. [PMID: 22350505 DOI: 10.1007/s00432-012-1164-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
158 Lv L, Liang X, Wu D, Wang F, Zhang Y, Cang H, Deng X, Li M. Is cardia cancer a special type of gastric cancer? A differential analysis of early cardia cancer and non-cardia cancer. J Cancer 2021;12:2385-94. [PMID: 33758614 DOI: 10.7150/jca.51433] [Reference Citation Analysis]
159 Xie F, Luo N, Blackhouse G, Goeree R, Lee HP. Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese. Int J Technol Assess Health Care. 2008;24:87-95. [PMID: 18218173 DOI: 10.1017/s0266462307080117] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
160 Signal V, Sarfati D, Cunningham R, Gurney J, Koea J, Ellison-Loschmann L. Indigenous inequities in the presentation and management of stomach cancer in New Zealand: a country with universal health care coverage. Gastric Cancer 2015;18:571-9. [PMID: 25098927 DOI: 10.1007/s10120-014-0410-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
161 Satolli MA, Buffoni L, Spadi R, Roato I. Gastric cancer: The times they are a-changin’. World J Gastrointest Oncol 2015; 7(11): 303-316 [PMID: 26600930 DOI: 10.4251/wjgo.v7.i11.303] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
162 Guo YD, Wang JH, Lu H, Li XN, Song WW, Zhang XD, Zhang WM. The human epididymis protein 4 acts as a prognostic factor and promotes progression of gastric cancer. Tumour Biol 2015;36:2457-64. [PMID: 25432133 DOI: 10.1007/s13277-014-2858-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
163 Park YM, Kim JH, Baik SJ, Park JJ, Youn YH, Park H. Clinical risk assessment for gastric cancer in asymptomatic population after a health check-up: An individualized consideration of the risk factors. Medicine (Baltimore) 2016;95:e5351. [PMID: 27858920 DOI: 10.1097/MD.0000000000005351] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
164 Li R, Chen W, Wang W, Tian W, Zhang X. Extraction, characterization of Astragalus polysaccharides and its immune modulating activities in rats with gastric cancer. Carbohydrate Polymers 2009;78:738-42. [DOI: 10.1016/j.carbpol.2009.06.005] [Cited by in Crossref: 92] [Cited by in F6Publishing: 58] [Article Influence: 7.1] [Reference Citation Analysis]
165 Motta EV, Lemos M, Costa JC, Banderó-filho VC, Sasse A, Sheridan H, Bastos JK. Galloylquinic acid derivatives from Copaifera langsdorffii leaves display gastroprotective activity. Chemico-Biological Interactions 2017;261:145-55. [DOI: 10.1016/j.cbi.2016.11.028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
166 Khatoon J, Rai RP, Prasad KN. Role of Helicobacter pylori in gastric cancer: Updates. World J Gastrointest Oncol 2016; 8(2): 147-158 [PMID: 26909129 DOI: 10.4251/wjgo.v8.i2.147] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
167 Chen K, Liao QL, Ma ZW, Jin Y, Hua M, Bi J, Huang L. Association of soil arsenic and nickel exposure with cancer mortality rates, a town-scale ecological study in Suzhou, China. Environ Sci Pollut Res Int 2015;22:5395-404. [PMID: 25410308 DOI: 10.1007/s11356-014-3790-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
168 Lee YS, Cho YS, Lee GK, Lee S, Kim YW, Jho S, Kim HM, Hong SH, Hwang JA, Kim SY. Genomic profile analysis of diffuse-type gastric cancers. Genome Biol. 2014;15:R55. [PMID: 24690483 DOI: 10.1186/gb-2014-15-4-r55] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 5.8] [Reference Citation Analysis]
169 Gao Y, Wang Y, Wang X, Zhao C, Wang F, Du J, Zhang H, Shi H, Feng Y, Li D, Yan J, Yao Y, Hu W, Ding R, Zhang M, Wang L, Huang C, Zhang J. miR-335-5p suppresses gastric cancer progression by targeting MAPK10. Cancer Cell Int 2021;21:71. [PMID: 33482821 DOI: 10.1186/s12935-020-01684-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
170 Lehours P, Yilmaz O. Epidemiology of Helicobacter pylori infection. Helicobacter. 2007;12 Suppl 1:1-3. [PMID: 17727452 DOI: 10.1111/j.1523-5378.2007.00541.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
171 Harada K, Mizrak Kaya D, Shimodaira Y, Song S, Baba H, Ajani JA. Translating genomic profiling to gastrointestinal cancer treatment. Future Oncol 2017;13:919-34. [PMID: 28067073 DOI: 10.2217/fon-2016-0422] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
172 Mokadem I, Dijksterhuis WPM, van Putten M, Heuthorst L, de Vos-Geelen JM, Haj Mohammad N, Nieuwenhuijzen GAP, van Laarhoven HWM, Verhoeven RHA. Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study. Gastric Cancer. 2019;. [PMID: 30949777 DOI: 10.1007/s10120-019-00956-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
173 Wang XQ, Terry PD, Yan H. Review of salt consumption and stomach cancer risk: Epidemiological and biological evidence. World J Gastroenterol 2009; 15(18): 2204-2213 [PMID: 19437559 DOI: 10.3748/wjg.15.2204] [Cited by in CrossRef: 96] [Cited by in F6Publishing: 89] [Article Influence: 7.4] [Reference Citation Analysis]
174 Wang J, Chen X, Li P, Su L, Yu B, Cai Q, Li J, Yu Y, Liu B, Zhu Z. CRKL promotes cell proliferation in gastric cancer and is negatively regulated by miR-126. Chemico-Biological Interactions 2013;206:230-8. [DOI: 10.1016/j.cbi.2013.09.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
175 Schulpen M, Peeters PH, van den Brandt PA. Mediterranean diet adherence and risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study. Gastric Cancer 2019;22:663-74. [PMID: 30771119 DOI: 10.1007/s10120-019-00927-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
176 Khalili M, Vasei M, Khalili D, Alimoghaddam K, Sadeghizadeh M, Mowla SJ. Downregulation of the Genes Involved in Reprogramming (SOX2, c-MYC, miR-302, miR-145, and P21) in Gastric Adenocarcinoma. J Gastrointest Cancer 2015;46:251-8. [PMID: 25904219 DOI: 10.1007/s12029-015-9695-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
177 Zhang L, Hou Y, Li N, Wu K, Zhai J. The influence of TXNDC5 gene on gastric cancer cell. J Cancer Res Clin Oncol 2010;136:1497-505. [PMID: 20157732 DOI: 10.1007/s00432-010-0807-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
178 Hu Y, Yoon SS. Extent of gastrectomy and lymphadenectomy for gastric adenocarcinoma. Surg Oncol 2021;40:101689. [PMID: 34839198 DOI: 10.1016/j.suronc.2021.101689] [Reference Citation Analysis]
179 Yoo J, Kim S, Hwang J, Hong S, Shin A, Choi IJ, Lee Y. Association Study between Folate Pathway Gene Single Nucleotide Polymorphisms and Gastric Cancer in Koreans. Genomics Inform 2012;10:184. [DOI: 10.5808/gi.2012.10.3.184] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
180 Wang Q, Chen Y, Zhang Y, Xu W, He H, Li X, Cui H. Quantitative assessment of the influence of glutathione S-transferase T1 null variant on gastric cancer risk. Tumour Biol 2014;35:849-58. [PMID: 23979980 DOI: 10.1007/s13277-013-1118-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
181 Gorini G, Giovannetti L, Masala G, Chellini E, Martini A, Mallone S, Costantini AS. Gastric Cancer Mortality Trends in Tuscany, Italy, 1971–2004. Tumori 2008;94:787-92. [DOI: 10.1177/030089160809400602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
182 Yousuf H, Saleem HMK, Maan MAA, Chaudhary NA. Atypical Presentation of Gastric Cancer Approached Via Retrograde Single Balloon Enteroscopy. Cureus 2018;10:e3249. [PMID: 30416900 DOI: 10.7759/cureus.3249] [Reference Citation Analysis]
183 Sjödahl K, Jansson C, Bergdahl IA, Adami J, Boffetta P, Lagergren J. Airborne exposures and risk of gastric cancer: A prospective cohort study. Int J Cancer 2007;120:2013-8. [DOI: 10.1002/ijc.22566] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
184 Jiang J, Shen S, Dong N, Liu J, Xu Q, Sun L, Yuan Y. Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases. Cancer Med 2018;7:4068-76. [PMID: 29963765 DOI: 10.1002/cam4.1615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
185 Marqués-Lespier JM, González-Pons M, Cruz-Correa M. Current Perspectives on Gastric Cancer. Gastroenterol Clin North Am 2016;45:413-28. [PMID: 27546840 DOI: 10.1016/j.gtc.2016.04.002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 11.8] [Reference Citation Analysis]
186 Sun QH, Zhang J, Shi YY, Zhang J, Fu WW, Ding SG. Microbiome changes in the gastric mucosa and gastric juice in different histological stages of Helicobacter pylori-negative gastric cancers. World J Gastroenterol 2022; 28(3): 365-380 [DOI: 10.3748/wjg.v28.i3.365] [Reference Citation Analysis]
187 Yi Y, Yu J, Li B, Yang F, Huang W, Sun H, Gong H, Zhou T, Lin H. Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume delineation of regional lymph node in patients with gastric carcinoma. Radiother Oncol 2010;96:223-30. [PMID: 20584555 DOI: 10.1016/j.radonc.2010.04.031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
188 Psaltopoulou T, Ntanasis-stathopoulos I, Tzanninis I, Kantzanou M, Georgiadou D, Sergentanis TN. Physical Activity and Gastric Cancer Risk: A Systematic Review and Meta-Analysis. Clinical Journal of Sport Medicine 2016;26:445-64. [DOI: 10.1097/jsm.0000000000000316] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
189 Pasini FS, Zilberstein B, Snitcovsky I, Roela RA, Mangone FR, Ribeiro U Jr, Nonogaki S, Brito GC, Callegari GD, Cecconello I, Alves VA, Eluf-Neto J, Chammas R, Federico MH. A gene expression profile related to immune dampening in the tumor microenvironment is associated with poor prognosis in gastric adenocarcinoma. J Gastroenterol 2014;49:1453-66. [PMID: 24217965 DOI: 10.1007/s00535-013-0904-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
190 Zhao Y, Wu K, Cai K, Zhai R, Tao K, Wang G, Wang J. Increased numbers of gastric-infiltrating mast cells and regulatory T cells are associated with tumor stage in gastric adenocarcinoma patients. Oncol Lett. 2012;4:755-758. [PMID: 23205096 DOI: 10.3892/ol.2012.830] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
191 You Q, Fang T, Yin X, Wang Y, Yang Y, Zhang L, Xue Y. Serum CD4 Is Associated with the Infiltration of CD4+T Cells in the Tumor Microenvironment of Gastric Cancer. J Immunol Res 2021;2021:6539702. [PMID: 34258299 DOI: 10.1155/2021/6539702] [Reference Citation Analysis]
192 Iwasaki RL, Ishiya K, Kanzawa-Kiriyama H, Kawai Y, Gojobori J, Satta Y. Evolutionary History of the Risk of SNPs for Diffuse-Type Gastric Cancer in the Japanese Population. Genes (Basel) 2020;11:E775. [PMID: 32664326 DOI: 10.3390/genes11070775] [Reference Citation Analysis]
193 Sakamoto N, Oue N, Sentani K, Anami K, Uraoka N, Naito Y, Oo HZ, Hinoi T, Ohdan H, Yanagihara K. Liver-intestine cadherin induction by epidermal growth factor receptor is associated with intestinal differentiation of gastric cancer. Cancer Sci. 2012;103:1744-1750. [PMID: 22676223 DOI: 10.1111/j.1349-7006.2012.02353.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
194 Kim M, Chang J, Kim WJ, Banerjee S, Park SM. Cumulative Dose Threshold for the Chemopreventive Effect of Aspirin Against Gastric Cancer: . American Journal of Gastroenterology 2018;113:845-54. [DOI: 10.14309/00000434-201806000-00015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
195 Thomassen I, van Gestel YR, van Ramshorst B, Luyer MD, Bosscha K, Nienhuijs SW, Lemmens VE, de Hingh IH. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer 2014;134:622-8. [PMID: 23832847 DOI: 10.1002/ijc.28373] [Cited by in Crossref: 199] [Cited by in F6Publishing: 199] [Article Influence: 22.1] [Reference Citation Analysis]
196 Signal V, Gurney J, Inns S, Mcleod M, Sika-paotonu D, Sowerbutts S, Teng A, Sarfati D. Helicobacter pylori , stomach cancer and its prevention in New Zealand. Journal of the Royal Society of New Zealand 2020;50:397-417. [DOI: 10.1080/03036758.2019.1650081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
197 Lordick F, Janjigian YY. Clinical impact of tumour biology in the management of gastroesophageal cancer. Nat Rev Clin Oncol. 2016;13:348-360. [PMID: 26925958 DOI: 10.1038/nrclinonc.2016.15] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 12.8] [Reference Citation Analysis]
198 Kim SH, Lee HJ, Park JH, Choi JH, Park SH, Choe HN, Oh SY, Suh YS, Kong SH, Park DJ, Yang HK. Proposal of a New TNM Classification for Gastric Cancer: Focusing on pN3b and Cytology-Positive (CY1) Disease. J Gastric Cancer 2019;19:329-43. [PMID: 31598375 DOI: 10.5230/jgc.2019.19.e33] [Reference Citation Analysis]
199 Melkonian SC, Pete D, Jim MA, Haverkamp D, Wiggins CL, Bruce MG, White MC. Gastric Cancer Among American Indian and Alaska Native Populations in the United States, 2005-2016. Am J Gastroenterol 2020;115:1989-97. [PMID: 32740090 DOI: 10.14309/ajg.0000000000000748] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
200 Mocellin S, Verdi D, Pooley KA, Nitti D. Genetic variation and gastric cancer risk: a field synopsis and meta-analysis. Gut. 2015;64:1209-1219. [PMID: 25731870 DOI: 10.1136/gutjnl-2015-309168] [Cited by in Crossref: 106] [Cited by in F6Publishing: 113] [Article Influence: 15.1] [Reference Citation Analysis]
201 Konstantoudakis G, Florou D, Mavridis K, Papadopoulos IN, Scorilas A. Kallikrein-related peptidase 13 (KLK13) gene expressional status contributes significantly in the prognosis of primary gastric carcinomas. Clin Biochem. 2010;43:1205-1211. [PMID: 20678496 DOI: 10.1016/j.clinbiochem.2010.07.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
202 Tatsumi Y, Harada A, Matsumoto T, Tani T, Nishida H. Feasibility and tolerance of 2-way and 4-way angulation videoscopes for unsedated patients undergoing transnasal EGD in GI cancer screening. Gastrointest Endosc. 2008;67:1021-1027. [PMID: 18279865 DOI: 10.1016/j.gie.2007.10.030] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
203 Qie YY, Xue XF, Wang XG, Dang SC. Application of artificial intelligence in the diagnosis and prediction of gastric cancer. Artif Intell Gastroenterol 2020; 1(1): 12-18 [DOI: 10.35712/aig.v1.i1.12] [Reference Citation Analysis]
204 Cambruzzi E, Azeredo AM, Kronhart A, Foltz KM, Zettler CG, Pêgas KL. The presence of metastases in regional lymph nodes is associated with tumor size and depth of invasion in sporadic gastric adenocarcinoma. Arq Bras Cir Dig 2014;27:18-21. [PMID: 24676292 DOI: 10.1590/s0102-67202014000100005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
205 Gunassekaran G, Kalpana Deepa Priya D, Gayathri R, Sakthisekaran D. In vitro and in vivo studies on antitumor effects of gossypol on human stomach adenocarcinoma (AGS) cell line and MNNG induced experimental gastric cancer. Biochemical and Biophysical Research Communications 2011;411:661-6. [DOI: 10.1016/j.bbrc.2011.06.167] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
206 Zhou DD, Liu XF, Lu CW, Pant OP, Liu XD. Long non-coding RNA PVT1: Emerging biomarker in digestive system cancer. Cell Prolif. 2017;50. [PMID: 29027279 DOI: 10.1111/cpr.12398] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 7.4] [Reference Citation Analysis]
207 Mocellin S, Marchet A, Nitti D. EUS for the staging of gastric cancer: a meta-analysis. Gastrointest Endosc. 2011;73:1122-1134. [PMID: 21444080 DOI: 10.1016/j.gie.2011.01.030] [Cited by in Crossref: 74] [Cited by in F6Publishing: 64] [Article Influence: 6.7] [Reference Citation Analysis]
208 Moschetta M, Scardapane A, Telegrafo M, Lorusso V, Angelelli G, Stabile Ianora AA. Differential diagnosis between benign and malignant ulcers: 320-row CT virtual gastroscopy. Abdom Imaging. 2012;37:1066-1073. [PMID: 22289996 DOI: 10.1007/s00261-012-9849-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
209 Steffen JS, Simon E, Warneke V, Balschun K, Ebert M, Röcken C. LGR4 and LGR6 are differentially expressed and of putative tumor biological significance in gastric carcinoma. Virchows Arch 2012;461:355-65. [PMID: 22855134 DOI: 10.1007/s00428-012-1292-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
210 Cao Y, Xiong JB, Zhang GY, Liu Y, Jie ZG, Li ZR. Long Noncoding RNA UCA1 Regulates PRL-3 Expression by Sponging MicroRNA-495 to Promote the Progression of Gastric Cancer. Mol Ther Nucleic Acids 2020;19:853-64. [PMID: 31982772 DOI: 10.1016/j.omtn.2019.10.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
211 Gotoda T, Uedo N, Yoshinaga S, Tanuma T, Morita Y, Doyama H, Aso A, Hirasawa T, Yano T, Uchita K, Ho SH, Hsieh PH. Basic principles and practice of gastric cancer screening using high-definition white-light gastroscopy: Eyes can only see what the brain knows. Dig Endosc. 2016;28 Suppl 1:2-15. [PMID: 26836611 DOI: 10.1111/den.12623] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 4.2] [Reference Citation Analysis]
212 Nam S, Lee J, Goh SH, Hong SH, Song N, Jang SG, Choi IJ, Lee YS. Differential gene expression pattern in early gastric cancer by an integrative systematic approach. Int J Oncol 2012;41:1675-82. [PMID: 22961301 DOI: 10.3892/ijo.2012.1621] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
213 Dhalla F, da Silva SP, Lucas M, Travis S, Chapel H. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol. 2011;165:1-7. [PMID: 21470209 DOI: 10.1111/j.1365-2249.2011.04384.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 5.7] [Reference Citation Analysis]
214 Minarikova P, Benesova L, Halkova T, Belsanova B, Tuckova I, Belina F, Dusek L, Zavoral M, Minarik M. Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric Cancers. Gastroenterol Res Pract 2016;2016:9408190. [PMID: 27781065 DOI: 10.1155/2016/9408190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
215 Murugan RS, Mohan KV, Uchida K, Hara Y, Prathiba D, Nagini S. Modulatory effects of black tea polyphenols on oxidant-antioxidant profile and expression of proliferation, apoptosis, and angiogenesis-associated proteins in the rat forestomach carcinogenesis model. J Gastroenterol. 2007;42:352-361. [PMID: 17530359 DOI: 10.1007/s00535-007-2018-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
216 Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol. 2009;472:467-477. [PMID: 19107449 DOI: 10.1007/978-1-60327-492-0_23] [Cited by in Crossref: 346] [Cited by in F6Publishing: 325] [Article Influence: 26.6] [Reference Citation Analysis]
217 Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev. 2009;18:1945-1952. [PMID: 19531677 DOI: 10.1158/1055-9965.epi-09-0250] [Cited by in Crossref: 120] [Cited by in F6Publishing: 66] [Article Influence: 9.2] [Reference Citation Analysis]
218 Kim HJ, Kim YJ, Seo SI, Shin WG, Park CH. Impact of the timing of Helicobacter pylori eradication on the risk of development of metachronous lesions after treatment of early gastric cancer: a population-based cohort study. Gastrointestinal Endoscopy 2020;92:613-622.e1. [DOI: 10.1016/j.gie.2020.05.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
219 Guo LL, Song CH, Wang P, Dai LP, Zhang JY, Wang KJ. Competing endogenous RNA networks and gastric cancer. World J Gastroenterol 2015; 21(41): 11680-11687 [PMID: 26556995 DOI: 10.3748/wjg.v21.i41.11680] [Cited by in CrossRef: 103] [Cited by in F6Publishing: 101] [Article Influence: 14.7] [Reference Citation Analysis]
220 Balmadrid B, Hwang JH. Endoscopic resection of gastric and esophageal cancer. Gastroenterol Rep (Oxf) 2015;3:330-8. [PMID: 26510452 DOI: 10.1093/gastro/gov050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
221 Jackson K, Soutto M, Peng D, Hu T, Marshal D, El-Rifai W. Epigenetic silencing of somatostatin in gastric cancer. Dig Dis Sci 2011;56:125-30. [PMID: 20927589 DOI: 10.1007/s10620-010-1422-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
222 Sturgeon CM, Duffy MJ, Hofmann BR, Lamerz R, Fritsche HA, Gaarenstroom K, Bonfrer J, Ecke TH, Grossman HB, Hayes P, Hoffmann RT, Lerner SP, Löhe F, Louhimo J, Sawczuk I, Taketa K, Diamandis EP; National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem 2010;56:e1-48. [PMID: 20207771 DOI: 10.1373/clinchem.2009.133124] [Cited by in Crossref: 146] [Cited by in F6Publishing: 119] [Article Influence: 12.2] [Reference Citation Analysis]
223 Yamanaka H, Tanaka Y, Takeuchi T, Sugiyama N, Yuasa H, Toyoizumi S, Morishima Y, Hirose T, Zwillich S. Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study. Arthritis Res Ther 2016;18:34. [PMID: 26818974 DOI: 10.1186/s13075-016-0932-2] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 12.7] [Reference Citation Analysis]
224 Wong H, Yau T. Molecular targeted therapies in advanced gastric cancer: does tumor histology matter? Therap Adv Gastroenterol. 2013;6:15-31. [PMID: 23320047 DOI: 10.1177/1756283x12453636] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
225 Kumar P, Sebastian A, Verma K, Dixit R, Kumari S, Singh J, Tiwary SK, Narayan G. mRNA Expression Analysis of E-Cadherin, VEGF, and MMPs in Gastric Cancer: a Pilot Study. Indian J Surg Oncol 2021;12:85-92. [PMID: 33994733 DOI: 10.1007/s13193-020-01096-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
226 Cunningham SC, Schulick RD. Palliative management of gastric cancer. Surg Oncol. 2007;16:267-275. [PMID: 17881220 DOI: 10.1016/j.suronc.2007.08.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
227 Calcagno DQ, Leal MF, Assumpção PP, Smith MAC, Burbano RR. MYC and gastric adenocarcinoma carcinogenesis. World J Gastroenterol 2008; 14(39): 5962-5968 [PMID: 18932273 DOI: 10.3748/wjg.14.5962] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 73] [Article Influence: 5.1] [Reference Citation Analysis]
228 Tsuji T, Nakamori M, Iwahashi M, Nakamura M, Ojima T, Iida T, Katsuda M, Hayata K, Ino Y, Todo T, Yamaue H. An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer. Int J Cancer 2013;132:485-94. [PMID: 22729516 DOI: 10.1002/ijc.27681] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
229 Lu YT, Gunathilake M, Lee J, Choi IJ, Kim YI, Kim J. Riboflavin intake, MTRR genetic polymorphism (rs1532268) and gastric cancer risk in a Korean population: a case-control study. Br J Nutr 2021;:1-8. [PMID: 34078503 DOI: 10.1017/S0007114521001811] [Reference Citation Analysis]
230 Price TJ, Shapiro JD, Segelov E, Karapetis CS, Pavlakis N, Van Cutsem E, Shah MA, Kang YK, Tebbutt NC. Management of advanced gastric cancer. Expert Rev Gastroenterol Hepatol. 2012;6:199-208; quiz 209. [PMID: 22375525 DOI: 10.1586/egh.11.103] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
231 Nelson R, Ko EB, Arrington A, Lee W, Kim J, Garcia-Aguilar J, Kim J. Race and correlations between lymph node number and survival for patients with gastric cancer. J Gastrointest Surg. 2013;17:471-481. [PMID: 23288716 DOI: 10.1007/s11605-012-2125-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
232 Zhou X, Du Y, Xu J, Huang Z, Qiu T, Wang X, Qian J, Zhu W, Liu P. The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage II/III gastric cancer. Tumour Biol. 2014;35:11659-11666. [PMID: 25139101 DOI: 10.1007/s13277-014-2504-x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
233 Geng J, Zhang YW, Huang GC, Chen LB. XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis. World J Gastroenterol 2008; 14(43): 6733-6737 [PMID: 19034980 DOI: 10.3748/wjg.14.6733] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
234 Yang C, Ma X, Liu D, Wang Y, Tang R, Zhu Y, Xu Z, Yang L. Promoter polymorphisms of miR-34b/c are associated with risk of gastric cancer in a Chinese population. Tumour Biol 2014;35:12545-54. [PMID: 25190020 DOI: 10.1007/s13277-014-2574-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
235 Shivappa N, Hébert JR, Ferraroni M, La Vecchia C, Rossi M. Association between Dietary Inflammatory Index and Gastric Cancer Risk in an Italian Case-Control Study. Nutr Cancer 2016;68:1262-8. [PMID: 27636679 DOI: 10.1080/01635581.2016.1224367] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
236 Venkatarame Gowda Saralamma V, Lee HJ, Hong GE, Park HS, Yumnam S, Raha S, Lee WS, Kim EH, Sung NJ, Lee SJ, Heo JD, Kim GS. Korean Scutellaria baicalensis Georgi flavonoid extract induces mitochondrially mediated apoptosis in human gastric cancer AGS cells. Oncol Lett 2017;14:607-14. [PMID: 28693212 DOI: 10.3892/ol.2017.6184] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
237 Ajani JA. Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction: Evolution of the docetaxel, cisplatin, and 5-fluorouracil regimen. Cancer 2008;113:945-55. [DOI: 10.1002/cncr.23661] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
238 Laranjinha J. Translation of Chemical Properties of Polyphenols into Biological Activity with Impact on Human Health. In: Santos-buelga C, Escribano-bailon MT, Lattanzio V, editors. Recent Advances in Polyphenol Research. Oxford: Wiley-Blackwell; 2010. pp. 269-82. [DOI: 10.1002/9781444323375.ch11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
239 Sugoor P, Shah S, Dusane R, Desouza A, Goel M, Shrikhande SV. Proximal gastrectomy versus total gastrectomy for proximal third gastric cancer: total gastrectomy is not always necessary. Langenbecks Arch Surg. 2016;401:687-697. [PMID: 27143021 DOI: 10.1007/s00423-016-1422-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
240 Lu CW, Zhou DD, Xie T, Hao JL, Pant OP, Lu CB, Liu XF. HOXA11 antisense long noncoding RNA (HOXA11-AS): A promising lncRNA in human cancers. Cancer Med. 2018;7:3792-3799. [PMID: 29992790 DOI: 10.1002/cam4.1571] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
241 Amoueian S, Attaranzadeh A, Montazer M. Intratumoral CD68-, CD117-, CD56-, and CD1a-positive immune cells and the survival of Iranian patients with non-metastatic intestinal-type gastric carcinoma. Pathology - Research and Practice 2015;211:326-31. [DOI: 10.1016/j.prp.2014.12.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
242 Zheng P, Wang W, Ji M, Zhu Q, Feng Y, Zhou F, He Q. TMEM119 silencing inhibits cell viability and causes the apoptosis of gastric cancer SGC-7901 cells. Oncol Lett 2018;15:8281-6. [PMID: 30112075 DOI: 10.3892/ol.2018.8358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
243 Dai M, Yuan F, Fu C, Shen G, Hu S, Shen G. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis. PLoS One 2017;12:e0175357. [PMID: 28403178 DOI: 10.1371/journal.pone.0175357] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
244 Qi W, Sun L, Liu N, Zhao S, Lv J, Qiu W. Tetraspanin family identified as the central genes detected in gastric cancer using bioinformatics analysis. Mol Med Rep. 2018;18:3599-3610. [PMID: 30106120 DOI: 10.3892/mmr.2018.9360] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
245 Nam MJ, Oh SJ, Oh CA, Kim DH, Bae YS, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S. Frequency and predictive factors of lymph node metastasis in mucosal cancer. J Gastric Cancer. 2010;10:162-167. [PMID: 22076181 DOI: 10.5230/jgc.2010.10.4.162] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
246 Díaz Del Arco C, Estrada Muñoz L, Ortega Medina L, Chávez Á, Ruiz Adelantado I, García Gómez de Las Heras S, Fernández Aceñero MJ. Update, validation and comparison of three different clinicopathological scores for patients with resected gastric cancer: A western experience. Ann Diagn Pathol 2020;49:151635. [PMID: 32980616 DOI: 10.1016/j.anndiagpath.2020.151635] [Reference Citation Analysis]
247 Tasdemir B, Güzel Y, Komek H, Can C. Evaluation of dual time-point fluorodeoxyglucose PET/computed tomography imaging in gastric cancer. Nucl Med Commun 2020;41:1322-7. [PMID: 32956249 DOI: 10.1097/MNM.0000000000001290] [Reference Citation Analysis]
248 Ribeiro U, Jorge UM, Safatle-Ribeiro AV, Yagi OK, Scapulatempo C, Perez RO, Corbett CE, Alves VA, Zilberstein B, Gama-Rodrigues J. Clinicopathologic and immunohistochemistry characterization of synchronous multiple primary gastric adenocarcinoma. J Gastrointest Surg. 2007;11:233-239. [PMID: 17458592 DOI: 10.1007/s11605-007-0101-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
249 Acikgoz Y, Aktürk Esen S, Ucar G, Dirikoc M, Ergun Y, Bal O, Uncu D. The Comparison of mDCF and mFOLFOX-6 as First-Line Treatment in Metastatic Gastric Cancer. Cureus 2021;13:e14882. [PMID: 34104608 DOI: 10.7759/cureus.14882] [Reference Citation Analysis]
250 Yang JY, Li D, Zhang Y, Guan BX, Gao P, Zhou XC, Zhou CJ. The Expression of MCM7 is a Useful Biomarker in the Early Diagnostic of Gastric Cancer. Pathol Oncol Res 2018;24:367-72. [PMID: 28540486 DOI: 10.1007/s12253-017-0251-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
251 Wang Z, Chen J, Su K, Dong Z. Abdominal drainage versus no drainage post gastrectomy for gastric cancer. Cochrane Database Syst Rev 2011;:CD008788. [PMID: 21833971 DOI: 10.1002/14651858.CD008788.pub2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
252 Byard RW. The complex spectrum of forensic issues arising from obesity. Forensic Sci Med Pathol 2012;8:402-13. [DOI: 10.1007/s12024-012-9322-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 4.2] [Reference Citation Analysis]
253 Luo D, Gao Y, Wang S, Wang M, Wu D, Wang W, Xu M, Zhou J, Gong W, Tan Y, Zhang Z. Genetic variation in PLCE1 is associated with gastric cancer survival in a Chinese population. J Gastroenterol 2011;46:1260-6. [PMID: 21837401 DOI: 10.1007/s00535-011-0445-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
254 Rafi M, Cabral H, Kano MR, Mi P, Iwata C, Yashiro M, Hirakawa K, Miyazono K, Nishiyama N, Kataoka K. Polymeric micelles incorporating (1,2-diaminocyclohexane)platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasis. J Control Release 2012;159:189-96. [PMID: 22326402 DOI: 10.1016/j.jconrel.2012.01.038] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 5.6] [Reference Citation Analysis]
255 Tabatabaiefar MA, Moridnia A. Gastrointestinal Cancers. In: Mehdipour P, editor. Cancer Genetics and Psychotherapy. Cham: Springer International Publishing; 2017. pp. 589-625. [DOI: 10.1007/978-3-319-64550-6_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
256 Kikuste I, Marques-Pereira R, Monteiro-Soares M, Pimentel-Nunes P, Areia M, Leja M, Dinis-Ribeiro M. Systematic review of the diagnosis of gastric premalignant conditions and neoplasia with high-resolution endoscopic technologies. Scand J Gastroenterol. 2013;48:1108-1117. [PMID: 24047392 DOI: 10.3109/00365521.2013.825315] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
257 Cho YJ, Kim JH, Yoon J, Cho SJ, Ko YS, Park JW, Lee HS, Lee HE, Kim WH, Lee BL. Constitutive activation of glycogen synthase kinase-3beta correlates with better prognosis and cyclin-dependent kinase inhibitors in human gastric cancer. BMC Gastroenterol. 2010;10:91. [PMID: 20704706 DOI: 10.1186/1471-230X-10-91] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
258 Hong SW, Jung KH, Lee HS, Son MK, Yan HH, Kang NS, Lee J, Hong SS. SB365, Pulsatilla saponin D, targets c-Met and exerts antiangiogenic and antitumor activities. Carcinogenesis 2013;34:2156-69. [PMID: 23671132 DOI: 10.1093/carcin/bgt159] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
259 Masoudi M, Saadat I, Omidvari S, Saadat M. Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer. Mol Biol Rep. 2009;36:781-784. [PMID: 18398695 DOI: 10.1007/s11033-008-9245-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 3.9] [Reference Citation Analysis]
260 Rudno-Rudzińska J, Donizy P, Frejlich E, Kotulski K, Dzięgiel P, Hałoń A, Kielan W. Lymphangiogenesis in early and advanced gastric cancer: is there any difference? J Gastroenterol Hepatol 2014;29 Suppl 4:107-11. [PMID: 25521742 DOI: 10.1111/jgh.12733] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
261 Hanada K, Graham DY. Helicobacter pylori and the molecular pathogenesis of intestinal-type gastric carcinoma. Expert Rev Anticancer Ther. 2014;14:947-954. [PMID: 24802804 DOI: 10.1586/14737140.2014.911092] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
262 Tong H, Wang Y, Li Y, Liu S, Chi C, Liu D, Guo L, Li E, Wang C. Volatile organic metabolites identify patients with gastric carcinoma, gastric ulcer, or gastritis and control patients. Cancer Cell Int 2017;17:108. [PMID: 29200968 DOI: 10.1186/s12935-017-0475-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
263 Han C, Zhou Y, An Q, Li F, Li D, Zhang X, Yu Z, Zheng L, Duan Z, Kan Q. MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET. Tumour Biol. 2015;Epub ahead of print. [PMID: 25874496 DOI: 10.1007/s13277-015-3358-6] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 6.6] [Reference Citation Analysis]
264 Kaczor-Urbanowicz KE, Martin Carreras-Presas C, Aro K, Tu M, Garcia-Godoy F, Wong DT. Saliva diagnostics - Current views and directions. Exp Biol Med (Maywood) 2017;242:459-72. [PMID: 27903834 DOI: 10.1177/1535370216681550] [Cited by in Crossref: 137] [Cited by in F6Publishing: 112] [Article Influence: 22.8] [Reference Citation Analysis]
265 Sun M, Jin FY, Xia R, Kong R, Li JH, Xu TP, Liu YW, Zhang EB, Liu XH, De W. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. BMC Cancer. 2014;14:319. [PMID: 24884417 DOI: 10.1186/1471-2407-14-319] [Cited by in Crossref: 201] [Cited by in F6Publishing: 209] [Article Influence: 25.1] [Reference Citation Analysis]
266 Frycz BA, Murawa D, Wysocki-Borejsza M, Marciniak R, Murawa P, Drews M, Jagodziński PP. Expression of 17β-hydroxysteroid dehydrogenase type 1 in gastric cancer. Biomed Pharmacother 2013;67:651-7. [PMID: 23916544 DOI: 10.1016/j.biopha.2013.06.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
267 Waziry R, Jawad M, Ballout RA, Al Akel M, Akl EA. The effects of waterpipe tobacco smoking on health outcomes: an updated systematic review and meta-analysis. Int J Epidemiol 2017;46:32-43. [PMID: 27075769 DOI: 10.1093/ije/dyw021] [Cited by in Crossref: 50] [Cited by in F6Publishing: 95] [Article Influence: 12.5] [Reference Citation Analysis]
268 Caglevic C, Silva S, Mahave M, Rolfo C, Gallardo J. The current situation for gastric cancer in Chile. Ecancermedicalscience 2016;10:707. [PMID: 28105078 DOI: 10.3332/ecancer.2016.707] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
269 Harada K, Mizrak Kaya D, Shimodaira Y, Ajani JA. Global chemotherapy development for gastric cancer. Gastric Cancer 2017;20:92-101. [PMID: 27718136 DOI: 10.1007/s10120-016-0655-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
270 Sun P, Xiang JB, Chen ZY. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg. 2009;96:26-33. [PMID: 19016271 DOI: 10.1002/bjs.6408] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 5.4] [Reference Citation Analysis]
271 Chen J, Liu NN, Li JQ, Yang L, Zeng Y, Zhao XM, Xu LL, Luo X, Wang B, Wang XR. Association between ITGA2 C807T polymorphism and gastric cancer risk. World J Gastroenterol 2011; 17(23): 2860-2866 [PMID: 21734795 DOI: 10.3748/wjg.v17.i23.2860] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
272 Wisnieski F, Calcagno DQ, Leal MF, Santos LCD, Gigek CO, Chen ES, Pontes TB, Assumpção PP, Assumpção MB, Demachki S, Burbano RR, Smith MAC. Reference genes for quantitative RT-PCR data in gastric tissues and cell lines. World J Gastroenterol 2013; 19(41): 7121-7128 [PMID: 24222956 DOI: 10.3748/wjg.v19.i41.7121] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
273 Gunji S, Ueda S, Yoshida M, Kanai M, Terajima H, Takabayashi A. Effects of rikkunshito, a kampo medicine, on quality of life after proximal gastrectomy. Journal of Surgical Research 2013;185:575-80. [DOI: 10.1016/j.jss.2013.06.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
274 Chandanos E, Lindblad M, Rubio CA, Jia C, Warner M, Gustafsson JA, Lagergren J. Tamoxifen exposure in relation to gastric adenocarcinoma development. Eur J Cancer. 2008;44:1007-1014. [PMID: 18394879 DOI: 10.1016/j.ejca.2008.02.049] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
275 Uen YH, Lin KY, Sun DP, Liao CC, Hsieh MS, Huang YK, Chen YW, Huang PH, Chen WJ, Tai CC. Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer. J Proteomics. 2013;83:197-213. [PMID: 23541716 DOI: 10.1016/j.jprot.2013.03.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
276 Wang Z, Chen JQ, Cao YF. Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer. World J Gastroenterol 2010; 16(9): 1138-1149 [PMID: 20205287 DOI: 10.3748/wjg.v16.i9.1138] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
277 Park JH, Park J, Choi JK, Lyu J, Bae MG, Lee YG, Bae JB, Park DY, Yang HK, Kim TY, Kim YJ. Identification of DNA methylation changes associated with human gastric cancer. BMC Med Genomics 2011;4:82. [PMID: 22133303 DOI: 10.1186/1755-8794-4-82] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
278 Lomba-Viana R, Dinis-Ribeiro M, Fonseca F, Vieira AS, Bento MJ, Lomba-Viana H. Serum pepsinogen test for early detection of gastric cancer in a European country. Eur J Gastroenterol Hepatol. 2012;24:37-41. [PMID: 21989121 DOI: 10.1097/meg.0b013e32834d0a0a] [Cited by in Crossref: 45] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
279 Turdikulova S, Dalimova D, Abdurakhimov A, Adilov B, Navruzov S, Yusupbekov A, Djuraev M, Abdujapparov S, Egamberdiev D, Mukhamedov R. Association of rs2294008 and rs9297976 Polymorphisms in PSCA Gene with Gastric Cancer Susceptibility in Uzbekistan. Cent Asian J Glob Health 2016;5:227. [PMID: 29138729 DOI: 10.5195/cajgh.2016.227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
280 Oh S, Oh S. Epidemiological and genome-wide association study of gastritis or gastric ulcer in korean populations. Genomics Inform 2014;12:127-33. [PMID: 25317112 DOI: 10.5808/GI.2014.12.3.127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
281 Zhang C, Huang JY, He ZQ, Weng H. Genetic association between interluekin-4 rs2243250 polymorphism and gastric cancer susceptibility: evidence based on a meta-analysis. Onco Targets Ther 2016;9:2403-8. [PMID: 27143935 DOI: 10.2147/OTT.S104181] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
282 Liu F, Li X, Wang C, Cai X, Du Z, Xu H, Li F. Downregulation of p21-activated kinase-1 inhibits the growth of gastric cancer cells involving cyclin B1. Int J Cancer. 2009;125:2511-2519. [PMID: 19610058 DOI: 10.1002/ijc.24588] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
283 Rhee J, Han SW, Oh DY, Im SA, Kim TY, Bang YJ. Clinicopathologic features and clinical outcomes of gastric cancer that initially presents with disseminated intravascular coagulation: a retrospective study. J Gastroenterol Hepatol. 2010;25:1537-1542. [PMID: 20796152 DOI: 10.1111/j.1440-1746.2010.06289.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
284 Shah MA, Khanin R, Tang L, Janjigian YY, Klimstra DS, Gerdes H, Kelsen DP. Molecular classification of gastric cancer: a new paradigm. Clin Cancer Res. 2011;17:2693-2701. [PMID: 21430069 DOI: 10.1158/1078-0432.ccr-10-2203] [Cited by in Crossref: 195] [Cited by in F6Publishing: 122] [Article Influence: 17.7] [Reference Citation Analysis]
285 Lowe KA, Danese MD, Gleeson ML, Langeberg WJ, Ke J, Kelsh MA. Racial and Ethnic Variability in the Prevalence and Incidence of Comorbidities Associated with Gastric Cancer in the United States. J Gastrointest Cancer 2016;47:168-81. [PMID: 26961791 DOI: 10.1007/s12029-016-9809-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
286 Wang S, Kang W, Go MY, Tong JH, Li L, Zhang N, Tao Q, Li X, To KF, Sung JJ, Yu J. Dapper homolog 1 is a novel tumor suppressor in gastric cancer through inhibiting the nuclear factor-κB signaling pathway. Mol Med 2012;18:1402-11. [PMID: 23073659 DOI: 10.2119/molmed.2012.00243] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
287 Park JY, Forman D, Waskito LA, Yamaoka Y, Crabtree JE. Epidemiology of Helicobacter pylori and CagA-Positive Infections and Global Variations in Gastric Cancer. Toxins (Basel). 2018;10:pii: E163. [PMID: 29671784 DOI: 10.3390/toxins10040163] [Cited by in Crossref: 57] [Cited by in F6Publishing: 42] [Article Influence: 14.3] [Reference Citation Analysis]
288 Vogiatzi P, Vindigni C, Roviello F, Renieri A, Giordano A. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J Cell Physiol. 2007;211:287-295. [PMID: 17238139 DOI: 10.1002/jcp.20982] [Cited by in Crossref: 73] [Cited by in F6Publishing: 79] [Article Influence: 4.9] [Reference Citation Analysis]
289 Zhang L, Xu Z, Xu X, Zhang B, Wu H, Wang M, Zhang X, Yang T, Cai J, Yan Y, Mao F, Zhu W, Shao Q, Qian H, Xu W. SALL4, a novel marker for human gastric carcinogenesis and metastasis. Oncogene 2014;33:5491-500. [PMID: 24276240 DOI: 10.1038/onc.2013.495] [Cited by in Crossref: 64] [Cited by in F6Publishing: 71] [Article Influence: 7.1] [Reference Citation Analysis]
290 Leal MF, Chung J, Calcagno DQ, Assumpção PP, Demachki S, da Silva ID, Chammas R, Burbano RR, de Arruda Cardoso Smith M. Differential proteomic analysis of noncardia gastric cancer from individuals of northern Brazil. PLoS One 2012;7:e42255. [PMID: 22860099 DOI: 10.1371/journal.pone.0042255] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
291 Spolverato G, Ejaz A, Kim Y, Squires MH, Poultsides GA, Fields RC, Schmidt C, Weber SM, Votanopoulos K, Maithel SK, Pawlik TM. Use of endoscopic ultrasound in the preoperative staging of gastric cancer: a multi-institutional study of the US gastric cancer collaborative. J Am Coll Surg 2015;220:48-56. [PMID: 25283742 DOI: 10.1016/j.jamcollsurg.2014.06.023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
292 Li H, Yao G, Zhai J, Hu D, Fan Y. LncRNA FTX Promotes Proliferation and Invasion of Gastric Cancer via miR-144/ZFX Axis. Onco Targets Ther 2019;12:11701-13. [PMID: 32021248 DOI: 10.2147/OTT.S220998] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
293 Sun GG, Sheng SH, Jing SW, Hu WN. An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance. Tumor Biol 2014;35:2641-8. [DOI: 10.1007/s13277-013-1347-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
294 Schrader K, Huntsman D. Hereditary diffuse gastric cancer. Cancer Treat Res 2010;155:33-63. [PMID: 20517687 DOI: 10.1007/978-1-4419-6033-7_3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
295 Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB. Dietary prevention of Helicobacter pylori-associated gastric cancer with kimchi. Oncotarget 2015;6:29513-26. [PMID: 26317548 DOI: 10.18632/oncotarget.4897] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
296 Han X, Jiang K, Wang B, Zhou L, Chen X, Li S. Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study. Clin Drug Investig 2015;35:665-73. [DOI: 10.1007/s40261-015-0329-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
297 Park CH, Park JC, Kim EH, Jung DH, Chung H, Shin SK, Lee SK, Lee YC. Learning curve for EUS in gastric cancer T staging by using cumulative sum analysis. Gastrointest Endosc 2015;81:898-905.e1. [PMID: 25442086 DOI: 10.1016/j.gie.2014.08.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
298 Kim CH, Park SM, Kim JJ. The Impact of Preoperative Low Body Mass Index on Postoperative Complications and Long-term Survival Outcomes in Gastric Cancer Patients. J Gastric Cancer 2018;18:274-86. [PMID: 30276004 DOI: 10.5230/jgc.2018.18.e30] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
299 Thiel A, Mrena J, Ristimäki A. Cyclooxygenase-2 and gastric cancer. Cancer Metastasis Rev. 2011;30:387-395. [PMID: 22002749 DOI: 10.1007/s10555-011-9312-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
300 Pyo JH, Lee H, Min B, Lee JH, Choi MG, Lee JH, Sohn TS, Bae JM, Kim KM, Ahn JH, Carriere KC, Kim JJ, Kim S. Long-Term Outcome of Endoscopic Resection vs. Surgery for Early Gastric Cancer: A Non-inferiority-Matched Cohort Study. American Journal of Gastroenterology 2016;111:240-9. [DOI: 10.1038/ajg.2015.427] [Cited by in Crossref: 99] [Cited by in F6Publishing: 99] [Article Influence: 16.5] [Reference Citation Analysis]
301 Dawsey SP, Hollenbeck A, Schatzkin A, Abnet CC. A prospective study of vitamin and mineral supplement use and the risk of upper gastrointestinal cancers. PLoS One 2014;9:e88774. [PMID: 24558423 DOI: 10.1371/journal.pone.0088774] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
302 Jun KH, Gholami S, Song TJ, Au J, Haddad D, Carson J, Chen CH, Mojica K, Zanzonico P, Chen NG, Zhang Q, Szalay A, Fong Y. A novel oncolytic viral therapy and imaging technique for gastric cancer using a genetically engineered vaccinia virus carrying the human sodium iodide symporter. J Exp Clin Cancer Res 2014;33:2. [PMID: 24383569 DOI: 10.1186/1756-9966-33-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
303 Sun Z, Wang ZN, Zhu Z, Xu YY, Xu Y, Huang BJ, Zhu GL, Xu HM. Evaluation of the seventh edition of American Joint Committee on Cancer TNM staging system for gastric cancer: results from a Chinese monoinstitutional study. Ann Surg Oncol. 2012;19:1918-1927. [PMID: 22246426 DOI: 10.1245/s10434-011-2206-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 5.6] [Reference Citation Analysis]
304 Crone SG, Jacobsen A, Federspiel B, Bardram L, Krogh A, Lund AH, Friis-Hansen L. microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer. 2012;11:71. [PMID: 22992343 DOI: 10.1186/1476-4598-11-71] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 6.6] [Reference Citation Analysis]
305 Kim KJ, Lee TH, Cho NY, Yang HK, Kim WH, Kang GH. Differential clinicopathologic features in microsatellite-unstable gastric cancers with and without MLH1 methylation. Hum Pathol. 2013;44:1055-1064. [PMID: 23266441 DOI: 10.1016/j.humpath.2012.09.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
306 Santero M, Pérez-Bracchiglione J, Acosta-Dighero R, Meade AG, Antequera A, Auladell-Rispau A, Quintana MJ, Requeijo C, Rodríguez-Grijalva G, Salas-Gama K, Dorantes-Romandia R, Salazar J, Solà I, Urrútia G, Bonfill Cosp X. Efficacy of systemic oncological treatments in patients with advanced esophageal or gastric cancers at high risk of dying in the middle and short term: an overview of systematic reviews. BMC Cancer 2021;21:712. [PMID: 34134661 DOI: 10.1186/s12885-021-08330-5] [Reference Citation Analysis]
307 Jiang CG, Wang ZN, Sun Z, Liu FN, Yu M, Xu HM. Clinicopathologic characteristics and prognosis of signet ring cell carcinoma of the stomach: results from a Chinese mono-institutional study. J Surg Oncol. 2011;103:700-703. [PMID: 21308685 DOI: 10.1002/jso.21878] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
308 D’Angelo G, Rienzo TD, Ojetti V. Microarray analysis in gastric cancer: A review. World J Gastroenterol 2014; 20(34): 11972-11976 [PMID: 25232233 DOI: 10.3748/wjg.v20.i34.11972] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
309 Dinani A, Desai A, Kohn N, Gutkin E, Nussbaum M, Somnay K. High rates of advanced gastric cancer in community of Flushing, New York. J Gastrointest Cancer 2012;43:44-9. [PMID: 20809397 DOI: 10.1007/s12029-010-9191-7] [Reference Citation Analysis]
310 Zhao D, Xu H, Li K, Sun Z. Prognostic factors for patients after curative resection for proximal gastric cancer. J Huazhong Univ Sci Technolog Med Sci 2010;30:530-5. [PMID: 20714884 DOI: 10.1007/s11596-010-0463-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
311 Oleksenko VV, Efetov SV, Aliev KA. [Spleen-preserving D2 lymphodissection in gastrectomy]. Khirurgiia (Mosk) 2015;:52-8. [PMID: 26978468 DOI: 10.17116/hirurgia20151052-58] [Reference Citation Analysis]
312 Xu S, Zhou Y, Du WD, Chen G, Zhou FS, Schneider M, Ma XL, Xu HY, Zhang XJ. Association of the variant rs2243421 of human DOC-2/DAB2 interactive protein gene (hDAB2IP) with gastric cancer in the Chinese Han population. Gene. 2013;515:200-204. [PMID: 23246699 DOI: 10.1016/j.gene.2012.11.043] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
313 Buommino E, D'Abrosca B, Donnarumma G, Parisi A, Scognamiglio M, Fiorentino A, De Luca A. Evaluation of the antioxidant properties of carexanes in AGS cells transfected with the Helicobacter pylori's protein HspB. Microb Pathog 2017;108:71-7. [PMID: 28479510 DOI: 10.1016/j.micpath.2017.05.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
314 Chen S, Li YF, Feng XY, Zhou ZW, Yuan XH, Chen YB. Significance of palliative gastrectomy for late-stage gastric cancer patients. J Surg Oncol. 2012;106:862-871. [PMID: 22648960 DOI: 10.1002/jso.23158] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
315 Lee SJ, Lee WW, Yoon HJ, Lee HY, Lee KH, Kim YH, Park DJ, Kim HH, So Y, Kim SE. Regional PET/CT after water gastric inflation for evaluating loco-regional disease of gastric cancer. Eur J Radiol 2013;82:935-42. [PMID: 23410909 DOI: 10.1016/j.ejrad.2013.01.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
316 Sun Z, Nussbaum DP, Speicher PJ, Czito BG, Tyler DS, Blazer DG 3rd. Neoadjuvant radiation therapy does not increase perioperative morbidity among patients undergoing gastrectomy for gastric cancer. J Surg Oncol 2015;112:46-50. [PMID: 26179329 DOI: 10.1002/jso.23957] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
317 Pereira C, Medeiros RM, Dinis-ribeiro MJ. Cyclooxygenase polymorphisms in gastric and colorectal carcinogenesis: are conclusive results available?: . European Journal of Gastroenterology & Hepatology 2009;21:76-91. [DOI: 10.1097/meg.0b013e32830ce7ba] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
318 Nagini S. Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol 2012; 4(7): 156-169 [PMID: 22844547 DOI: 10.4251/wjgo.v4.i7.156] [Cited by in CrossRef: 256] [Cited by in F6Publishing: 232] [Article Influence: 25.6] [Reference Citation Analysis]
319 Lynch HT, Kaurah P, Wirtzfeld D, Rubinstein WS, Weissman S, Lynch JF, Grady W, Wiyrick S, Senz J, Huntsman DG. Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy. Cancer. 2008;112:2655-2663. [PMID: 18442100 DOI: 10.1002/cncr.23501] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 3.9] [Reference Citation Analysis]
320 West AC, Jenkins BJ. Investigating the Role of Toll-Like Receptors in Mouse Models of Gastric Cancer. Methods Mol Biol. 2016;1390:427-449. [PMID: 26803643 DOI: 10.1007/978-1-4939-3335-8_25] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
321 Sharma M, Rai P, Rameshbabu CS. Techniques of imaging of nodal stations of gastric cancer by endoscopic ultrasound. Endosc Ultrasound. 2014;3:179-190. [PMID: 25184125 DOI: 10.4103/2303-9027.138793] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
322 de Souza Giusti ACB, de Oliveira Salvador PTC, dos Santos J, Meira KC, Camacho AR, Guimarães RM, Souza DL. Trends and predictions for gastric cancer mortality in Brazil. World J Gastroenterol 2016; 22(28): 6527-6538 [PMID: 27605887 DOI: 10.3748/wjg.v22.i28.6527] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
323 Rerknimitr R, Imraporn B, Klaikeaw N, Ridtitid W, Jutaghokiat S, Ponauthai Y, Kongkam P, Kullavanijaya P. Non-sequential narrow band imaging for targeted biopsy and monitoring of gastric intestinal metaplasia. World J Gastroenterol 2011; 17(10): 1336-1342 [PMID: 21455334 DOI: 10.3748/wjg.v17.i10.1336] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
324 Goudarzi F, Asadi A, Afsharpour M, Jamadi RH. In Vitro Characterization and Evaluation of the Cytotoxicity Effects of Nisin and Nisin-Loaded PLA-PEG-PLA Nanoparticles on Gastrointestinal (AGS and KYSE-30), Hepatic (HepG2) and Blood (K562) Cancer Cell Lines. AAPS PharmSciTech 2018;19:1554-66. [PMID: 29470827 DOI: 10.1208/s12249-018-0969-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
325 Pinto MP, Córdova-Delgado M, Retamal IN, Muñoz-Medel M, Bravo ML, Durán D, Villanueva F, Sanchez C, Acevedo F, Mondaca S, Koch É, Ibañez C, Galindo H, Madrid J, Nervi B, Peña J, Torres J, Owen GI, Corvalán AH, Armisén R, Garrido M. A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability. Cancers (Basel) 2020;12:E1863. [PMID: 32664343 DOI: 10.3390/cancers12071863] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
326 Díaz Pérez JA, García Ramírez CA, Ferreira Bohorquez EJ, Rivero Rendon LA, Olarte Villamizar JM, Orozco Vargas LC. [Evaluation of endoscopic visualisation for identifying premalignant gastric lesions in a Columbian population using histopathology as a reference]. Aten Primaria 2009;41:85-9. [PMID: 19231703 DOI: 10.1016/j.aprim.2008.05.008] [Reference Citation Analysis]
327 Sayed IM, Sahan AZ, Venkova T, Chakraborty A, Mukhopadhyay D, Bimczok D, Beswick EJ, Reyes VE, Pinchuk I, Sahoo D, Ghosh P, Hazra TK, Das S. Helicobacter pylori infection downregulates the DNA glycosylase NEIL2, resulting in increased genome damage and inflammation in gastric epithelial cells. J Biol Chem 2020;295:11082-98. [PMID: 32518160 DOI: 10.1074/jbc.RA119.009981] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 8.5] [Reference Citation Analysis]
328 Aversa JG, Diggs LP, Hagerty BL, Dominguez DA, Ituarte PHG, Hernandez JM, Davis JL, Blakely AM. Multivisceral Resection for Locally Advanced Gastric Cancer. J Gastrointest Surg 2021;25:609-22. [PMID: 32705611 DOI: 10.1007/s11605-020-04719-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
329 Liu H, Merrell DS, Semino-Mora C, Goldman M, Rahman A, Mog S, Dubois A. Diet synergistically affects helicobacter pylori-induced gastric carcinogenesis in nonhuman primates. Gastroenterology. 2009;137:1367-1379.e1-6. [PMID: 19622359 DOI: 10.1053/j.gastro.2009.07.041] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
330 Wu Z, Zhang L, Li N, Sha L, Zhang K. An immunohistochemical study of thioredoxin domain-containing 5 expression in gastric adenocarcinoma. Oncol Lett 2015;9:1154-8. [PMID: 25663872 DOI: 10.3892/ol.2014.2832] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
331 Schlansky B, Sonnenberg A. Epidemiology of noncardia gastric adenocarcinoma in the United States. Am J Gastroenterol. 2011;106:1978-1985. [PMID: 22008896 DOI: 10.1038/ajg.2011.213] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 4.2] [Reference Citation Analysis]
332 Kim J, Pyun JA, Cho SW, Lee K, Kwack K. Lymph node metastasis of gastric cancer is associated with the interaction between poly (ADP-ribose) polymerase 1 and matrix metallopeptidase 2. DNA Cell Biol. 2011;30:1011-1017. [PMID: 21612407 DOI: 10.1089/dna.2011.1250] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
333 Ru GQ, Han Y, Wang W, Chen Y, Wang HJ, Xu WJ, Ma J, Ye M, Chen X, He XL, Győrffy B, Zhao ZS, Huang D. CEACAM6 is a prognostic biomarker and potential therapeutic target for gastric carcinoma. Oncotarget 2017;8:83673-83. [PMID: 29137373 DOI: 10.18632/oncotarget.19415] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
334 Xie F, O'Reilly D, Ferrusi IL, Blackhouse G, Bowen JM, Tarride JE, Goeree R. Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada. J Am Coll Radiol. 2009;6:317-323. [PMID: 19394572 DOI: 10.1016/j.jacr.2009.01.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
335 Xiong B, Ma L, Huang W, Cheng Y, Zhao Q, Liu J. WITHDRAWN: Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: An updated meta-analysis of 12 randomized controlled trials. Surg Oncol 2014:S0960-7404(14)00097-8. [PMID: 25515042 DOI: 10.1016/j.suronc.2014.11.005] [Reference Citation Analysis]
336 Auyeung KK, Woo PK, Law PC, Ko JK. Astragalus saponins modulate cell invasiveness and angiogenesis in human gastric adenocarcinoma cells. J Ethnopharmacol 2012;141:635-41. [PMID: 21864667 DOI: 10.1016/j.jep.2011.08.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
337 Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S. Gastric adenocarcinoma. Nat Rev Dis Primers. 2017;3:17036. [PMID: 28569272 DOI: 10.1038/nrdp.2017.36] [Cited by in Crossref: 178] [Cited by in F6Publishing: 184] [Article Influence: 35.6] [Reference Citation Analysis]
338 Ribeiro ADA, Nardocci AC. Desigualdades socioeconômicas na incidência e mortalidade por câncer: revisão de estudos ecológicos, 1998-2008. Saude soc 2013;22:878-91. [DOI: 10.1590/s0104-12902013000300020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
339 Mancini S, Ravaioli A, Giuliani O, Giorgetti S, Falcini F, Colamartini A, Bucchi L. Gastric cancer incidence in the Romagna Region of Italy: A spatial and temporal analysis. Dig Liver Dis 2015;47:1076-81. [PMID: 26476476 DOI: 10.1016/j.dld.2015.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
340 Zheng L, Wu C, Xi P, Zhu M, Zhang L, Chen S, Li X, Gu J, Zheng Y. The survival and the long-term trends of patients with gastric cancer in Shanghai, China. BMC Cancer 2014;14:300. [PMID: 24779704 DOI: 10.1186/1471-2407-14-300] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
341 Du F, Sun L, Chu Y, Li T, Lei C, Wang X, Jiang M, Min Y, Lu Y, Zhao X, Nie Y, Fan D. DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways. Cancer Commun (Lond) 2018;38:45. [PMID: 29976242 DOI: 10.1186/s40880-018-0315-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
342 Cho YS, Chung IK, Kim JH, Jung Y, Lee TH, Park SH, Kim SJ. Risk factors of developing interval early gastric cancer after negative endoscopy. Dig Dis Sci. 2015;60:936-943. [PMID: 25316551 DOI: 10.1007/s10620-014-3384-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
343 Chen X, Wang G, Lu X, Gao P, Song Y, Sun J, Li A, Xu Y, Xu H, Wang Z. Polymorphisms and haplotypes of the miR-148/152 family are associated with the risk and clinicopathological features of gastric cancer in a Northern Chinese population. Mutagenesis 2014;29:401-7. [PMID: 25261463 DOI: 10.1093/mutage/geu050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
344 Aznab M, Maleksabet D, Khazaei S, Khazaei M, Rezaei M. The Role of Human Epidermal Growth Factor Receptor (HER2/neu) in the Prognosis of Patients with Gastric Cancer. Asian Pac J Cancer Prev 2019;20:1989-94. [PMID: 31350955 DOI: 10.31557/APJCP.2019.20.7.1989] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
345 Dong L, Li J, Lou XP, Miao JH, Lu P, Chang ZW, Han ZF. Comparison of short-term efficacy and safety of TIROX and DCF regimens for advanced gastric cancer. J Int Med Res. 2014;42:737-743. [PMID: 24717407 DOI: 10.1177/0300060513510657] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
346 Li J, Jin H, Wang X. Epigenetic biomarkers: potential applications in gastrointestinal cancers. ISRN Gastroenterol. 2014;2014:464015. [PMID: 24729878 DOI: 10.1155/2014/464015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
347 Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Kokubo K, Kobayashi H, Kim MS, Sidransky D, Watanabe M. Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer. Oncogene. 2010;29:3263-3275. [PMID: 20228841 DOI: 10.1038/onc.2010.76] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
348 Rosa F, Quero G, Fiorillo C, Bissolati M, Cipollari C, Rausei S, Chiari D, Ruspi L, de Manzoni G, Costamagna G, Doglietto GB, Alfieri S. Total vs proximal gastrectomy for adenocarcinoma of the upper third of the stomach: a propensity-score-matched analysis of a multicenter western experience (On behalf of the Italian Research Group for Gastric Cancer-GIRCG).Gastric Cancer. 2018;21:845-852. [PMID: 29423892 DOI: 10.1007/s10120-018-0804-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
349 Wu W, Chung MC. The gastric fluid proteome as a potential source of gastric cancer biomarkers. J Proteomics. 2013;90:3-13. [PMID: 23665003 DOI: 10.1016/j.jprot.2013.04.035] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
350 Maduekwe UN, Yoon SS. An evidence-based review of the surgical treatment of gastric adenocarcinoma. J Gastrointest Surg 2011;15:730-41. [PMID: 21399886 DOI: 10.1007/s11605-011-1477-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
351 Bashash M, Shah A, Hislop G, Brooks-Wilson A, Le N, Bajdik C. Incidence and survival for gastric and esophageal cancer diagnosed in British Columbia, 1990 to 1999. Can J Gastroenterol 2008;22:143-8. [PMID: 18299732 DOI: 10.1155/2008/645107] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
352 Deng S, Zhang X, Qin Y, Chen W, Fan H, Feng X, Wang J, Yan R, Zhao Y, Cheng Y, Wei Y, Fan X, Ashktorab H, Smoot D, Meltzer SJ, Li S, Li K, Peng Y, Jin Z. miRNA-192 and -215 activate Wnt/β-catenin signaling pathway in gastric cancer via APC. J Cell Physiol 2020;235:6218-29. [PMID: 32091625 DOI: 10.1002/jcp.29550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
353 Bilici A. Treatment options in patients with metastatic gastric cancer: Current status and future perspectives. World J Gastroenterol 2014; 20(14): 3905-3915 [PMID: 24744580 DOI: 10.3748/wjg.v20.i14.3905] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 51] [Article Influence: 6.6] [Reference Citation Analysis]
354 Jaehn P, Holleczek B, Becher H, Winkler V. Histologic types of gastric cancer among migrants from the former Soviet Union and the general population in Germany: what kind of prevention do we need? Eur J Gastroenterol Hepatol 2016;28:863-70. [PMID: 27187801 DOI: 10.1097/MEG.0000000000000645] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
355 Kapoor S, Dharmesh SM. Pectic Oligosaccharide from tomato exhibiting anticancer potential on a gastric cancer cell line: Structure-function relationship. Carbohydrate Polymers 2017;160:52-61. [DOI: 10.1016/j.carbpol.2016.12.046] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 5.2] [Reference Citation Analysis]
356 Huang B, Sun Z, Wang Z, Lu C, Xing C, Zhao B, Xu H. Factors associated with peritoneal metastasis in non-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected database. BMC Cancer. 2013;13:57. [PMID: 23379700 DOI: 10.1186/1471-2407-13-57] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
357 Lin SJ, Gagnon-Bartsch JA, Tan IB, Earle S, Ruff L, Pettinger K, Ylstra B, van Grieken N, Rha SY, Chung HC. Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas. Gut. 2015;64:1721-1731. [PMID: 25385008 DOI: 10.1136/gutjnl-2014-308252] [Cited by in Crossref: 127] [Cited by in F6Publishing: 122] [Article Influence: 15.9] [Reference Citation Analysis]
358 Chevallier JM, Arman GA, Guenzi M, Rau C, Bruzzi M, Beaupel N, Zinzindohoué F, Berger A. One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obes Surg 2015;25:951-8. [PMID: 25585612 DOI: 10.1007/s11695-014-1552-z] [Cited by in Crossref: 150] [Cited by in F6Publishing: 109] [Article Influence: 21.4] [Reference Citation Analysis]
359 Hu K, Wang S, Wang Z, Li L, Huang Z, Yu W, Chen Z, Wu QF. Clinicopathological risk factors for gastric cancer: a retrospective cohort study in China. BMJ Open 2019;9:e030639. [PMID: 31542754 DOI: 10.1136/bmjopen-2019-030639] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
360 Shao L, Li P, Ye J, Chen J, Han Y, Cai J, Lu X. Risk of gastric cancer among patients with gastric intestinal metaplasia. Int J Cancer. 2018;. [PMID: 29707766 DOI: 10.1002/ijc.31571] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
361 Li GQ, Xie J, Lei XY, Zhang L. Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway. World J Gastroenterol 2009; 15(44): 5541-5548 [PMID: 19938192 DOI: 10.3748/wjg.15.5541] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
362 Einama T, Abe H, Shichi S, Matsui H, Kanazawa R, Shibuya K, Suzuki T, Matsuzawa F, Hashimoto T, Kohei N, Homma S, Kawamura H, Taketomi A. Long-term survival and prognosis associated with conversion surgery in patients with metastatic gastric cancer. Mol Clin Oncol 2017;6:163-6. [PMID: 28357085 DOI: 10.3892/mco.2017.1128] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
363 Wang X, Deng H, Zou F, Fu Z, Chen Y, Wang Z, Liu L. ER-α36-mediated gastric cancer cell proliferation via the c-Src pathway. Oncol Lett. 2013;6:329-335. [PMID: 24137325 DOI: 10.3892/ol.2013.1416] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
364 Wang Z, Tang X, Wu X, Yang M, Wang W, Wang L, Tang D, Wang D. Cardamonin exerts anti-gastric cancer activity via inhibiting LncRNA-PVT1-STAT3 axis. Biosci Rep 2019;39:BSR20190357. [PMID: 31028131 DOI: 10.1042/BSR20190357] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
365 Avcı N, Ture M, Deligonul A, Cubukcu E, Olmez OF, Sahinturk S, Topak A, Kurt E, Evrensel T, Şahin AB, Yakut T. Association and Prognostic Significance of the Functional -1562C/T Polymorphism in the Promoter Region of MMP-9 in Turkish Patients with Gastric Cancer. Pathol Oncol Res 2015;21:1243-7. [PMID: 26156886 DOI: 10.1007/s12253-015-9950-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
366 Ge L, Wang HJ, Yin D, Lei C, Zhu JF, Cai XH, Zhang GQ. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: A meta-analysis. World J Gastroenterol 2012; 18(48): 7384-7393 [PMID: 23326149 DOI: 10.3748/wjg.v18.i48.7384] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
367 Kim J, Wang TC. Helicobacter pylori and Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:451-65. [PMID: 34053633 DOI: 10.1016/j.giec.2021.03.003] [Reference Citation Analysis]
368 Menges M, Hoehler T. Neoadjuvant Therapy of Gastric Cancer: A Decisive Step Forward. Gastrointest Tumors 2014;1:99-104. [PMID: 26675677 DOI: 10.1159/000362577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
369 Wang Y, Yu SJ, Li YX, Luo HS. Expression and clinical significance of matrix metalloproteinase-17 and -25 in gastric cancer. Oncol Lett 2015;9:671-6. [PMID: 25621036 DOI: 10.3892/ol.2014.2747] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
370 He X, Sun J, Huang X, Zeng C, Ge Y, Zhang J, Wu J. Comparison of Oral Contrast-Enhanced Transabdominal Ultrasound Imaging With Transverse Contrast-Enhanced Computed Tomography in Preoperative Tumor Staging of Advanced Gastric Carcinoma: Ultrasound in Preoperative Tumor Staging of Advanced Gastric Carcinoma. J Ultrasound Med 2017;36:2485-93. [DOI: 10.1002/jum.14290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
371 Flanagan DJ, Vincan E, Phesse TJ. Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers. Br J Pharmacol 2017;174:4666-83. [PMID: 28568899 DOI: 10.1111/bph.13890] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
372 Kang MY, Jung J, Koo JW, Kim I, Kim HR, Myong JP. Increased risk of gastric cancer in workers with occupational dust exposure. Korean J Intern Med 2021;36:S18-26. [PMID: 32375207 DOI: 10.3904/kjim.2019.421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
373 Nakayama T, Ling ZQ, Mukaisho K, Hattori T, Sugihara H. Lineage analysis of early and advanced tubular adenocarcinomas of the stomach: continuous or discontinuous? BMC Cancer 2010;10:311. [PMID: 20565940 DOI: 10.1186/1471-2407-10-311] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
374 Schizas D, Mastoraki A, Naar L, Tsilimigras DI, Katsaros I, Fragkiadaki V, Karachaliou GS, Arkadopoulos N, Liakakos T, Moris D. Histone Deacetylases (HDACs) in Gastric Cancer: An Update of their Emerging Prognostic and Therapeutic Role. Curr Med Chem 2020;27:6099-111. [PMID: 31309879 DOI: 10.2174/0929867326666190712160842] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
375 Lee HJ, Venkatarame Gowda Saralamma V, Kim SM, Ha SE, Raha S, Lee WS, Kim EH, Lee SJ, Heo JD, Kim GS. Pectolinarigenin Induced Cell Cycle Arrest, Autophagy, and Apoptosis in Gastric Cancer Cell via PI3K/AKT/mTOR Signaling Pathway. Nutrients 2018;10:E1043. [PMID: 30096805 DOI: 10.3390/nu10081043] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
376 Cao LL, Yue Z, Liu L, Pei L, Yin Y, Qin L, Zhao J, Liu H, Wang H, Jia M. The expression of histone deacetylase HDAC1 correlates with the progression and prognosis of gastrointestinal malignancy. Oncotarget 2017;8:39241-53. [PMID: 28424407 DOI: 10.18632/oncotarget.16843] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
377 Pourfarzi F, Whelan A, Kaldor J, Malekzadeh R. The role of diet and other environmental factors in the causation of gastric cancer in Iran--a population based study. Int J Cancer. 2009;125:1953-1960. [PMID: 19569234 DOI: 10.1002/ijc.24499] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 5.8] [Reference Citation Analysis]
378 Khan N, Donohoe CL, Phillips AW, Griffin SM, Reynolds JV. Signet ring gastric and esophageal adenocarcinomas: characteristics and prognostic implications. Dis Esophagus 2020;33:doaa016. [PMID: 32378712 DOI: 10.1093/dote/doaa016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
379 Park B, Shin A, Park SK, Ko KP, Ma SH, Lee EH, Gwack J, Jung EJ, Cho LY, Yang JJ. Ecological study for refrigerator use, salt, vegetable, and fruit intakes, and gastric cancer. Cancer Causes Control. 2011;22:1497-1502. [PMID: 21805052 DOI: 10.1007/s10552-011-9823-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
380 Chen W, Cui Y, Wang J, Yuan Y, Sun X, Zhang L, Shen S, Cheng J. Effects of downregulated expression of microRNA-187 in gastric cancer. Exp Ther Med 2018;16:1061-70. [PMID: 30112051 DOI: 10.3892/etm.2018.6318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
381 Ohta H, Aoyagi K, Fukaya M, Danjoh I, Ohta A, Isohata N, Saeki N, Taniguchi H, Sakamoto H, Shimoda T. Cross talk between hedgehog and epithelial-mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancers. Br J Cancer. 2009;100:389-398. [PMID: 19107131 DOI: 10.1038/sj.bjc.6604846] [Cited by in Crossref: 70] [Cited by in F6Publishing: 72] [Article Influence: 5.0] [Reference Citation Analysis]
382 Engevik AC. The Age of Angiogenesis: A Novel Role of NGF in Gastric Repair. Cell Mol Gastroenterol Hepatol 2018;6:227-8. [PMID: 30105285 DOI: 10.1016/j.jcmgh.2018.06.001] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
383 Mapel D, Roberts M, Overhiser A, Mason A. The epidemiology, diagnosis, and cost of dyspepsia and Helicobacter pylori gastritis: a case-control analysis in the Southwestern United States. Helicobacter. 2013;18:54-65. [PMID: 23067108 DOI: 10.1111/j.1523-5378.2012.00988.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
384 Coupland VH, Lagergren J, Konfortion J, Allum W, Mendall MA, Hardwick RH, Linklater KM, Møller H, Jack RH. Ethnicity in relation to incidence of oesophageal and gastric cancer in England. Br J Cancer. 2012;107:1908-1914. [PMID: 23059745 DOI: 10.1038/bjc.2012.465] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
385 Zhang L, Liu X, Jin H, Guo X, Xia L, Chen Z, Bai M, Liu J, Shang X, Wu K, Pan Y, Fan D. miR-206 inhibits gastric cancer proliferation in part by repressing cyclinD2. Cancer Lett. 2013;332:94-101. [PMID: 23348698 DOI: 10.1016/j.canlet.2013.01.023] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 9.1] [Reference Citation Analysis]
386 Solanki S, Chakinala RC, Haq KF, Khan MA, Kifayat A, Linder K, Khan Z, Mansuri U, Haq KS, Nabors C, Aronow WS. Inpatient burden of gastric cancer in the United States. Ann Transl Med 2019;7:772. [PMID: 32042788 DOI: 10.21037/atm.2019.11.54] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
387 Chen S, Zheng Z, Tang J, Lin X, Wang X, Lin J. Association of polymorphisms and haplotype in the region of TRIT1, MYCL1 and MFSD2A with the risk and clinicopathological features of gastric cancer in a southeast Chinese population. Carcinogenesis 2013;34:1018-24. [PMID: 23349019 DOI: 10.1093/carcin/bgt010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
388 Xie F, Luo N, Lee HP. Cost effectiveness analysis of population-based serology screening and 13C-Urea breath test for Helicobacter pylori to prevent gastric cancer: A markov model. World J Gastroenterol 2008; 14(19): 3021-3027 [PMID: 18494053 DOI: 10.3748/wjg.14.3021] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
389 Wang K, Yang C, Duan L, Yang X, Xia Z, Cui R, Jin Z, Mcnutt M. Changing Pattern of Adenocarcinoma of the Esophagogastric Junction in Recent 10 Years: Experience at a Large Tertiary Medical Center in China. Tumori 2012;98:568-74. [DOI: 10.1177/030089161209800505] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
390 Beda NV, Nedospasov AA. NO-dependent modifications of nucleic acids. Russ J Bioorg Chem 2007;33:181-212. [DOI: 10.1134/s106816200702001x] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
391 Fajardo CA, Quiroga AJ, Coronado A, Labrador K, Acosta N, Delgado P, Jaramillo C, Bravo MM. CagA EPIYA polymorphisms in Colombian Helicobacter pylori strains and their influence on disease-associated cellular responses. World J Gastrointest Oncol 2013; 5(3): 50-59 [PMID: 23671731 DOI: 10.4251/wjgo.v5.i3.50] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
392 Wang XQ, Xiao L, Duan PB, Xu Q, Yang LH, Wang AQ, Wang Y. The feasibility and efficacy of perioperative auricular acupuncture technique via intradermal needle buried for postoperative movement-evoked pain after open radical gastrectomy: A randomized controlled pilot trial. Explore (NY) 2021:S1550-8307(21)00192-0. [PMID: 34642104 DOI: 10.1016/j.explore.2021.09.007] [Reference Citation Analysis]
393 Sano H, Futamura M, Gaowa S, Kamino H, Nakamura Y, Yamaguchi K, Tanaka Y, Yasufuku I, Nakakami A, Arakawa H, Yoshida K. p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers. Biochem Biophys Res Commun 2020;529:582-9. [PMID: 32736677 DOI: 10.1016/j.bbrc.2020.05.168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
394 Danis N, Ozkan AE, Karatas F, Cakici C, Yigitbasi T, Sevencan NO, Kayhan B. The importance of antioxidant status in gastric intestinal metaplasia. J Med Biochem 2021;40:378-83. [PMID: 34616227 DOI: 10.5937/jomb0-29349] [Reference Citation Analysis]
395 Johnson SM, Evers BM. Translational research in gastric malignancy. Surg Oncol Clin N Am 2008;17:323-40, viii. [PMID: 18375355 DOI: 10.1016/j.soc.2008.01.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
396 Jones KR, Whitmire JM, Merrell DS. A Tale of Two Toxins: Helicobacter Pylori CagA and VacA Modulate Host Pathways that Impact Disease. Front Microbiol. 2010;1:115. [PMID: 21687723 DOI: 10.3389/fmicb.2010.00115] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 7.6] [Reference Citation Analysis]
397 Leclerc H. Sur quelques aspects épidémiologiques de l’infection à Helicobacter pylori. Bulletin de l'Académie Nationale de Médecine 2006;190:949-62. [DOI: 10.1016/s0001-4079(19)33277-7] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
398 Kirac I, Sekerija M, Simunović I, Zgaga L, Velimir Vrdoljak D, Kovacević D, Kulis T, Znaor A. Incidence and mortality trends of gastric and colorectal cancers in Croatia, 1988-2008. Croat Med J 2012;53:124-34. [PMID: 22522990 DOI: 10.3325/cmj.2012.53.124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
399 Nissan A, Stojadinovic A, Garofalo A, Esquivel J, Piso P. Evidence-based medicine in the treatment of peritoneal carcinomatosis: Past, present, and future. J Surg Oncol. 2009;100:335-344. [PMID: 19697442 DOI: 10.1002/jso.21323] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
400 Lee JM, Kim SS, Cho YS. The Role of PPARγ in Helicobacter pylori Infection and Gastric Carcinogenesis. PPAR Res 2012;2012:687570. [PMID: 22936949 DOI: 10.1155/2012/687570] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
401 Xu X, Jiang H, Li H, Zhang T, Zhou Q, Liu N. Apoptosis of stomach cancer cell SGC-7901 and regulation of Akt signaling way induced by bovine lactoferrin. Journal of Dairy Science 2010;93:2344-50. [DOI: 10.3168/jds.2009-2926] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
402 Meng YB, Cai XY, Lu WQ, Yang LH, Gan TQ, Drummen GP. Meta-analysis of the association of glutathione S-transferase T1 null/presence gene polymorphism with the risk of gastric carcinoma. Mol Biol Rep 2014;41:639-49. [PMID: 24352702 DOI: 10.1007/s11033-013-2902-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
403 Song HR, Kim HN, Piao JM, Kweon SS, Choi JS, Bae WK, Chung IJ, Park YK, Kim SH, Choi YD, Shin MH. Association of a common genetic variant in prostate stem-cell antigen with gastric cancer susceptibility in a Korean population. Mol Carcinog 2011;50:871-5. [PMID: 21538581 DOI: 10.1002/mc.20796] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
404 Choi YY, Bae JM, An JY, Kwon IG, Cho I, Shin HB, Eiji T, Aburahmah M, Kim HI, Cheong JH. Is microsatellite instability a prognostic marker in gastric cancer? A systematic review with meta-analysis. J Surg Oncol. 2014;110:129-135. [PMID: 24737677 DOI: 10.1002/jso.23618] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 8.5] [Reference Citation Analysis]
405 He Y, Wang Y, Luan F, Yu Z, Feng H, Chen B, Chen W. Chinese and global burdens of gastric cancer from 1990 to 2019. Cancer Med 2021;10:3461-73. [PMID: 33931958 DOI: 10.1002/cam4.3892] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
406 Zhou Y, Liu C, Huang Y. Wireless Power Transfer for Implanted Medical Application: A Review. Energies 2020;13:2837. [DOI: 10.3390/en13112837] [Cited by in Crossref: 13] [Article Influence: 6.5] [Reference Citation Analysis]
407 Hu L, Kong F, Pan Y. Association between IL-17A G197A polymorphism and gastric cancer risk: an updated meta-analysis based on 6,624 cases and 7,631 controls. Onco Targets Ther 2018;11:703-10. [PMID: 29440917 DOI: 10.2147/OTT.S151129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
408 Shah MA. Update on metastatic gastric and esophageal cancers. J Clin Oncol. 2015;33:1760-1769. [PMID: 25918288 DOI: 10.1200/jco.2014.60.1799] [Cited by in Crossref: 104] [Cited by in F6Publishing: 66] [Article Influence: 14.9] [Reference Citation Analysis]
409 Shephard RJ. Cancers of the Esophagus and Stomach: Potential Mechanisms Behind the Beneficial Influence of Physical Activity. Clin J Sport Med 2017;27:415-21. [PMID: 27428674 DOI: 10.1097/JSM.0000000000000353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
410 Yoon SL, Roh YG, Lee SH, Kim SH, Kim MC, Kim SJ, Leem SH. Analysis of promoter methylation and polymorphic minisatellites of BORIS and lack of association with gastric cancer. DNA Cell Biol 2011;30:691-8. [PMID: 21495859 DOI: 10.1089/dna.2011.1248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
411 Song H, Wang T, Tian L, Bai S, Chen L, Zuo Y, Xue Y. Macrophages on the Peritoneum are involved in Gastric Cancer Peritoneal Metastasis. J Cancer 2019;10:5377-87. [PMID: 31632482 DOI: 10.7150/jca.31787] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
412 Dreznik A, Purim O, Idelevich E, Kundel Y, Sulkes J, Sulkes A, Brenner B. Gastric cancer: biology and clinical manifestations in Israel. J Surg Oncol 2012;105:316-22. [PMID: 21882200 DOI: 10.1002/jso.22078] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
413 Chen X, Wang Y, Zang W, Du Y, Li M, Zhao G. miR-194 targets RBX1 gene to modulate proliferation and migration of gastric cancer cells. Tumour Biol. 2015;36:2393-2401. [PMID: 25412959 DOI: 10.1007/s13277-014-2849-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
414 Fujita T, Yanagihara K, Takeshita F, Aoyagi K, Nishimura T, Takigahira M, Chiwaki F, Fukagawa T, Katai H, Ochiya T, Sakamoto H, Konno H, Yoshida T, Sasaki H. Intraperitoneal delivery of a small interfering RNA targeting NEDD1 prolongs the survival of scirrhous gastric cancer model mice. Cancer Sci 2013;104:214-22. [PMID: 23106787 DOI: 10.1111/cas.12054] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
415 Ansari S, Gantuya B, Tuan VP, Yamaoka Y. Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity. Int J Mol Sci 2018;19:E2424. [PMID: 30115886 DOI: 10.3390/ijms19082424] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
416 Rickard J, Beilman G, Forrester J, Sawyer R, Stephen A, Weiser TG, Valenzuela J. Surgical Infections in Low- and Middle-Income Countries: A Global Assessment of the Burden and Management Needs. Surg Infect (Larchmt) 2020;21:478-94. [PMID: 31816263 DOI: 10.1089/sur.2019.142] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
417 Smolińska M, Grzanka D, Antosik P, Kasperska A, Neska-Długosz I, Jóźwicki J, Klimaszewska-Wiśniewska A. HER2, NF-κB, and SATB1 Expression Patterns in Gastric Cancer and Their Correlation with Clinical and Pathological Parameters. Dis Markers 2019;2019:6315936. [PMID: 31737131 DOI: 10.1155/2019/6315936] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
418 Snider JL, Cardelli JA. Helicobacter pylori induces cancer cell motility independent of the c-Met receptor. J Carcinog 2009;8:7. [PMID: 19439912 DOI: 10.4103/1477-3163.50892] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
419 Sunakawa Y, Stremitzer S, Cao S, Zhang W, Yang D, Wakatsuki T, Ning Y, Yamauchi S, Stintzing S, Sebio A, El-Khoueiry R, Matsusaka S, Parekh A, Barzi A, Azuma M, Watanabe M, Koizumi W, Lenz HJ. Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer. Ann Oncol 2015;26:332-9. [PMID: 25411415 DOI: 10.1093/annonc/mdu542] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
420 Okines A, Verheij M, Allum W, Cunningham D, Cervantes A; ESMO Guidelines Working Group. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21 Suppl 5:v50-v54. [PMID: 20555102 DOI: 10.1093/annonc/mdq164] [Cited by in Crossref: 195] [Cited by in F6Publishing: 204] [Article Influence: 16.3] [Reference Citation Analysis]
421 André AR, Ferreira MV, Mota RM, Ferrasi AC, Pardini MI, Rabenhorst SH. Gastric adenocarcinoma and Helicobacter pylori: correlation with p53 mutation and p27 immunoexpression. Cancer Epidemiol 2010;34:618-25. [PMID: 20541486 DOI: 10.1016/j.canep.2010.05.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
422 Zhang Y, Wang M, Gu D, Wu D, Zhang X, Gong W, Tan Y, Zhou J, Wu X, Tang C, Zhang Z, Chen J. Association of XRCC1 gene polymorphisms with the survival and clinicopathological characteristics of gastric cancer. DNA Cell Biol 2013;32:111-8. [PMID: 23425027 DOI: 10.1089/dna.2012.1840] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
423 Golemis EA, Scheet P, Beck TN, Scolnick EM, Hunter DJ, Hawk E, Hopkins N. Molecular mechanisms of the preventable causes of cancer in the United States. Genes Dev 2018;32:868-902. [PMID: 29945886 DOI: 10.1101/gad.314849.118] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]
424 Kim J, Chin H, Jun K. Surgical outcomes and survival after gastrectomy in octogenarians with gastric cancer. Journal of Surgical Research 2015;198:80-6. [DOI: 10.1016/j.jss.2015.05.046] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
425 Luo Z, Zhou L, Balde AI, Li Z, He L, ZhenWei C, Zou Z, Huang S, Han S, Wei Zhou M, Zhang GQ, Cai Z. Prognostic impact of preoperative prognostic nutritional index in resected advanced gastric cancer: A multicenter propensity score analysis. Eur J Surg Oncol 2019;45:425-31. [PMID: 30366877 DOI: 10.1016/j.ejso.2018.09.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
426 Ronellenfitsch U, Kyobutungi C, Ott JJ, Paltiel A, Razum O, Schwarzbach M, Winkler V, Becher H. Stomach cancer mortality in two large cohorts of migrants from the Former Soviet Union to Israel and Germany: are there implications for prevention? Eur J Gastroenterol Hepatol. 2009;21:409-416. [PMID: 19242359 DOI: 10.1097/meg.0b013e3283155220] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
427 Men F, Wei L, Liu B, Wu F, Liu J, Guo N, Niu Q. Comparison of the safety of the application of painless gastroscopy and ordinary gastroscopy in chronic hypertension patients combined with early gastric cancer. Oncol Lett 2018;15:3558-61. [PMID: 29467876 DOI: 10.3892/ol.2018.7737] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
428 Gong W, Zhang L, Yu H, Yu Q, Pan WK, Wang Y, Wu XL, Liu Q. Dihydroartemisinin suppresses the proliferation of Epstein-Barr virus-associated gastric carcinoma cells via downregulation of latent membrane protein 2A. Oncol Lett 2018;16:2613-9. [PMID: 30013656 DOI: 10.3892/ol.2018.8950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
429 Fei X, Lou Z, Christakos G, Ren Z, Liu Q, Lv X. The association between heavy metal soil pollution and stomach cancer: a case study in Hangzhou City, China. Environ Geochem Health 2018;40:2481-90. [DOI: 10.1007/s10653-018-0113-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
430 Nie C, Zhou J, Qin X, Shi X, Zeng Q, Liu J, Yan S, Zhang L. Reduction of apoptosis by proanthocyanidin-induced autophagy in the human gastric cancer cell line MGC-803. Oncol Rep 2016;35:649-58. [PMID: 26572257 DOI: 10.3892/or.2015.4419] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
431 Bryan NS, Alexander DD, Coughlin JR, Milkowski AL, Boffetta P. Ingested nitrate and nitrite and stomach cancer risk: An updated review. Food and Chemical Toxicology 2012;50:3646-65. [DOI: 10.1016/j.fct.2012.07.062] [Cited by in Crossref: 166] [Cited by in F6Publishing: 119] [Article Influence: 16.6] [Reference Citation Analysis]
432 Bae JM, Shin SH, Kwon HJ, Park SY, Kook MC, Kim YW, Cho NY, Kim N, Kim TY, Kim D, Kang GH. ALU and LINE-1 hypomethylations in multistep gastric carcinogenesis and their prognostic implications. Int J Cancer 2012;131:1323-31. [PMID: 22120154 DOI: 10.1002/ijc.27369] [Cited by in F6Publishing: 58] [Reference Citation Analysis]
433 Mulholland HG, Murray LJ, Cardwell CR, Cantwell MM. Glycemic index, glycemic load, and risk of digestive tract neoplasms: a systematic review and meta-analysis. The American Journal of Clinical Nutrition 2009;89:568-76. [DOI: 10.3945/ajcn.2008.26823] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 4.1] [Reference Citation Analysis]
434 Kasochi C, Julius P, Mweemba I, Kayamba V. Human epidermal growth factor receptor 2 overexpression in gastric and gastroesophageal junction adenocarcinoma in patients seen at the University Teaching Hospital, Lusaka, Zambia. Afr Health Sci 2020;20:1857-64. [PMID: 34394249 DOI: 10.4314/ahs.v20i4.41] [Reference Citation Analysis]
435 Lai HT, Koriyama C, Tokudome S, Tran HH, Tran LT, Nandakumar A, Akiba S, Le NT. Waterpipe Tobacco Smoking and Gastric Cancer Risk among Vietnamese Men. PLoS One 2016;11:e0165587. [PMID: 27802311 DOI: 10.1371/journal.pone.0165587] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
436 Pan L, He M, Ma J, Tang W, Gao G, He R, Su H, Cui D. Phase and size controllable synthesis of NaYbF4 nanocrystals in oleic acid/ionic liquid two-phase system for targeted fluorescent imaging of gastric cancer. Theranostics 2013;3:210-22. [PMID: 23471455 DOI: 10.7150/thno.5298] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 4.2] [Reference Citation Analysis]
437 Saeki N, Ono H, Sakamoto H, Yoshida T. Genetic factors related to gastric cancer susceptibility identified using a genome-wide association study. Cancer Sci. 2013;104:1-8. [PMID: 23057512 DOI: 10.1111/cas.12042] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
438 Smith JP, Nadella S, Osborne N. Gastrin and Gastric Cancer. Cell Mol Gastroenterol Hepatol. 2017;4:75-83. [PMID: 28560291 DOI: 10.1016/j.jcmgh.2017.03.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
439 Shah MA, Kurtz RC. Upper gastrointestinal cancer predisposition syndromes. Hematol Oncol Clin North Am 2010;24:815-35. [PMID: 20816576 DOI: 10.1016/j.hoc.2010.06.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
440 Shen XJ, Zhang H, Tang GS, Wang XD, Zheng R, Wang Y, Zhu Y, Xue XC, Bi JW. Caveolin-1 is a modulator of fibroblast activation and a potential biomarker for gastric cancer. Int J Biol Sci. 2015;11:370-379. [PMID: 25798057 DOI: 10.7150/ijbs.10666] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
441 Hudler P. Genetic aspects of gastric cancer instability. ScientificWorldJournal. 2012;2012:761909. [PMID: 22606061 DOI: 10.1100/2012/761909] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 5.6] [Reference Citation Analysis]
442 Ejaz A, Spolverato G, Kim Y, Poultsides GA, Fields RC, Bloomston M, Cho CS, Votanopoulos K, Maithel SK, Pawlik TM. Impact of body mass index on perioperative outcomes and survival after resection for gastric cancer. J Surg Res 2015;195:74-82. [PMID: 25619462 DOI: 10.1016/j.jss.2014.12.048] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
443 Trivanovic D, Plestina S, Honovic L, Dobrila-Dintinjana R, Vlasic Tanaskovic J, Vrbanec D. Gastric cancer detection using the serum pepsinogen test method. Tumori 2021;:3008916211014961. [PMID: 33993805 DOI: 10.1177/03008916211014961] [Reference Citation Analysis]
444 Perumalsamy H, Sankarapandian K, Veerappan K, Natarajan S, Kandaswamy N, Thangavelu L, Balusamy SR. In silico and in vitro analysis of coumarin derivative induced anticancer effects by undergoing intrinsic pathway mediated apoptosis in human stomach cancer. Phytomedicine 2018;46:119-30. [DOI: 10.1016/j.phymed.2018.04.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
445 Sun Z, Zhu GL, Lu C, Guo PT, Huang BJ, Li K, Xu Y, Wang ZN, Xu HM. A novel subclassification of pT2 gastric cancers according to the depth of muscularis propria invasion: superficial muscularis propria versus deep muscularis propria/subserosa. Ann Surg 2009;249:768-75. [PMID: 19387327 DOI: 10.1097/SLA.0b013e3181a3df77] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
446 Huang Q, Sun Q, Fan XS, Zhou D, Zou XP. Recent advances in proximal gastric carcinoma. J Dig Dis. 2016;17:421-432. [PMID: 27129018 DOI: 10.1111/1751-2980.12355] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
447 Badiali L, Cedernaes J, Olszewski PK, Nylander O, Vergoni AV, Schiöth HB. Adhesion GPCRs are widely expressed throughout the subsections of the gastrointestinal tract. BMC Gastroenterol. 2012;12:134. [PMID: 23009096 DOI: 10.1186/1471-230x-12-134] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
448 Song HR, Kweon SS, Kim HN, Piao JM, Yun WJ, Choi JS, Hwang JE, Yoon JY, Kim HR, Park YK. p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population. Gastric Cancer. 2011;14:242-248. [PMID: 21461655 DOI: 10.1007/s10120-011-0034-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
449 Lee J, Goh SH, Song N, Hwang JA, Nam S, Choi IJ, Shin A, Kim IH, Ju MH, Jeong JS, Lee YS. Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism. Am J Pathol. 2012;181:43-52. [PMID: 22609115 DOI: 10.1016/j.ajpath.2012.03.027] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
450 Safarzad M, Besharat S, Salimi S, Azarhoush R, Behnampour N, Joshaghani HR. Association between selenium, cadmium, and arsenic levels and genetic polymorphisms in DNA repair genes (XRCC5, XRCC6) in gastric cancerous and non-cancerous tissue. J Trace Elem Med Biol 2019;55:89-95. [PMID: 31345372 DOI: 10.1016/j.jtemb.2019.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
451 Haley ES, Au GG, Carlton BR, Barry RD, Shafren DR. Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer. J Mol Med (Berl) 2009;87:385-99. [PMID: 19139835 DOI: 10.1007/s00109-008-0433-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
452 Kupcinskaite-Noreikiene R, Ugenskiene R, Noreika A, Rudzianskas V, Gedminaite J, Skieceviciene J, Juozaityte E. Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach. BMC Cancer 2016;16:40. [PMID: 26810771 DOI: 10.1186/s12885-016-2077-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
453 Chen CY, Kuo YT, Lee CH, Hsieh TJ, Jan CM, Jaw TS, Huang WT, Yu FJ. Differentiation between malignant and benign gastric ulcers: CT virtual gastroscopy versus optical gastroendoscopy. Radiology. 2009;252:410-417. [PMID: 19487467 DOI: 10.1148/radiol.2522081249] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
454 Kolin DL, Sy K, Rotondo F, Bassily MN, Kovacs K, Brezden-Masley C, Streutker CJ, Yousef GM. Prognostic significance of human tissue kallikrein-related peptidases 11 and 15 in gastric cancer. Tumour Biol 2016;37:437-46. [PMID: 26224476 DOI: 10.1007/s13277-015-3802-7] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
455 Wu D, Zhao L, Liu Y, Wang J, Hu W, Feng X, Lv Z, Li Y, Yao X. The superiority of 256-slice spiral computed tomography angiography for preoperative evaluation of surrounding arteries in patients with gastric cancer. Onco Targets Ther 2017;10:927-33. [PMID: 28243128 DOI: 10.2147/OTT.S88330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
456 Schrader KA, Masciari S, Boyd N, Wiyrick S, Kaurah P, Senz J, Burke W, Lynch HT, Garber JE, Huntsman DG. Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer 2008;7:73-82. [PMID: 18046629 DOI: 10.1007/s10689-007-9172-6] [Cited by in Crossref: 92] [Cited by in F6Publishing: 69] [Article Influence: 6.6] [Reference Citation Analysis]
457 Bilici A, Sonkaya A, Ercan S, Ustaalioglu BB, Seker M, Aliustaoglu M, Orcun A, Gumus M. The changing of serum vitamin B12 and homocysteine levels after gastrectomy in patients with gastric cancer: do they associate with clinicopathological factors? Tumour Biol 2015;36:823-8. [PMID: 25296737 DOI: 10.1007/s13277-014-2705-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
458 Helyer LK, O'Brien C, Coburn NG, Swallow CJ. Surgeons' knowledge of quality indicators for gastric cancer surgery. Gastric Cancer 2007;10:205-14. [PMID: 18095075 DOI: 10.1007/s10120-007-0435-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
459 Golberg D, Szilagyi A, Graves L. Hyperemesis gravidarum and Helicobacter pylori infection: a systematic review. Obstet Gynecol. 2007;110:695-703. [PMID: 17766620 DOI: 10.1097/01.aog.0000278571.93861.26] [Cited by in Crossref: 49] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
460 Mogos VT, Dondoi CI, Bajko DE. Carcinogenic Substances Naturrally Occuring in the Human Diet. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 2018;25:105-8. [DOI: 10.2478/rjdnmd-2018-0012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
461 Park YS, Hwang HS, Park HJ, Ryu M, Chang H, Yook JH, Kim BS, Jang SJ, Kang Y. Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use? Human Pathology 2012;43:413-22. [DOI: 10.1016/j.humpath.2011.05.019] [Cited by in Crossref: 50] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
462 Rollan A, Ferreccio C, Gederlini A, Serrano C, Torres J, Harris P. Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer. World J Gastroenterol 2006; 12(44): 7172-7178 [PMID: 17131482 DOI: 10.3748/wjg.v12.i44.7172] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
463 Păun I, Costin AI, Constantin VD, Lomaca I, Ianoşi NG, Socea B, Tutunaru CV, Zlatian OM, Ianoşi SL, Neagoe CD, Crafciuc AV, Stancu MI. Gastric cancer - histopathological correlations between tumor and non-tumor gastric mucosa changes. Rom J Morphol Embryol 2020;61:1129-41. [PMID: 34171062 DOI: 10.47162/RJME.61.4.15] [Reference Citation Analysis]
464 Resende C, Regalo G, Durães C, Pinto MT, Wen X, Figueiredo C, Carneiro F, Machado JC. Interleukin-1B signalling leads to increased survival of gastric carcinoma cells through a CREB-C/EBPβ-associated mechanism. Gastric Cancer 2016;19:74-84. [DOI: 10.1007/s10120-014-0448-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
465 Chen S, Ren C, Zheng H, Sun X, Dai J. The Effect of Long Non-Coding RNA (lncRNA) HCP5 on Regulating Epithelial-Mesenchymal Transition (EMT)-Related Markers in Gastric Carcinoma Is Partially Reversed by miR-27b-3p. Med Sci Monit 2020;26:e921383. [PMID: 32357145 DOI: 10.12659/MSM.921383] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
466 Frustaci S, Buonadonna A, Turchet E, Corona G, Tabaro G, Miolo G, Torrisi E, Lo Re G, Tumolo S, Toffoli G. Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients. Int J Clin Oncol 2013;18:510-6. [PMID: 22669361 DOI: 10.1007/s10147-012-0410-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
467 Jiang C, Wang W, Yan W, Zhang Y, Yang J, Zhang S, Zhang C, Zhang W, Han W, Wang J, Zhang YQ. Clinical implications and characteristics of factor forkhead box protein 3 in gastric cancer. Exp Ther Med 2011;2:667-73. [PMID: 22977558 DOI: 10.3892/etm.2011.264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
468 Agkoc M, Dursun H, Albayrak F, Yilmaz O, Kiziltunc A, Yilmaz A, Gundogdu C. Usefulness of serum pepsinogen levels as a screening test for atrophic gastritis and gastric cancer. Eurasian J Med 2010;42:15-8. [PMID: 25610111 DOI: 10.5152/eajm.2010.05] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
469 Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, Yan M. microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep. 2012;27:1019-1026. [PMID: 22267008 DOI: 10.3892/or.2012.1645] [Cited by in Crossref: 182] [Cited by in F6Publishing: 180] [Article Influence: 18.2] [Reference Citation Analysis]
470 Ushimaru Y, Fujiwara Y, Shishido Y, Yanagimoto Y, Moon JH, Sugimura K, Omori T, Miyata H, Yano M. Clinical Outcomes of Gastric Cancer Patients Who Underwent Proximal or Total Gastrectomy: A Propensity Score-Matched Analysis. World J Surg 2018;42:1477-84. [PMID: 29058068 DOI: 10.1007/s00268-017-4306-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
471 de Vries E, Uribe C, Pardo C, Lemmens V, Van de Poel E, Forman D. Gastric cancer survival and affiliation to health insurance in a middle-income setting. Cancer Epidemiol 2015;39:91-6. [PMID: 25652310 DOI: 10.1016/j.canep.2014.10.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
472 Kim MG, Lee JH, Ha TK, Kwon SJ. The distance of proximal resection margin dose not significantly influence on the prognosis of gastric cancer patients after curative resection. Ann Surg Treat Res. 2014;87:223-231. [PMID: 25368847 DOI: 10.4174/astr.2014.87.5.223] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
473 Wu B, Zhang Q, Shen W, Zhu J. Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line. Mol Cell Biochem 2008;313:125-32. [PMID: 18398671 DOI: 10.1007/s11010-008-9749-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
474 Huo J, Wu L, Zang Y. Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer. J Immunol Res 2021;2021:5554342. [PMID: 34007851 DOI: 10.1155/2021/5554342] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
475 Sun X, Sun Z, Zhu Z, Li C, Zhang J, Xu H, Sun M. Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer. Tumor Biol 2015;36:7521-30. [DOI: 10.1007/s13277-015-3470-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
476 Wang F, Wang Z, Zhou N, An X, Xu R, He Y, Li Y. Phase II Study of Biweekly Paclitaxel Plus Infusional 5-Fluorouracil and Leucovorin as First-Line Chemotherapy in Patients With Advanced Gastric Cancer. American Journal of Clinical Oncology 2011;34:401-5. [DOI: 10.1097/coc.0b013e3181e84b63] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
477 Zabaleta J. Multifactorial etiology of gastric cancer. Methods Mol Biol. 2012;863:411-435. [PMID: 22359309 DOI: 10.1007/978-1-61779-612-8_26.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
478 Wu ZF, Cao QH, Wu XY, Chen C, Xu Z, Li WS, Yao XQ, Liu FK. Regional Arterial Infusion Chemotherapy improves the Pathological Response rate for advanced gastric cancer with Short-term Neoadjuvant Chemotherapy. Sci Rep. 2015;5:17516. [PMID: 26620627 DOI: 10.1038/srep17516] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
479 Nolen LD, Vindigni SM, Parsonnet J; Symposium leaders. Combating Gastric Cancer in Alaska Native People: An Expert and Community Symposium.Gastroenterology. 2020;158:1197-1201. [PMID: 31836529 DOI: 10.1053/j.gastro.2019.11.299] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
480 Weyers A, Yang B, Park JH, Kim YS, Kim SM, Lee SE, Zhang F, Lee KB, Linhardt RJ. Microanalysis of stomach cancer glycosaminoglycans. Glycoconj J 2013;30:701-7. [PMID: 23604988 DOI: 10.1007/s10719-013-9476-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
481 Salazar CR, Sun J, Li Y, Francois F, Corby P, Perez-Perez G, Dasanayake A, Pei Z, Chen Y. Association between selected oral pathogens and gastric precancerous lesions. PLoS One 2013;8:e51604. [PMID: 23308100 DOI: 10.1371/journal.pone.0051604] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
482 Yoon SB, Park JM, Lim CH, Cho YK, Choi MG. Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis. Helicobacter. 2014;19:243-248. [PMID: 25056262 DOI: 10.1111/hel.12146] [Cited by in Crossref: 92] [Cited by in F6Publishing: 81] [Article Influence: 13.1] [Reference Citation Analysis]
483 Ng CJ, Teo CH, Abdullah N, Tan WP, Tan HM. Relationships between cancer pattern, country income and geographical region in Asia. BMC Cancer 2015;15:613. [PMID: 26335225 DOI: 10.1186/s12885-015-1615-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
484 Lin D, Koskella B. Friend and foe: factors influencing the movement of the bacterium Helicobacter pylori along the parasitism-mutualism continuum. Evol Appl. 2015;8:9-22. [PMID: 25667600 DOI: 10.1111/eva.12231] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
485 Gigek CO, Chen ES, Calcagno DQ, Wisnieski F, Burbano RR, Smith MA. Epigenetic mechanisms in gastric cancer. Epigenomics. 2012;4:279-294. [PMID: 22690664 DOI: 10.2217/epi.12.22] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 7.3] [Reference Citation Analysis]
486 Wu X, Tang H, Guan A, Sun F, Wang H, Shu J. Finding gastric cancer related genes and clinical biomarkers for detection based on gene-gene interaction network. Math Biosci 2016;276:1-7. [PMID: 26700107 DOI: 10.1016/j.mbs.2015.12.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
487 Wu D, Lv J, Zhao R, Wu Z, Zheng D, Shi J, Lin S, Wang S, Wu Q, Long Y, Li P, Yao Y. PSCA is a target of chimeric antigen receptor T cells in gastric cancer. Biomark Res 2020;8:3. [PMID: 32010446 DOI: 10.1186/s40364-020-0183-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
488 Wang XY, Wang LL, Zheng X, Meng LN, Lyu B, Jin HF. Expression of p-STAT3 and vascular endothelial growth factor in MNNG-induced precancerous lesions and gastric tumors in rats. World J Gastrointest Oncol 2016; 8(3): 305-313 [PMID: 26989466 DOI: 10.4251/wjgo.v8.i3.305] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
489 Mattioli E, Vogiatzi P, Sun A, Abbadessa G, Angeloni G, D’Ugo D, Trani D, Gaughan JP, Vecchio FM, Cevenini G. Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer. J Cell Physiol. 2007;210:183-191. [PMID: 16998811 DOI: 10.1002/jcp.20833] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
490 Wang Z, Chen JQ. Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review. BMC Gastroenterol. 2011;11:19. [PMID: 21385469 DOI: 10.1186/1471-230x-11-19] [Cited by in Crossref: 71] [Cited by in F6Publishing: 32] [Article Influence: 6.5] [Reference Citation Analysis]
491 Busuttil RA, Boussioutas A. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis. J Gastroenterol Hepatol. 2009;24:193-201. [PMID: 19215332 DOI: 10.1111/j.1440-1746.2008.05774.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
492 Nasri S, Humara B, Anjomshoaa A, Moradi N, Gholipour N, Mashjoor S, Zhang P. Early Hereditary Diffuse Gastric Cancer (eHDGC) is Characterized by Subtle Genomic Instability and Active DNA Damage Response. Pathol Oncol Res 2019;25:711-21. [PMID: 30547291 DOI: 10.1007/s12253-018-0547-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
493 Mabula JB, McHembe MD, Koy M, Chalya PL, Massaga F, Rambau PF, Masalu N, Jaka H. Gastric cancer at a university teaching hospital in northwestern Tanzania: a retrospective review of 232 cases. World J Surg Oncol. 2012;10:257. [PMID: 23181624 DOI: 10.1186/1477-7819-10-257] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
494 O'Doherty MG, Freedman ND, Hollenbeck AR, Schatzkin A, Murray LJ, Cantwell MM, Abnet CC. Association of dietary fat intakes with risk of esophageal and gastric cancer in the NIH-AARP diet and health study. Int J Cancer 2012;131:1376-87. [PMID: 22116732 DOI: 10.1002/ijc.27366] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
495 Song HR, Kim HN, Kweon SS, Choi JS, Shim HJ, Cho SH, Chung IJ, Park YK, Kim SH, Choi YD. Common genetic variants at 1q22 and 10q23 and gastric cancer susceptibility in a Korean population. Tumour Biol. 2014;35:3133-3137. [PMID: 24254309 DOI: 10.1007/s13277-013-1409-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
496 Zhang T, Chen H, Yin X, He Q, Man J, Yang X, Lu M. Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: Findings from Global Burden of Disease Study. Chin J Cancer Res 2021;33:11-26. [PMID: 33707924 DOI: 10.21147/j.issn.1000-9604.2021.01.02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
497 Ishige T, Nishimura M, Satoh M, Fujimoto M, Fukuyo M, Semba T, Kado S, Tsuchida S, Sawai S, Matsushita K, Togawa A, Matsubara H, Kaneda A, Nomura F. Combined Secretomics and Transcriptomics Revealed Cancer-Derived GDF15 is Involved in Diffuse-Type Gastric Cancer Progression and Fibroblast Activation. Sci Rep 2016;6:21681. [PMID: 26892343 DOI: 10.1038/srep21681] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
498 Naserpour Farivar T, Johari P, Najafipour R, Farzam A, Nasirian N, Hajmanouchehri F, Jahani Hashemi H, Azimi A, Bahrami M. The Relationship Between Gastric Cancer and Helicobacter Pylori in Formaldehyde Fixed Paraffin Embedded Gastric Tissues of Gastric Cancer Patients-Scorpion Real-Time PCR Assay Findings. Pathol Oncol Res 2014;20:113-7. [DOI: 10.1007/s12253-013-9669-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
499 Jimenez-Fonseca P, Carmona-Bayonas A, Martínez de Castro E, Custodio A, Pericay Pijaume C, Hernandez R, Aguado G, Castro Unanua N, Cano JM, López F, Garrido M, Fernández Montes A, Visa L, Sánchez Cánovas M, Limón ML, Martínez Lago N, Pimentel P, Hurtado A, Azkárate A, Longo F, Diez M, Arias-Martinez A, Sauri T, Martín Carnicero A, Mangas M, Martín Richard M, Granja M, Ramchandani A, Hernández Pérez C, Cerdá P, Gil-Negrete A, Calvo M, Vidal Tocino R, Gallego J. External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit? Gastric Cancer 2021;24:445-56. [PMID: 32970266 DOI: 10.1007/s10120-020-01116-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
500 Young K, Chau I. Targeted Therapies for Advanced Oesophagogastric Cancer: Recent Progress and Future Directions. Drugs 2016;76:13-26. [PMID: 26620367 DOI: 10.1007/s40265-015-0510-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
501 Ciliberto D, Staropoli N, Caglioti F, Gualtieri S, Fiorillo L, Chiellino S, De Angelis AM, Mendicino F, Botta C, Caraglia M, Tassone P, Tagliaferri P. A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate? Cancer Biol Ther 2015;16:1148-59. [PMID: 26061272 DOI: 10.1080/15384047.2015.1056415] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
502 Wang D, Liu K, Chen E. LINC00511 promotes proliferation and invasion by sponging miR-515-5p in gastric cancer. Cell Mol Biol Lett 2020;25:4. [PMID: 32042282 DOI: 10.1186/s11658-020-0201-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
503 Wang P, Tang JT, Peng YS, Chen XY, Zhang YJ, Fang JY. XRCC1 downregulated through promoter hypermethylation is involved in human gastric carcinogenesis. J Dig Dis. 2010;11:343-351. [PMID: 21091896 DOI: 10.1111/j.1751-2980.2010.00459.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
504 Vahid F, Davoodi SH. Nutritional Factors Involved in the Etiology of Gastric Cancer: A Systematic Review. Nutr Cancer 2021;73:376-90. [PMID: 32336147 DOI: 10.1080/01635581.2020.1756353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
505 Zhao LY, Wang JJ, Zhao YL, Chen XZ, Yang K, Chen XL, Zhang WH, Liu K, Song XH, Zheng JB, Zhou ZG, Yu PW, Li Y, Hu JK. Superiority of Tumor Location-Modified Lauren Classification System for Gastric Cancer: A Multi-Institutional Validation Analysis.Ann Surg Oncol. 2018;25:3257-3263. [PMID: 30051368 DOI: 10.1245/s10434-018-6654-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
506 Lindkvist B, Almquist M, Bjørge T, Stocks T, Borena W, Johansen D, Hallmans G, Engeland A, Nagel G, Jonsson H, Selmer R, Diem G, Häggström C, Tretli S, Stattin P, Manjer J. Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can). Cancer Causes Control 2013;24:107-16. [DOI: 10.1007/s10552-012-0096-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
507 Dong J, Li J, Liu SM, Feng XY, Chen S, Chen YB, Zhang XS. CD33+/p-STAT1+ double-positive cell as a prognostic factor for stage IIIa gastric cancer. Med Oncol. 2013;30:442. [PMID: 23307253 DOI: 10.1007/s12032-012-0442-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
508 Espinosa-Parrilla Y, Muñoz X, Bonet C, Garcia N, Venceslá A, Yiannakouris N, Naccarati A, Sieri S, Panico S, Huerta JM, Barricarte A, Menéndez V, Sánchez-Cantalejo E, Dorronsoro M, Brennan P, Duarte-Salles T, B As Bueno-de-Mesquita H, Weiderpass E, Lund E, Clavel-Chapelon F, Boutron-Ruault MC, Racine A, Numans ME, Tumino R, Canzian F, Campa D, Sund M, Johansson M, Ohlsson B, Lindkvist B, Overvad K, Tjønneland A, Palli D, Travis RC, Khaw KT, Wareham N, Boeing H, Nesi G, Riboli E, Gonzalez CA, Sala N. Genetic association of gastric cancer with miRNA clusters including the cancer-related genes MIR29, MIR25, MIR93 and MIR106: results from the EPIC-EURGAST study. Int J Cancer 2014;135:2065-76. [PMID: 24643999 DOI: 10.1002/ijc.28850] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
509 Hoffmann A, Behrens HM, Heckl S, Krüger S, Becker T, Röcken C. Neoadjuvant/Perioperative Treatment Affects Spatial Distribution and Densities of Tumor Associated Neutrophils and CD8+ Lymphocytes in Gastric Cancer. J Pers Med 2021;11:1184. [PMID: 34834537 DOI: 10.3390/jpm11111184] [Reference Citation Analysis]
510 Messier KP, Serre ML. Lung and stomach cancer associations with groundwater radon in North Carolina, USA. Int J Epidemiol 2017;46:676-85. [PMID: 27639278 DOI: 10.1093/ije/dyw128] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
511 Aytaç E, Aslan F, Çicek B, Erdamar S, Gürses B, Güven K, Falay O, Karahasanoğlu T, Selçukbiricik F, Selek U, Atalar B, Balık E, Tözün N, Rozanes İ, Arıcan A, Hamzaoğlu İ, Baca B, Molinas Mandel N, Saruç M, Göksel S, Demir G, Ağaoğlu F, Yakıcıer C, Özbek U, Özben V, Özyar E, Güner AL, Er Ö, Kaban K, Bölükbaşı Y, Buğra D, Group Tİ. Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group. Turk J Gastroenterol 2019;30:584-98. [PMID: 30541724 DOI: 10.5152/tjg.2018.18737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
512 Marano L, Petrillo M, Pezzella M, Patriti A, Braccio B, Esposito G, Grassia M, Romano A, Torelli F, De Luca R, Fabozzi A, Falco G, Di Martino N. Applicability of the Proposed Japanese Model for the Classification of Gastric Cancer Location: The "PROTRADIST" Retrospective Study. J Invest Surg 2017;30:210-6. [PMID: 27690693 DOI: 10.1080/08941939.2016.1230248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
513 Chao Y, Hsieh JS, Yeh HT, Su YC, Wu CC, Chen JS, Tai CJ, Bai LY, Yeh KH, Su WC, Li CP. A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer. Cancer Chemother Pharmacol 2014;73:799-806. [PMID: 24531611 DOI: 10.1007/s00280-014-2407-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
514 Fernández Aceñero MJ, Caso Viesca A, Díaz del Arco C. Role of fine needle aspiration cytology in the management of supraclavicular lymph node metastasis: Review of our experience. Diagnostic Cytopathology 2018;47:181-6. [DOI: 10.1002/dc.24064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
515 Ajoodhea H, Zhang RC, Xu XW, Jin WW, Chen K, He YT, Mou YP. Fever as a first manifestation of advanced gastric adenosquamous carcinoma: A case report. World J Gastroenterol 2014; 20(29): 10193-10201 [PMID: 25110448 DOI: 10.3748/wjg.v20.i29.10193] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
516 Wang Z, Zhang L, Guo Z, Liu L, Ji J, Zhang J, Chen X, Liu B, Zhang J, Ding Q, Wang X, Zhao W, Zhu Z, Yu Y. A unique feature of iron loss via close adhesion of Helicobacter pylori to host erythrocytes. PLoS One 2012;7:e50314. [PMID: 23185604 DOI: 10.1371/journal.pone.0050314] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
517 Sun J, Zhou M, Salazar CR, Hays R, Bedi S, Chen Y, Li Y. Chronic Periodontal Disease, Periodontal Pathogen Colonization, and Increased Risk of Precancerous Gastric Lesions. J Periodontol 2017;88:1124-34. [PMID: 28671506 DOI: 10.1902/jop.2017.160829] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
518 Voron T, Messager M, Duhamel A, Lefevre J, Mabrut JY, Goere D, Meunier B, Brigand C, Hamy A, Glehen O, Mariette C, Paye F. Is signet-ring cell carcinoma a specific entity among gastric cancers? Gastric Cancer. 2016;19:1027-1040. [PMID: 26606931 DOI: 10.1007/s10120-015-0564-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
519 Saha AK, Maitra S, Hazra SC. Epidemiology of gastric cancer in the gangetic areas of west bengal. ISRN Gastroenterol 2013;2013:823483. [PMID: 24251042 DOI: 10.1155/2013/823483] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
520 Xiong B, Ma L, Cheng Y, Zhang C. Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: an updated meta-analysis of randomized controlled trials. Eur J Surg Oncol. 2014;40:1321-1330. [PMID: 25239442 DOI: 10.1016/j.ejso.2014.01.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
521 D'Hondt M, Van Rooy F, Devriendt D, Vansteenkiste F, Vanhauwaert H. Laparoscopic solution for early gastric cancer in a morbidly obese patient. Obes Surg 2007;17:420-2. [PMID: 17546855 DOI: 10.1007/s11695-007-9052-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
522 Griffin N, Burke C, Grant LA. Common primary tumours of the abdomen and pelvis and their patterns of tumour spread as seen on multi-detector computed tomography. Insights Imaging 2011;2:205-14. [PMID: 22347948 DOI: 10.1007/s13244-011-0089-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
523 Lee RJ, Madan RA, Kim J, Posadas EM, Yu EY. Disparities in Cancer Care and the Asian American Population. Oncologist 2021;26:453-60. [PMID: 33683795 DOI: 10.1002/onco.13748] [Reference Citation Analysis]
524 Hsieh HL, Tsai MM. Tumor progression-dependent angiogenesis in gastric cancer and its potential application. World J Gastrointest Oncol 2019; 11(9): 686-704 [PMID: 31558974 DOI: 10.4251/wjgo.v11.i9.686] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
525 Yoshioka T, Nishida T, Tsujii M, Kato M, Hayashi Y, Komori M, Yoshihara H, Nakamura T, Egawa S, Yoshio T. Renal dysfunction is an independent risk factor for bleeding after gastric ESD. Endosc Int Open. 2015;3:E39-E45. [PMID: 26134770 DOI: 10.1055/s-0034-1390762] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
526 Liu H, Xu L, Wei JE, Xie MR, Wang SE, Zhou RX. Role of CD4+ CD25+ regulatory T cells in melatonin-mediated inhibition of murine gastric cancer cell growth in vivo and in vitro. Anat Rec (Hoboken). 2011;294:781-788. [PMID: 21416626 DOI: 10.1002/ar.21361] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
527 Santoro R, Ettorre GM, Santoro E. Subtotal gastrectomy for gastric cancer. World J Gastroenterol 2014; 20(38): 13667-13680 [PMID: 25320505 DOI: 10.3748/wjg.v20.i38.13667] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
528 Xie Y, Wang Y, Zhao Y, Guo Z. Single-nucleotide polymorphisms of microRNA processing machinery genes are associated with risk for gastric cancer. Onco Targets Ther. 2015;8:567-571. [PMID: 25784816 DOI: 10.2147/ott.s79150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
529 Kim HH. Endoscopic Raman Spectroscopy for Molecular Fingerprinting of Gastric Cancer: Principle to Implementation. Biomed Res Int. 2015;2015:670121. [PMID: 26106612 DOI: 10.1155/2015/670121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
530 Xu X, Cao W, Sun W, Wang Z, Chen H, Zheng Z, Yang X. Knockdown Of CCDC132 Attenuates Gastric Cancer Cells Proliferation And Tumorigenesis By Facilitating DNA Damage Signaling. Cancer Manag Res 2019;11:9585-97. [PMID: 31814760 DOI: 10.2147/CMAR.S215631] [Reference Citation Analysis]
531 Mohammad NH, ter Veer E, Ngai L, Mali R, van Oijen MG, van Laarhoven HW. Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis. Cancer Metastasis Rev 2015;34:429-41. [PMID: 26267802 DOI: 10.1007/s10555-015-9576-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
532 Formica V, Morelli C, Patrikidou A, Murias C, Butt S, Nardecchia A, Lucchetti J, Renzi N, Shiu K, Roselli M, Arkenau H. Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint Inhibitors. Targ Oncol 2020;15:327-36. [DOI: 10.1007/s11523-020-00723-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
533 Lu Y, Wei G, Liu L, Mo Y, Chen Q, Xu L, Liao R, Zeng D, Zhang K. Direct targeting of MAPK8IP1 by miR-10a-5p is a major mechanism for gastric cancer metastasis. Oncol Lett 2017;13:1131-6. [PMID: 28454224 DOI: 10.3892/ol.2016.5544] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
534 Machaca Quea NR, Emura F, Barreda Bolaños F, Salvador Arias Y, Arévalo Suárez FA, Piscoya Rivera A. Effectiveness of systematic alphanumeric coded endoscopy for diagnosis of gastric intraepithelial neoplasia in a low socioeconomic population. Endosc Int Open 2016;4:E1083-9. [PMID: 27747283 DOI: 10.1055/s-0042-115408] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
535 Zhu X, Mao Y, Huang T, Yan C, Yu F, Du J, Dai J, Ma H, Jin G. High mitochondrial DNA copy number was associated with an increased gastric cancer risk in a Chinese population. Mol Carcinog 2017;56:2593-600. [DOI: 10.1002/mc.22703] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
536 Nishida T, Kato M, Yoshio T, Akasaka T, Yoshioka T, Michida T, Yamamoto M, Hayashi S, Hayashi Y, Tsujii M, Takehara T. Endoscopic submucosal dissection in early gastric cancer in elderly patients and comorbid conditions. World J Gastrointest Endosc 2015; 7(5): 524-531 [PMID: 25992191 DOI: 10.4253/wjge.v7.i5.524] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
537 Vega WA, Rodriguez MA, Gruskin E. Health disparities in the Latino population. Epidemiol Rev. 2009;31:99-112. [PMID: 19713270 DOI: 10.1093/epirev/mxp008] [Cited by in Crossref: 213] [Cited by in F6Publishing: 180] [Article Influence: 16.4] [Reference Citation Analysis]
538 Kalan Farmanfarma K, Mahdavifar N, Hassanipour S, Salehiniya H. Epidemiologic Study of Gastric Cancer in Iran: A Systematic Review. Clin Exp Gastroenterol 2020;13:511-42. [PMID: 33177859 DOI: 10.2147/CEG.S256627] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
539 Zhou LP, Luan H, Dong XH, Jin GJ, Man DL, Shang H. Vascular endothelial growth factor +936C/T polymorphism and gastric cancer risk: A meta-analysis. Exp Ther Med 2011;2:931-6. [PMID: 22977600 DOI: 10.3892/etm.2011.278] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
540 Sakamoto N, Naito Y, Oue N, Sentani K, Uraoka N, Zarni Oo H, Yanagihara K, Aoyagi K, Sasaki H, Yasui W. MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis. Cancer Sci. 2014;105:236-243. [PMID: 24283384 DOI: 10.1111/cas.12330] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 7.8] [Reference Citation Analysis]
541 Jafari N, Bohlooli S, Mohammadi S, Mazani M. Cytotoxicity of methylsulfonylmethane on gastrointestinal (AGS, HepG2, and KEYSE-30) cancer cell lines. J Gastrointest Cancer. 2012;43:420-425. [PMID: 21626237 DOI: 10.1007/s12029-011-9291-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
542 Khazaei S, Mohammadbeigi A, Jenabi E, Asgarian A, Heidari H, Saghafipour A, Arsang-Jang S, Ansari H. Environmental and ecological factors of stomach cancer incidence and mortality: a systematic review study on ecological studies. Rev Environ Health 2020;35:443-52. [PMID: 32683335 DOI: 10.1515/reveh-2020-0022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
543 Soleimani A, Ghanadi K, Noormohammadi Z, Irani S. The correlation between miR-146a C/G polymorphism and UHRF1 gene expression level in gastric tumor. J Dig Dis 2016;17:169-74. [PMID: 26896831 DOI: 10.1111/1751-2980.12329] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
544 Lee SR, Shin JW, Kim HO, Son BH, Yoo CH, Shin JH. Determining the effect of transforming growth factor-β1 on cdk4 and p27 in gastric cancer and cholangiocarcinoma. Oncol Lett 2013;5:694-8. [PMID: 23420090 DOI: 10.3892/ol.2012.1024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
545 Hamajima N, Naito M, Kondo T, Goto Y. Genetic factors involved in the development of Helicobacter pylori-related gastric cancer. Cancer Sci. 2006;97:1129-1138. [PMID: 16879717 DOI: 10.1111/j.1349-7006.2006.00290.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 4.4] [Reference Citation Analysis]
546 Cisco RM, Ford JM, Norton JA. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery. Cancer. 2008;113:1850-1856. [PMID: 18798546 DOI: 10.1002/cncr.23650] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 4.2] [Reference Citation Analysis]
547 de Araújo RM, de Melo CF, Neto FM, da Silva JN, Soares LF, de Arruda Cardoso Smith M, Sousa EC Jr, Burbano RM, de Medeiros AC, Lima EM. Association study of SNPs of genes IFNGR1 (rs137854905), GSTT1 (rs71748309), and GSTP1 (rs1695) in gastric cancer development in samples of patient in the northern and northeastern Brazil. Tumour Biol 2014;35:4983-6. [PMID: 24453034 DOI: 10.1007/s13277-014-1656-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
548 Barzegar F, Zaefizadeh M, Yari R, Salehzadeh A. Synthesis of Nano-Paramagnetic Oleuropein to Induce KRAS Over-Expression: A New Mechanism to Inhibit AGS Cancer Cells. Medicina (Kaunas) 2019;55:E388. [PMID: 31330954 DOI: 10.3390/medicina55070388] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
549 Obermannová R, Lordick F. Insights into next developments in advanced gastric cancer. Curr Opin Oncol 2016;28:367-75. [PMID: 27092990 DOI: 10.1097/CCO.0000000000000289] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
550 Lee J, Kim S, Kim P, Liu X, Lee T, Kim KM, Do IG, Park JO, Park SH, Jang J. A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers. PLoS One. 2013;8:e54644. [PMID: 23372746 DOI: 10.1371/journal.pone.0054644] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
551 Zhang L, Hu JF, Li GQ, Xiao X, Su Q. Rosiglitazone reverses mitomycin C resistance in human gastric cancer cells. Am J Med Sci. 2012;343:382-387. [PMID: 22052411 DOI: 10.1097/maj.0b013e31822f3c63] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
552 Colquhoun A, Hannah H, Corriveau A, Hanley B, Yuan Y, Goodman KJ; CANHelp Working Group. Gastric Cancer in Northern Canadian Populations: A Focus on Cardia and Non-Cardia Subsites. Cancers (Basel) 2019;11:E534. [PMID: 30991639 DOI: 10.3390/cancers11040534] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
553 Kim Y, Park J, Nam BH, Ki M. Stomach cancer incidence rates among Americans, Asian Americans and Native Asians from 1988 to 2011. Epidemiol Health 2015;37:e2015006. [PMID: 25687951 DOI: 10.4178/epih/e2015006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
554 Yang W, Mok MT, Li MS, Kang W, Wang H, Chan AW, Chou JL, Chen J, Ng EK, To KF, Yu J, Chan MW, Chan FK, Sung JJ, Cheng AS. Epigenetic silencing of GDF1 disrupts SMAD signaling to reinforce gastric cancer development. Oncogene 2016;35:2133-44. [PMID: 26212015 DOI: 10.1038/onc.2015.276] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
555 Das K, Gunasegaran B, Tan IB, Deng N, Lim KH, Tan P. Mutually exclusive FGFR2, HER2, and KRAS gene amplifications in gastric cancer revealed by multicolour FISH. Cancer Lett. 2014;353:167-175. [PMID: 25086186 DOI: 10.1016/j.canlet.2014.07.021] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
556 Li GQ, Xie J, Lei XY, Zhang L. Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway. World J Gastroenterol. 2009;15:5541-5548. [PMID: 19938192 DOI: 10.3748/wjg.15.554] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
557 Andersen M, Schønnemann KR, Yilmaz M, Jensen HA, Vestermark LW, Pfeiffer P. Phase I study of docetaxel, oxaliplatin and capecitabine (TEX) as first line therapy to patients with advanced gastro-oesophageal cancer. Acta Oncol 2010;49:1246-52. [PMID: 20429725 DOI: 10.3109/02841861003767521] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
558 Sun J, Song Y, Wang Z, Gao P, Chen X, Xu Y, Liang J, Xu H. Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials. BMC Cancer. 2012;12:526. [PMID: 23153379 DOI: 10.1186/1471-2407-12-526] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
559 Zhou X, Xu L, Huang Z, Zhang L, Zhang H, Zhu W, Liu P. The hematologic markers as prognostic factors in patients with resectable gastric cancer. Cancer Biomark 2016;17:359-67. [PMID: 27434296 DOI: 10.3233/CBM-160648] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
560 Wu H, Xue R, Tang Z, Deng C, Liu T, Zeng H, Sun Y, Shen X. Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry. Anal Bioanal Chem. 2010;396:1385-1395. [PMID: 20012946 DOI: 10.1007/s00216-009-3317-4] [Cited by in Crossref: 87] [Cited by in F6Publishing: 82] [Article Influence: 6.7] [Reference Citation Analysis]
561 Zhang C, Cleveland K, Schnoll-Sussman F, McClure B, Bigg M, Thakkar P, Schultz N, Shah MA, Betel D. Identification of low abundance microbiome in clinical samples using whole genome sequencing. Genome Biol. 2015;16:265. [PMID: 26614063 DOI: 10.1186/s13059-015-0821-z] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 8.1] [Reference Citation Analysis]
562 Abioye AI, Odesanya MO, Abioye AI, Ibrahim NA. Physical activity and risk of gastric cancer: a meta-analysis of observational studies. Br J Sports Med 2015;49:224-9. [DOI: 10.1136/bjsports-2013-092778] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
563 Sun GG, Hu WN, Cui DW, Zhang J. Decreased expression of CCNG2 is significantly linked to the malignant transformation of gastric carcinoma. Tumour Biol 2014;35:2631-9. [PMID: 24248541 DOI: 10.1007/s13277-013-1346-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
564 Chandanos E, Lagergren J. Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer. 2008;44:2397-2403. [PMID: 18755583 DOI: 10.1016/j.ejca.2008.07.031] [Cited by in Crossref: 95] [Cited by in F6Publishing: 94] [Article Influence: 6.8] [Reference Citation Analysis]
565 Cai J, Wang M, Zhu M, Zhang Q, Zhang X, Yan Y, Qian H, Xu W. N-methyl-N-nitro-N'-nitrosoguanidine induces the expression of CCR2 in human gastric epithelial cells promoting CCL2-mediated migration. Mol Med Rep 2016;13:1083-90. [PMID: 26648448 DOI: 10.3892/mmr.2015.4650] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
566 Davidson M, Chau I. Immunotherapy for oesophagogastric cancer. Expert Opin Biol Ther 2016;16:1197-207. [PMID: 27409159 DOI: 10.1080/14712598.2016.1213233] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
567 Taja-Chayeb L, Vidal-Millán S, Trejo-Becerril C, Pérez-Cárdenas E, Chávez-Blanco A, Domínguez-Gómez G, González-Fierro A, Romo-Pérez A, Dueñas-González A. Hereditary Diffuse Gastric Cancer (HDGC). An overview. Clin Res Hepatol Gastroenterol 2021;:101820. [PMID: 34656755 DOI: 10.1016/j.clinre.2021.101820] [Reference Citation Analysis]
568 Nemati A, Mahdavi R, Naghizadeh Baghi A. Case-control study of dietary pattern and other risk factors for gastric cancer. Health Promot Perspect 2012;2:20-7. [PMID: 24688914 DOI: 10.5681/hpp.2012.003] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
569 Lee YJ, Han ME, Baek SJ, Kim SY, Oh SO. MED30 Regulates the Proliferation and Motility of Gastric Cancer Cells. PLoS One 2015;10:e0130826. [PMID: 26110885 DOI: 10.1371/journal.pone.0130826] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
570 Le H, Wang L, Zhang L, Chen P, Xu B, Peng D, Yang M, Tan Y, Cai C, Li H, Zhao Q. Magnifying endoscopy in detecting early gastric cancer: A network meta-analysis of prospective studies. Medicine (Baltimore) 2021;100:e23934. [PMID: 33545965 DOI: 10.1097/MD.0000000000023934] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
571 Zhang XD, Shu YQ, Liang J, Zhang FC, Ma XZ, Huang JJ, Chen L, Shi GM, Cao WG, Guo CY, Shen L, Jin ML. Combination chemotherapy with paclitaxel, cisplatin and fluorouracil for patients with advanced and metastatic gastric or esophagogastric junction adenocarcinoma: a multicenter prospective study. Chin J Cancer Res 2012;24:291-8. [PMID: 23359329 DOI: 10.3978/j.issn.1000-9604.2012.08.04] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
572 Strebel K, Rolle-Kampczyk U, Richter M, Kindler A, Richter T, Schlink U. A rigorous small area modelling-study for the Helicobacter pylori epidemiology. Sci Total Environ 2010;408:3931-42. [PMID: 20444496 DOI: 10.1016/j.scitotenv.2010.03.045] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
573 Bernstein C, Bernstein H, Payne CM, Dvorak K, Garewal H. Field defects in progression to gastrointestinal tract cancers. Cancer Lett. 2008;260:1-10. [PMID: 18164807 DOI: 10.1016/j.canlet.2007.11.027] [Cited by in Crossref: 35] [Cited by in F6Publishing: 42] [Article Influence: 2.3] [Reference Citation Analysis]
574 Malvezzi M, Bonifazi M, Bertuccio P, Levi F, La Vecchia C, Decarli A, Negri E. An age-period-cohort analysis of gastric cancer mortality from 1950 to 2007 in Europe. Ann Epidemiol. 2010;20:898-905. [PMID: 21074104 DOI: 10.1016/j.annepidem.2010.08.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
575 Postlewait LM, Squires MH 3rd, Kooby DA, Poultsides GA, Weber SM, Bloomston M, Fields RC, Pawlik TM, Votanopoulos KI, Schmidt CR, Ejaz A, Acher AW, Worhunsky DJ, Saunders N, Swords D, Jin LX, Cho CS, Winslow ER, Cardona K, Staley CA, Maithel SK. The Prognostic Value of Signet-Ring Cell Histology in Resected Gastric Adenocarcinoma. Ann Surg Oncol 2015;22 Suppl 3:S832-9. [PMID: 26156656 DOI: 10.1245/s10434-015-4724-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
576 Wu SD, Su Y, Fan Y, Zhang ZH, Wang HL, Kong J, Tian Y. Relationship between intraduodenal peri-ampullary diverticulum and biliary disease in 178 patients undergoing ERCP. Hepatobiliary Pancreat Dis Int. 2007;6:299-302. [PMID: 17548255 DOI: 10.1111/j.1523-5378.2007.00502.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
577 Guo L, Wang X, Ma B, Yang K, Zhang Q, Ye X, Luo H, Liu R. Radiotherapy combined with surgical treatment for gastric cancer: a meta-analysis. Chin -Ger J Clin Oncol 2011;10:442-9. [DOI: 10.1007/s10330-011-0827-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
578 Jayavelu ND, Bar NS. Metabolomic studies of human gastric cancer: Review. World J Gastroenterol 2014; 20(25): 8092-8101 [PMID: 25009381 DOI: 10.3748/wjg.v20.i25.8092] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
579 Xiao H, Zhang Y, Kim Y, Kim S, Kim JJ, Kim KM, Yoshizawa J, Fan LY, Cao CX, Wong DT. Differential Proteomic Analysis of Human Saliva using Tandem Mass Tags Quantification for Gastric Cancer Detection. Sci Rep 2016;6:22165. [PMID: 26911362 DOI: 10.1038/srep22165] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 9.2] [Reference Citation Analysis]
580 Vita FD, Martino ND, Fabozzi A, Laterza MM, Ventriglia J, Savastano B, Petrillo A, Gambardella V, Sforza V, Marano L, Auricchio A, Galizia G, Ciardiello F, Orditura M. Clinical management of advanced gastric cancer: The role of new molecular drugs. World J Gastroenterol 2014; 20(40): 14537-14558 [PMID: 25356019 DOI: 10.3748/wjg.v20.i40.14537] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
581 Sjödahl K, Lagergren J. Epidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible? EPMA J 2010;1:461-71. [PMID: 23199088 DOI: 10.1007/s13167-010-0043-0] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
582 Fujita T, Chiwaki F, Takahashi RU, Aoyagi K, Yanagihara K, Nishimura T, Tamaoki M, Komatsu M, Komatsuzaki R, Matsusaki K, Ichikawa H, Sakamoto H, Yamada Y, Fukagawa T, Katai H, Konno H, Ochiya T, Yoshida T, Sasaki H. Identification and Characterization of CXCR4-Positive Gastric Cancer Stem Cells. PLoS One. 2015;10:e0130808. [PMID: 26110809 DOI: 10.1371/journal.pone.0130808] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
583 Lu J, Ma Y, Zhao Z. MiR-142 suppresses progression of gastric carcinoma via directly targeting LRP8. Clin Res Hepatol Gastroenterol 2021;45:101520. [PMID: 33268037 DOI: 10.1016/j.clinre.2020.08.001] [Reference Citation Analysis]
584 Kawamoto M, Onishi H, Koya N, Konomi H, Mitsugi K, Tanaka R, Motoshita J, Morisaki T, Nakamura M. Stage IV gastric cancer successfully treated by multidisciplinary therapy including chemotherapy, immunotherapy, and surgery: a case report. Surg Case Rep 2017;3:112. [PMID: 29063447 DOI: 10.1186/s40792-017-0380-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
585 da Costa AC, Santa-Cruz F, Mattos LAR, Rêgo Aquino MA, Martins CR, Bandeira Ferraz ÁA, Figueiredo JL. Cathepsin S as a target in gastric cancer. Mol Clin Oncol 2020;12:99-103. [PMID: 31929878 DOI: 10.3892/mco.2019.1958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
586 Shaibu Z, Chen Z, Mzee SAS, Theophilus A, Danbala IA. Effects of reconstruction techniques after proximal gastrectomy: a systematic review and meta-analysis. World J Surg Oncol 2020;18:171. [PMID: 32677956 DOI: 10.1186/s12957-020-01936-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
587 Shi S, Li D, Li Y, Feng Z, Du Y, Nie Y. LncRNA CR749391 acts as a tumor suppressor to upregulate KLF6 expression via interacting with miR-181a in gastric cancer. Exp Ther Med 2020;19:569-78. [PMID: 31853323 DOI: 10.3892/etm.2019.8226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
588 Lu J, Zheng CH, Xu BB, Xie JW, Wang JB, Lin JX, Chen QY, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Zheng HL, Huang CM, Li P. Assessment of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer: A Randomized Controlled Trial. Ann Surg 2021;273:858-67. [PMID: 32889876 DOI: 10.1097/SLA.0000000000004466] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
589 Meng X, Ni C, Shen Y, Hu X, Chen X, Li Z, Hu D. Differentiating malignant from benign gastric mucosal lesions with quantitative analysis in dual energy spectral computed tomography: Initial experience. Medicine (Baltimore) 2017;96:e5878. [PMID: 28079827 DOI: 10.1097/MD.0000000000005878] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
590 Vahid F, Rahmani G, Jafari Naeini A, Falahnejad H, Davoodi SH. The Association Between Index of Nutritional Quality (INQ) and Gastric Cancer and Evaluation of Nutrient Intakes of Gastric Cancer Patients: A Case-Control Study. Int J Cancer Manag 2018;11. [DOI: 10.5812/ijcm.9747] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
591 Zebrowska M, Salagacka A, Jelen A, Jesionek-Kupnicka D, Mirowski M, Balcerczak E. Is the ABCB1 gene associated with the increased risk of gastric cancer development?--preliminary research. Pathol Res Pract 2014;210:872-8. [PMID: 25236528 DOI: 10.1016/j.prp.2014.08.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
592 Cesana GC, Romano F, Piacentini G, Scotti M, Brenna A, Bovo G, Vaghi M, Aletti G, Caprotti R, Kaufman H. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis. Ann Surg Oncol. 2007;14:1295-1304. [PMID: 17225981 DOI: 10.1245/s10434-006-9239-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
593 Yang Y, Yin X, Sheng L, Xu S, Dong L, Liu L. Perioperative chemotherapy more of a benefit for overall survival than adjuvant chemotherapy for operable gastric cancer: an updated Meta-analysis. Sci Rep 2015;5:12850. [PMID: 26242393 DOI: 10.1038/srep12850] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
594 Patel JN, Fuchs CS, Owzar K, Chen Z, McLeod HL. Gastric cancer pharmacogenetics: progress or old tripe? Pharmacogenomics 2013;14:1053-64. [PMID: 23837480 DOI: 10.2217/pgs.13.88] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
595 Miles S, Piazuelo MB, Semino-Mora C, Washington MK, Dubois A, Peek RM Jr, Correa P, Merrell DS. Detailed in vivo analysis of the role of Helicobacter pylori Fur in colonization and disease. Infect Immun 2010;78:3073-82. [PMID: 20421381 DOI: 10.1128/IAI.00190-10] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
596 Hosokawa O, Miyanaga T, Kaizaki Y, Hattori M, Dohden K, Ohta K, Itou Y, Aoyagi H. Decreased death from gastric cancer by endoscopic screening: association with a population-based cancer registry. Scand J Gastroenterol. 2008;43:1112-1115. [PMID: 18609154 DOI: 10.1080/00365520802085395] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 5.4] [Reference Citation Analysis]
597 Spolverato G, Paro A, Capelli G, Dalmacy D, Poultsides GA, Fields RC, Weber SM, Votanopoulos KI, He J, Maithel SK, Pucciarelli S, Pawlik TM. Surgical treatment of gastric adenocarcinoma: Are we achieving textbook oncologic outcomes for our patients? J Surg Oncol 2021. [PMID: 34964983 DOI: 10.1002/jso.26778] [Reference Citation Analysis]
598 Song H, Peng JS, Dong-Sheng Y, Yang ZL, Liu HL, Zeng YK, Shi XP, Lu BY. Serum metabolic profiling of human gastric cancer based on gas chromatography/mass spectrometry. Braz J Med Biol Res. 2012;45:78-85. [PMID: 22124703 DOI: 10.1590/s0100-879x2011007500158] [Cited by in Crossref: 45] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
599 Dudeja V, Habermann EB, Abraham A, Zhong W, Parsons HM, Tseng JF, Al-Refaie WB. Is there a role for surgery with adequate nodal evaluation alone in gastric adenocarcinoma? J Gastrointest Surg. 2012;16:238-246; discussion 246-247. [PMID: 22089951 DOI: 10.1007/s11605-011-1756-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
600 Pereira C, Sousa H, Ferreira P, Fragoso M, Moreira-Dias L, Lopes C, Medeiros R, Dinis-Ribeiro M. -765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia. World J Gastroenterol 2006; 12(34): 5473-5478 [PMID: 17006983 DOI: 10.3748/wjg.v12.i34.5473] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
601 You Y, Liu L, Zhang M, Zhu Y, He L, Li D, Zhang J. Genomic characterization of a Helicobacter pylori isolate from a patient with gastric cancer in China. Gut Pathog 2014;6:5. [PMID: 24565107 DOI: 10.1186/1757-4749-6-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
602 Spolverato G, Ejaz A, Kim Y, Squires MH, Poultsides GA, Fields RC, Schmidt C, Weber SM, Votanopoulos K, Maithel SK. Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis. J Am Coll Surg. 2014;219:664-675. [PMID: 25154671 DOI: 10.1016/j.jamcollsurg.2014.03.062] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 9.5] [Reference Citation Analysis]
603 Azarkhazin F, Tehrani GA. Detecting promoter methylation pattern of apoptotic genes Apaf1 and Caspase8 in gastric carcinoma patients undergoing chemotherapy. J Gastrointest Oncol 2018;9:295-302. [PMID: 29755768 DOI: 10.21037/jgo.2017.12.05] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
604 Korivi BR, Faria S, Aly A, Sun J, Patnana M, Jensen CT, Wagner-Bartak N, Bhosale PR. Intestinal and diffuse gastric cancer: a retrospective study comparing primary sites. Clin Imaging 2019;56:33-40. [PMID: 30870726 DOI: 10.1016/j.clinimag.2019.03.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
605 Yoon H, Kim N, Lee HS, Shin CM, Park YS, Lee DH, Park DJ, Kim HH, Jung HC. Effect of endoscopic screening at 1-year intervals on the clinicopathologic characteristics and treatment of gastric cancer in South Korea. J Gastroenterol Hepatol 2012;27:928-34. [PMID: 22142434 DOI: 10.1111/j.1440-1746.2011.07038.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
606 Gong EJ, Ahn JY, Jung HY, Lim H, Choi KS, Lee JH, Kim DH, Choi KD, Song HJ, Lee GH. Risk factors and clinical outcomes of gastric cancer identified by screening endoscopy: a case-control study. J Gastroenterol Hepatol. 2014;29:301-309. [PMID: 24117845 DOI: 10.1111/jgh.12387] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
607 Huerta JM, Chirlaque MD, Molina AJ, Amiano P, Martín V, Fernández-Villa T, Pérez-Gómez B, Moreno V, Burgui R, Gómez-Acebo I, Ramos-Lora M, Fernández-Tardón G, Peiró R, Olmedo-Requena R, Pollán M, Kogevinas M, Castaño-Vinyals G, Aragonés N; Navarro. Physical activity domains and risk of gastric adenocarcinoma in the MCC-Spain case-control study. PLoS One 2017;12:e0179731. [PMID: 28683070 DOI: 10.1371/journal.pone.0179731] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
608 Ruan J, Ji J, Song H, Qian Q, Wang K, Wang C, Cui D. Fluorescent magnetic nanoparticle-labeled mesenchymal stem cells for targeted imaging and hyperthermia therapy of in vivo gastric cancer. Nanoscale Res Lett. 2012;7:309. [PMID: 22709686 DOI: 10.1186/1556-276x-7-309] [Cited by in Crossref: 49] [Cited by in F6Publishing: 24] [Article Influence: 4.9] [Reference Citation Analysis]
609 Li C, Tian Y, Liang Y, Li Q. Circ_0008035 contributes to cell proliferation and inhibits apoptosis and ferroptosis in gastric cancer via miR-599/EIF4A1 axis. Cancer Cell Int 2020;20:84. [PMID: 32190008 DOI: 10.1186/s12935-020-01168-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
610 Cavaleiro-Pinto M, Peleteiro B, Lunet N, Barros H. Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis. Cancer Causes Control. 2011;22:375-387. [PMID: 21184266 DOI: 10.1007/s10552-010-9707-2] [Cited by in Crossref: 95] [Cited by in F6Publishing: 93] [Article Influence: 7.9] [Reference Citation Analysis]
611 Cao D, Chu L, Xu Z, Gong J, Deng R, Wang B, Zhou S. Visfatin facilitates gastric cancer malignancy by targeting snai1 via the NF-κB signaling. Hum Exp Toxicol 2021;:9603271211006168. [PMID: 33823623 DOI: 10.1177/09603271211006168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
612 Shin D, Park SS. Clinical importance and surgical decision-making regarding proximal resection margin for gastric cancer. World J Gastrointest Oncol 2013; 5(1): 4-11 [PMID: 23738049 DOI: 10.4251/wjgo.v5.i1.4] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
613 Jiang J, Dong L, Qin B, Shi H, Guo X, Wang Y. Decreased expression of TLR7 in gastric cancer tissues and the effects of TLR7 activation on gastric cancer cells. Oncol Lett 2016;12:631-6. [PMID: 27347192 DOI: 10.3892/ol.2016.4617] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
614 Hoppo T, Jobe BA. Endoscopy and role of endoscopic resection in gastric cancer. J Surg Oncol. 2013;107:243-249. [PMID: 22532029 DOI: 10.1002/jso.23126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
615 Kim JG, Kim TO, Bae JH, Shim JW, Kang MJ, Yang K, Ting AH, Yi JM. Epigenetically regulated MIR941 and MIR1247 target gastric cancer cell growth and migration. Epigenetics. 2014;9:1018-1030. [PMID: 24785261 DOI: 10.4161/epi.29007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
616 Cheng XJ, Lin JC, Tu SP. Etiology and Prevention of Gastric Cancer. Gastrointest Tumors 2016;3:25-36. [PMID: 27722154 DOI: 10.1159/000443995] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 9.3] [Reference Citation Analysis]
617 Resende C, Ristimäki A, Machado JC. Genetic and epigenetic alteration in gastric carcinogenesis. Helicobacter. 2010;15 Suppl 1:34-39. [PMID: 21054651 DOI: 10.1111/j.1523-5378.2010.00782.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
618 Li Z, Gao H, Liu Y, Wu H, Li W, Xing Y, Zhang Z, Zhang X. Genetic variants in the regulation region of TLR4 reduce the gastric cancer susceptibility. Gene 2021;767:145181. [PMID: 33007372 DOI: 10.1016/j.gene.2020.145181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
619 Sherman KL, Merkow RP, Bilimoria KY, Wang CE, Mulcahy MF, Benson AB, Bentrem DJ. Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States. Ann Surg Oncol 2013;20:362-70. [PMID: 22890592 DOI: 10.1245/s10434-012-2552-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
620 Zhang Y, Chen L, Cao Y, Chen S, Xu C, Xing J, Zhang K. LETM1 Promotes Gastric Cancer Cell Proliferation, Migration, and Invasion via the PI3K/Akt Signaling Pathway. J Gastric Cancer 2020;20:139-51. [PMID: 32595998 DOI: 10.5230/jgc.2020.20.e12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
621 Sanchez FA. Best Practices and Practical Nuances in the Treatment of Gastric Cancer in High-Risk Global Areas. Am Soc Clin Oncol Educ Book 2017;37:258-60. [PMID: 28561673 DOI: 10.1200/EDBK_175226] [Reference Citation Analysis]
622 Mansour-Ghanaei F, Joukar F, Baghaee M, Sepehrimanesh M, Hojati A. Only serum pepsinogen I and pepsinogen I/II ratio are specific and sensitive biomarkers for screening of gastric cancer. Biomol Concepts 2019;10:82-90. [PMID: 31188744 DOI: 10.1515/bmc-2019-0010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
623 Wang X, Shen Y, Zhu H, Zhao Y, Li Z, Qiu M, Li Q, Gou H, Yang Y, Cao D, Liu J, Yi C, Liao Z, Luo D, Bi F, Xu F. A phase II trial of concurrent 3D-CRT/IMRT and oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) in gastric cancer patients with R0 gastrectomy and D2 lymph node dissection. Gastric Cancer 2016;19:245-54. [PMID: 25609451 DOI: 10.1007/s10120-015-0461-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
624 Park CH, Kim B, Chung H, Lee H, Park JC, Shin SK, Lee SK, Lee YC. Endoscopic Quality Indicators for Esophagogastroduodenoscopy in Gastric Cancer Screening. Dig Dis Sci 2015;60:38-46. [DOI: 10.1007/s10620-014-3288-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
625 Baj J, Brzozowska K, Forma A, Maani A, Sitarz E, Portincasa P. Immunological Aspects of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Gastric Carcinogenesis. Int J Mol Sci 2020;21:E2544. [PMID: 32268527 DOI: 10.3390/ijms21072544] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
626 Arnold M, Moore SP, Hassler S, Ellison-Loschmann L, Forman D, Bray F. The burden of stomach cancer in indigenous populations: a systematic review and global assessment. Gut. 2014;63:64-71. [PMID: 24153248 DOI: 10.1136/gutjnl-2013-305033] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 7.3] [Reference Citation Analysis]
627 Chen H, Xie GH, Wang WW, Yuan XL, Xing WM, Liu HJ, Chen J, Dou M, Shen LS. Epigenetically downregulated Semaphorin 3E contributes to gastric cancer. Oncotarget 2015;6:20449-65. [PMID: 26036259 DOI: 10.18632/oncotarget.3936] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
628 Yang XM. SiRNA-mediated silencing of fibroblast growth factor receptor improves chemotherapy effect in a xenograft mouse model of gastric cancer. Shijie Huaren Xiaohua Zazhi 2014; 22(19): 2728-2733 [DOI: 10.11569/wcjd.v22.i19.2728] [Reference Citation Analysis]
629 Martínez-Galindo MG, Zamarripa-Dorsey F, Carmona-Castañeda A, Angeles-Labra A, Peñavera-Hernández R, Ugarte-Briones C, Blanco-Vela CI. Histopathologic characteristics of gastric adenocarcinoma in Mexican patients: a 10-year experience at the Hospital Juárez of Mexico. Rev Gastroenterol Mex 2015;80:21-6. [PMID: 25747884 DOI: 10.1016/j.rgmx.2014.11.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
630 Zhang L, Zhang Y, Wang L, Wang J, Liu Y. Diagnosis of gastric lesions through a deep convolutional neural network. Dig Endosc. 2020;. [PMID: 32961597 DOI: 10.1111/den.13844] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
631 Pierini R, Gee JM, Belshaw NJ, Johnson IT. Flavonoids and intestinal cancers. Br J Nutr 2008;99 E Suppl 1:ES53-9. [PMID: 18503735 DOI: 10.1017/S0007114508965764] [Cited by in Crossref: 40] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
632 Wang MY, Yue JY, Zhang YX, Liu XD, Gao XZ. Helicobacter pylori infection in asymptomatic HBV carriers, alcohol users and normal adult population in Shandong Province, China. Clin Res Hepatol Gastroenterol 2011;35:560-2. [PMID: 21680277 DOI: 10.1016/j.clinre.2010.12.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
633 Retana A, Silverstein T, Wassef W. An update in endoscopic management of gastric cancer. Curr Opin Gastroenterol. 2011;27:576-582. [PMID: 21946028 DOI: 10.1097/MOG.0b013e32834b9e5e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
634 Ebrahimi V, Soleimanian A, Ebrahimi T, Azargun R, Yazdani P, Eyvazi S, Tarhriz V. Epigenetic modifications in gastric cancer: Focus on DNA methylation. Gene 2020;742:144577. [DOI: 10.1016/j.gene.2020.144577] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
635 Johnson IT, Belshaw NJ. Environment, diet and CpG island methylation: epigenetic signals in gastrointestinal neoplasia. Food Chem Toxicol 2008;46:1346-59. [PMID: 17976883 DOI: 10.1016/j.fct.2007.09.101] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
636 Dong J, Dai J, Zhang M, Hu Z, Shen H. Potentially functional COX-2 −1195G>A polymorphism increases the risk of digestive system cancers: A meta-analysis: Cox-2 polymorphism and digestive system cancers. Journal of Gastroenterology and Hepatology 2010;25:1042-50. [DOI: 10.1111/j.1440-1746.2010.06293.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
637 Menges M, Hoehler T. Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction. J Cancer Res Clin Oncol 2009;135:29-38. [PMID: 18523800 DOI: 10.1007/s00432-008-0425-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
638 Yue Z, Song Y, Wang Z, Luo Y, Jiang L, Xing L, Xu H, Zhang X. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer. J Surg Oncol 2010;102:68-72. [PMID: 20578081 DOI: 10.1002/jso.21584] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
639 Kim DK, Oh SY, Kwon HC, Lee S, Kwon KA, Kim BG, Kim SG, Kim SH, Jang JS, Kim MC. Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer. 2009;9:155. [PMID: 19457231 DOI: 10.1186/1471-2407-9-155] [Cited by in Crossref: 118] [Cited by in F6Publishing: 110] [Article Influence: 9.1] [Reference Citation Analysis]
640 Chang WW, Zhang L, Su H, Yao YS. An updated meta-analysis of transforming growth factor-β1 gene: three polymorphisms with gastric cancer. Tumour Biol 2014;35:2837-44. [PMID: 24254308 DOI: 10.1007/s13277-013-1408-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
641 Borràs J, Gispert R, Domènech J, Clèries R. Análisis de la incidencia, la supervivencia y la mortalidad según las principales localizaciones tumorales, 1985-2019: cáncer de estómago. Medicina Clínica 2008;131:78-82. [DOI: 10.1016/s0025-7753(08)76439-x] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
642 Bhattacharya S, Mukherjee O, Mukhopadhyay AK, Chowdhury R, Pal AK, Dhar KK. A Conserved Helicobacter pylori Gene, HP0102, Is Induced Upon Contact With Gastric Cells and Has Multiple Roles in Pathogenicity. J Infect Dis 2016;214:196-204. [PMID: 27056952 DOI: 10.1093/infdis/jiw139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
643 Liang Ong SC, Batumaly SK, Jusoh SM. Portal vein tumor thrombus from gastric cancer. J Ultrason 2018;18:365-8. [PMID: 30763024 DOI: 10.15557/JoU.2018.0054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
644 Bowden MB, Walsh NJ, Jones AJ, Talukder AM, Lawson AG, Kruse EJ. Demographic and clinical factors associated with suicide in gastric cancer in the United States. J Gastrointest Oncol 2017;8:897-901. [PMID: 29184695 DOI: 10.21037/jgo.2017.08.02] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
645 Rao X, Liu X, Liu N, Zhang Y, Zhang Z, Zhou L, Han G, Cen R, Shi N, Zhu H, Gong H, Huang C, Ji Q, Li Q. Long noncoding RNA NEAT1 promotes tumorigenesis in H. pylori gastric cancer by sponging miR-30a to regulate COX-2/BCL9 pathway. Helicobacter 2021;:e12847. [PMID: 34396632 DOI: 10.1111/hel.12847] [Reference Citation Analysis]
646 Tong JH, Sun Z, Zhu Z, Wang ZN, Xu YY, Huang BJ, Xu Y, Xu HM. Prognostic significance of lymph node station 7 for patients with gastric cancers underwent radical surgery. J Surg Oncol 2012;105:805-12. [PMID: 22212911 DOI: 10.1002/jso.23011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
647 Galván-Portillo MV, Cantoral A, Oñate-Ocaña LF, Chen J, Herrera-Goepfert R, Torres-Sanchez L, Hernandez-Ramirez RU, Palma-Coca O, López-Carrillo L. Gastric cancer in relation to the intake of nutrients involved in one-carbon metabolism among MTHFR 677 TT carriers. Eur J Nutr 2009;48:269-76. [PMID: 19288150 DOI: 10.1007/s00394-009-0010-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
648 Chen S, Li J, Liu H, Zeng J, Yang G, Wang J, Lu W, Yu N, Huang Z, Xu H, Zeng X. Esophagogastrostomy plus gastrojejunostomy: a novel reconstruction procedure after curative resection for proximal gastric cancer. J Gastrointest Surg. 2014;18:497-504. [PMID: 24163139 DOI: 10.1007/s11605-013-2391-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
649 Peng Q, Chen Z, Lu Y, Lao X, Mo C, Li R, Qin X, Li S. Current evidences on XPC polymorphisms and gastric cancer susceptibility: a meta-analysis. Diagn Pathol. 2014;9:96. [PMID: 24886180 DOI: 10.1186/1746-1596-9-96] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
650 Almeida PR, Ferreira FV, Santos CC, Rocha-Filho FD, Feitosa RR, Falcão EA, Cavada BK, Lima-Júnior RC, Ribeiro RA. Immunoexpression of cyclooxygenase-2 in primary gastric carcinomas and lymph node metastases. World J Gastroenterol 2012; 18(8): 778-784 [PMID: 22371637 DOI: 10.3748/wjg.v18.i8.778] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
651 Lucenteforte E, Scita V, Bosetti C, Bertuccio P, Negri E, La Vecchia C. Food groups and alcoholic beverages and the risk of stomach cancer: a case-control study in Italy. Nutr Cancer. 2008;60:577-584. [PMID: 18791920 DOI: 10.1080/01635580802054512] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
652 Robinson K, Atherton JC. Helicobacter pylori. In: Fratamico PM, Smith JL, Brogden KA, editors. Sequelae and Long-Term Consequences of Infectious Diseases. Washington: ASM Press; 2009. pp. 107-33. [DOI: 10.1128/9781555815486.ch7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
653 Wu C, Xie Y, Gao F, Wang Y, Guo Y, Tian H, Li Y, Fan W. Lgr5 expression as stem cell marker in human gastric gland and its relatedness with other putative cancer stem cell markers. Gene 2013;525:18-25. [DOI: 10.1016/j.gene.2013.04.067] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
654 Baize N, Abakar-Mahamat A, Mounier N, Berthier F, Caroli-Bosc FX. Phase II study of paclitaxel combined with capecitabine as second-line treatment for advanced gastric carcinoma after failure of cisplatin-based regimens. Cancer Chemother Pharmacol. 2009;64:549-555. [PMID: 19123051 DOI: 10.1007/s00280-008-0903-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
655 Capovilla G, Froiio C, Lang H, Berlth F, Grimminger PP. [Complete response after neoadjuvant therapy for gastric cancer: implications for surgery]. Chirurg 2021. [PMID: 34622304 DOI: 10.1007/s00104-021-01516-4] [Reference Citation Analysis]
656 Jiang X, Hiki N, Nunobe S, Kumagai K, Kubota T, Aikou S, Sano T, Yamaguchi T. Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer. 2012;107:275-279. [PMID: 22713657 DOI: 10.1038/bjc.2012.262] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 7.8] [Reference Citation Analysis]
657 Zhang Z, Guo Y, Zhang L, Zhang J, Wei X. Chelerythrine chloride from Macleaya cordata induces growth inhibition and apoptosis in human gastric cancer BGC-823 cells. Acta Pharmaceutica Sinica B 2012;2:464-71. [DOI: 10.1016/j.apsb.2011.12.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
658 Corso S, Giordano S. How Can Gastric Cancer Molecular Profiling Guide Future Therapies? Trends Mol Med. 2016;22:534-544. [PMID: 27260398 DOI: 10.1016/j.molmed.2016.05.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 7.2] [Reference Citation Analysis]
659 Bilici A, Selcukbiricik F. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy. Tumour Biol. 2015;36:6191-6199. [PMID: 25761877 DOI: 10.1007/s13277-015-3304-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
660 Díaz de Liaño A, Yárnoz C, Artieda C, Aguilar R, Viana S, Artajona A, Ortiz H. Results of R0 surgery with D2 lymphadenectomy for the treatment of localised gastric cancer. Clin Transl Oncol 2009;11:178-82. [PMID: 19293056 DOI: 10.1007/s12094-009-0335-9] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
661 Xing YN, Xu XY, Nie XC, Yang X, Yu M, Xu HM, Liu YP, Takano Y, Zheng HC. Role and clinicopathologic significance of CXC chemokine ligand 16 and chemokine (C-X-C motif) receptor 6 expression in gastric carcinomas. Hum Pathol. 2012;43:2299-2307. [PMID: 22863086 DOI: 10.1016/j.humpath.2011.08.027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
662 Zhang L, Huang H, Wu K, Wang M, Wu B. Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro. Mol Biol Rep 2010;37:2579-86. [PMID: 19728149 DOI: 10.1007/s11033-009-9777-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
663 Wu JM, Ho TW, Chang YT, Hsu C, Tsai CJ, Lai F, Lin MT. Wearable-Based Mobile Health App in Gastric Cancer Patients for Postoperative Physical Activity Monitoring: Focus Group Study. JMIR Mhealth Uhealth 2019;7:e11989. [PMID: 31012858 DOI: 10.2196/11989] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
664 Poonyam P, Aumpan N, Vilaichone RK. Prognostic factors for survival in patients with gastric adenocarcinoma. Cancer Rep (Hoboken) 2021;4:e1305. [PMID: 33074592 DOI: 10.1002/cnr2.1305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
665 Lima EM, Lopes OS, Soares LF, Arruda TD, Gigek CO, Melo CGF, Smith MAC, Oliveira JRG, Medeiros A, Delatorre P, Burbano RR. Dideoxy single allele-specific PCR - DSASP new method to discrimination allelic. Braz arch biol technol 2015;58:414-20. [DOI: 10.1590/s1516-8913201500434] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
666 Zhang L, Ding Y, Yuan Z, Liu J, Sun J, Lei F, Wu S, Li S, Zhang D. MicroRNA-500 sustains nuclear factor-κB activation and induces gastric cancer cell proliferation and resistance to apoptosis. Oncotarget 2015;6:2483-95. [PMID: 25595906 DOI: 10.18632/oncotarget.2800] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
667 Li AL, Song YX, Wang ZN, Gao P, Miao Y, Zhu JL, Yue ZY, Xu HM. Polymorphisms and a haplotype in heparanase gene associations with the progression and prognosis of gastric cancer in a northern Chinese population. PLoS One 2012;7:e30277. [PMID: 22276173 DOI: 10.1371/journal.pone.0030277] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
668 Dammann K, Khare V, Gasche C. Republished: tracing PAKs from GI inflammation to cancer. Postgrad Med J 2014;90:657-68. [PMID: 25335797 DOI: 10.1136/postgradmedj-2014-306768rep] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
669 Fattahi S, Nikbakhsh N, Taheri H, Ghadami E, Kosari-monfared M, Amirbozorgi G, Asouri M, Pilehchian-langroudi M, Ranaee M, Samadani AA, Paryan M, Akhavan-niaki H. Prevalence of multiple infections and the risk of gastric adenocarcinoma development at earlier age. Diagnostic Microbiology and Infectious Disease 2018;92:62-8. [DOI: 10.1016/j.diagmicrobio.2018.04.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
670 Bai F, Jiu M, You Y, Feng Y, Xin R, Liu X, Mo L, Nie Y. miR‑29a‑3p represses proliferation and metastasis of gastric cancer cells via attenuating HAS3 levels. Mol Med Rep 2018;17:8145-52. [PMID: 29693123 DOI: 10.3892/mmr.2018.8896] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
671 Ferrari F, Reis MAM. Study of risk factors for gastric cancer by populational databases analysis. World J Gastroenterol 2013; 19(48): 9383-9391 [PMID: 24409066 DOI: 10.3748/wjg.v19.i48.9383] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
672 Da W, Zhu J, Wang L, Sun Q. Curcumin suppresses lymphatic vessel density in an in vivo human gastric cancer model. Tumor Biol 2015;36:5215-23. [DOI: 10.1007/s13277-015-3178-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
673 Hong S, Li Q, Yang Y, Jing D, Zhu F. Silencing of Long Non-coding RNA LINC01106 Represses Malignant Behaviors of Gastric Cancer Cells by Targeting miR-34a-5p/MYCN Axis. Mol Biotechnol 2021. [PMID: 34550549 DOI: 10.1007/s12033-021-00402-y] [Reference Citation Analysis]
674 Kang KJ, Lee JH. Characteristics of Gastric Cancer in Korea - with an Emphasis on the Increase of the Early Gastric Cancer (EGC). J Korean Med Assoc 2010;53:283. [DOI: 10.5124/jkma.2010.53.4.283] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
675 Gu D, Wang M, Wang S, Zhang Z, Chen J. The DNA repair gene APE1 T1349G polymorphism and risk of gastric cancer in a Chinese population. PLoS One. 2011;6:e28971. [PMID: 22205985 DOI: 10.1371/journal.pone.0028971] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
676 Ruan J, Song H, Qian Q, Li C, Wang K, Bao C, Cui D. HER2 monoclonal antibody conjugated RNase-A-associated CdTe quantum dots for targeted imaging and therapy of gastric cancer. Biomaterials 2012;33:7093-102. [PMID: 22796163 DOI: 10.1016/j.biomaterials.2012.06.053] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
677 Xiong B, Cheng Y, Ma L, Zhang C. An Updated Meta-Analysis of Randomized Controlled Trial Assessing the Effect of Neoadjuvant Chemotherapy in Advanced Gastric Cancer. Cancer Investigation 2014;32:272-84. [DOI: 10.3109/07357907.2014.911877] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
678 Cong H, Yao RY, Sun ZQ, Qiu WS, Yao YS, Feng TT, Xin C, Liang J, Yue LU. DNA hypermethylation of the vimentin gene inversely correlates with vimentin expression in intestinal- and diffuse-type gastric cancer. Oncol Lett 2016;11:842-8. [PMID: 26870294 DOI: 10.3892/ol.2015.3937] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
679 Zhang Q, Wang F, Chen ZY, Wang Z, Zhi FC, Liu SD, Bai Y. Comparison of the diagnostic efficacy of white light endoscopy and magnifying endoscopy with narrow band imaging for early gastric cancer: a meta-analysis. Gastric Cancer. 2016;19:543-552. [PMID: 25920526 DOI: 10.1007/s10120-015-0500-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
680 Zheng J, Zhao M, Li J, Lou G, Yuan Y, Bu S, Xi Y. Obesity-associated digestive cancers: A review of mechanisms and interventions. Tumour Biol 2017;39:1010428317695020. [PMID: 28351315 DOI: 10.1177/1010428317695020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]